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Abstract 
 
Two-component systems (TCSs) are a primary means of responding to 
environmental cues across the bacterial domain, and usually act independently 
of one another, forming discrete, isolated units. Multikinase networks (MKNs) are 
systems of multiple TCSs which can interact to integrate numerous signals into a 
decided cellular output, conferring an advantage to the cell. This work focuses on 
a novel MKN from the opportunistic pathogen, Burkholderia cenocepacia. 
Through purification of each putative TCS, their ability to undergo non-cognate 
phosphorylation with one another was assessed in vitro through the 
phosphotransfer assay. This revealed that three sensor kinases, BCAM0442, 
BCAM0715 and BCAS0585 are able to phosphorylate one another’s response 
regulators. This non-cognate phosphotransfer was also possible, albeit to a 
lesser extent, in the presence of the cognate response regulator protein. 
Deletion mutants of each TCS and investigation of TCS promoter induction 
revealed that BCAM0442/3 is implicated in copper resistance, and BCAM0714/5 
is implicated in cadmium and zinc resistance. Exposure of B. cenocepacia to 
copper or zinc enhances resistance to imipenem, a phenomenon in which this 
MKN is implicated. A MKN deletion mutant is heavily attenuated in virulence in 
Galleria mellonella, linking the metal response with virulence in B. cenocepacia. 
Additionally, exploration of the copper response by RNA-seq analysis revealed 
substantial upregulation of the genes surrounding BCAM0442/3. A CopABCDE-
like system was strongly upregulated in a BCAM0442/3-dependent manner, 
suggesting that BCAM0442/3 directly regulates this system. 
Previous work identified that BCAM0714/5 regulates a downstream gene region, 
BCAM0716-21, deletion of which confers susceptibility to zinc in B. cenocepacia. 
Complementation with the BCAM0716/17 gene region restored resistance to 
zinc, implicating these genes in the zinc response of B. cenocepacia. 
Given the environmental impact of heavy metal pollution and the use of metals 
as both an antibacterial strategy by the immune system and in medical devices, 
understanding the mechanisms of bacterial metal resistance is vital. This work 
has identified a novel metal-sensing MKN in B. cenocepacia, linking the 
cadmium, zinc and copper responses with virulence and carbapenem resistance. 
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1.1 – An introduction to the Burkholderia cepacia complex 
 
1.1.1 – Burkholderia and the Burkholderia cepacia complex 
 
The first Burkholderia species was described in 1950 as the cause of skin rot on 
onions bulbs, and hence given the name Pseudomonas cepacia 1. This species, 
and six others, were transferred to the new Burkholderia genus in 1992, when 
analysis of 16S rRNA sequences justified their reclassification 2. Belonging to the 
class β-proteobacteria, the genus has grown in the following decades to 
approximately 100 species, with members occupying a wide range of 
environmental niches and acting as significant mammalian pathogens 3,4. 
Recent phylogenetic analyses have identified two distinct clades within the 
Burkholderia genus, with a smaller clade containing groups of clinical relevance 
that are able to cause a range of disease in both humans and animals, and a 
larger clade composed of largely environmental species, with conserved 
sequence indels having been identified for both clades (Fig 1.1) 5–7. 
Consequently, it was proposed to transfer the larger clade into the new genus 
Paraburkholderia, leaving the smaller clade, containing mainly human, animal 
and plant pathogens, within Burkholderia 6,7. Since this reclassification, another 
novel genus has been proposed to accommodate a distinct clade in this ever-
growing phylogenetic tree, named Caballeronia 8. 
As a result of the reclassification of Burkholderia, the genus’ current members 
are generally considered to be either human, animal or plant pathogens. 
Burkholderia can be split into three groups, the largest of which is the 
Burkholderia cepacia complex (BCC), which is comprised of approximately 20 
different species. The BCC is a highly diverse complex sitting within a highly 
diverse genus, with members found throughout various natural environments and 
are also able to act as opportunistic pathogens to the immunocompromised 9. 
The Burkholderia pseudomallei group consists of 4 species, B. pseudomallei, 
Burkholderia mallei, Burkholderia thailandensis and Burkholderia oklahomensis. 
B. pseudomallei and B. mallei are the causative agents of melioidosis and equine 
glanders respectively, with B. pseudomallei being considered as a potential 
bioterror threat in the United States 10. The final subclade consists of 
19 
 
phytopathogens, such as Burkholderia glumae, Burkholderia gladioli and 
Burkholderia plantarii. 
 
Figure 1.1: Maximum likelihood phylogenetic tree of genome-sequenced 
Burkholderia species based on sequences of 21 conserved proteins. Clade 
I is split into the BCC, the B. pseudomallei group and the phytopathogens, while 
Clade II is also described as the Paraburkholderia genus. Image taken from 
Sawana et al (2014).  
Upon its formation in 1992, the Burkholderia genus contained 7 species, of which 
Burkholderia cepacia was the type species. However, isolates identified as B. 
cepacia were relatively heterogeneous, giving remarkably varied results in a 
range of biochemical and phenotypic identification tests 11–13. A polyphasic 
Figure 1 
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taxonomy study by Vandamme and colleagues (1997) looked at B. cepacia 
isolates from human samples and the environment, which ultimately resulted in 
the splitting of B. cepacia into five genomovars (I-V), collectively known as the 
BCC 14. The decades since have seen the identification of several novel BCC 
species, and the complex currently contains at least 24 different Burkholderia 
species 7,9,15,16.  
Unsurprisingly, the BCC are very closely related genetically, with levels of DNA-
DNA hybridisation of 30 to 50 % (whereas levels between other Burkholderia 
species are below 30 %), and high sequence similarity in their recA (94 to 95 %) 
and 16S rRNA (98 to 99 %) genes 17–19. Differentiating between these species is 
vital for accurate clinical diagnostics, however due to their phenotypic similarities 
in standard laboratory testing and sequence similarity in 16S and 23S rRNA 
genes, differentiating between BCC species is troublesome. Sequencing of the 
recA or hisA genes appear to be superior tools for identification of BCC species 
than other commonly used methodologies, though not always possible in less 
well-equipped laboratories 19,20.   
Despite these phylogenetic similarities, the BCC are able to occupy a broad range 
of environmental niches, perhaps in part due to their large, multireplicon 
genomes, which may also contribute to their high levels of intrinsic antimicrobial 
resistance to aminoglycosides, polymyxins and many β-lactam antibiotics 21–24. 
BCC species have been identified as both promoting plant growth and acting as 
phytopathogens, located in a variety of natural environments and as opportunistic 
pathogens to both humans and animals. 
 
1.1.2 – The BCC in the natural environment 
 
BCC species have been detected in several soil ecosystems, and are considered 
to form mutualistic relationships with plants, as well as act as phytopathogens in 
different situations. BCC species are reportedly commonly found in soils; 82 % of 
urban soil sites tested in 3 US cities reported positive for BCC via polymerase 
chain reaction (PCR)-based assays 25. The BCC are particularly known for 
associating with the soil surrounding plant roots, known as the rhizosphere, of 
several crops across the globe, such as maize, rice, pea, cotton, tomato and 
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onion 26–31. Additionally, some BCC species have been identified residing within 
plants, indicating the addition of some endophytic activity to their interactions with 
plants 32. Abundance of Burkholderia species in rhizosphere soil was found to be 
over 100-fold greater than in non-rhizosphere soil, highlighting the specific 
interaction between Burkholderia and plant roots 26.  
The BCC can act as phytopathogens, causing various rots against onion, banana 
and apricot 1,33,34. Conversely, certain BCC species, such as Burkholderia 
vietnamiensis and Burkholderia ambifaria, are known promoters of plant growth, 
with studies demonstrating their ability to improve crop yield and protect plants 
from fungal infections 35–37. Specifically, they are capable of the production of 
antibacterial and antifungal agents, the fixation of nitrogen and the lowering of 
ethylene levels in plants 37–41. These properties, coupled with certain species’ 
ability to degrade a range of toxic chemicals, have inclined discussions 
surrounding the use of the BCC as potential biocontrol or bioremediation agents 
42,43. However, concerns about the potential pathogenicity of environmental BCC 
strains, as well as the banning of the use of the BCC as biocontrol agents by the 
United States Environmental Protection Agency in 2004 has restricted discussion 
on this topic 29. 
While BCC species are known to be found in terrestrial environments across the 
world, there is comparatively little information in the literature regarding their 
abundance in freshwater or marine environments. A handful of studies have 
reported the presence of BCC species in rivers and coastal waters both in Europe 
and the United States, and also in Mussel samples off the Croatian coast 44–48. 
Despite these reports, the information surrounding BCC abundance in aquatic 
environments is limited, and it may be presumed that these areas do not harbour 
the same large BCC presence that many terrestrial environments have. 
 
1.1.3 – The BCC and cystic fibrosis 
 
As an opportunistic pathogen, the BCC is able to infect the immunocompromised, 
such as cystic fibrosis (CF) patients, but rarely affects healthy individuals. CF 
affects approximately 1 in every 3500 births in Caucasian populations, and is the 
most common autosomal recessive condition in Europe 49–51. CF is characterised 
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by mutations in the cystic fibrosis transmembrane conductance regulator (CFTR), 
a chloride channel that is expressed in various epithelia throughout the body, 
such as in the lungs, intestine, kidney and pancreas, as well as in neuronal cells, 
though the respiratory system is the most affected 52. The majority of patients with 
CF will suffer from severe chronic lung disease, often with extremely variable 
chronic infection statuses. Due to improvements in clinical care and availability of 
targeted medications, life expectancy is improving; median predicted survival age 
is now 47 in the UK 53. There are potentially thousands of different CFTR 
mutations that may lead to CF, though empirical evidence linking mutations 
directly to CF exists for only a fraction of this number 54. The ∆F508 mutation 
dominates in CF populations, affecting approximately 90 % with CF in the UK and 
USA 53,55.  
The decline or absence of function of the CFTR gene leads to ineffective chloride 
secretion from the lung epithelia into the airway, thus depleting overall water 
content of the surface (periciliary) liquid by increased reuptake of water from the 
airway into epithelial cells 56. This renders airway mucus thick and difficult to clear, 
leading to airway obstruction, trapping of microbes and eventual bronchiectasis 
and inflammation, a debilitating cycle that leads to the damaging of lung tissue 
and significantly impaired respiratory function. 
CF patients usually suffer from various chronic pulmonary infections from 
bacteria, fungi and viruses throughout their lives, leading to a decline in lung 
function and ultimately respiratory failure, which serves as the primary cause of 
mortality in these patients 57,58. As such, it is imperative that these chronic 
respiratory infections are closely managed and understood. Culture-independent 
methods have shed light on the sheer microbial diversity of the CF lung, with each 
patient having a unique bacterial profile when samples were examined using 
sequencing technologies 58–60. The most common respiratory pathogens found in 
children with CF are Staphylococcus aureus and Haemophilus influenzae, while 
in adults Pseudomonas aeruginosa tends to dominate, being cultured from at 
least 44 % of adult CF patients in the UK and USA 53,55. 
The BCC is comparatively less common in the CF lung, having been cultured 
from 1.4 % of child and 5.1 % of adult patients in the UK in 2017 53. Frequency is 
even lower in the USA, where only 2.4 % of CF patients were reported to have 
BCC infection 55. Despite its relatively low prevalence, the BCC is especially 
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feared among the CF community due to the unpredictable nature of the infection. 
Many patients may be asymptomatically chronically infected with the BCC for 
years, however some will suffer from cepacia syndrome, a combination of 
bacteraemia and necrotising pneumonia, leading to an ultimately fatal decline in 
respiratory function 61,62. Cepacia syndrome can occur both acutely after 
colonisation or after many years of chronic infection, the exact pathophysiology 
of which is poorly understood 63–65. BCC species are also known to grow 
anaerobically in the CF lung, which contains pockets of low/no oxygen due to the 
presence of characteristically thick and viscous mucus 66,67. 
In addition to cepacia syndrome, the high levels of transmissibility between 
patients and intrinsic antimicrobial resistance of the BCC renders infection with 
the complex a particular cause for concern for the CF community. Transmission 
of the BCC and other bacteria can occur between patients in close proximity 
(such as via direct contact or infectious droplets); as such CF patients are 
recommended to not meet one another if possible. An example of the threat close 
contact between CF patients can cause are the reports of significant cross-
infection with bacteria such as the BCC and P. aeruginosa following summer 
camps that were run for those with CF around the turn of the millennium 68–72. 
Infection with BCC is also a contraindication for lung transplantation, a lifesaving 
avenue that can bring great improvements in quality of life; patients infected with 
BCC prior to transplantation reportedly suffered significantly worse outcomes 
than those without, with Burkholderia cenocepacia having the greatest impact on 
post-transplant survival of the BCC species 73–80. One retrospective study of CF 
patients between 1988 and 2012 concluded that median post-transplant survival 
for patients infected with BCC was 3.3 years, as opposed to 12.4 years for 
patients not infected with BCC 77. 
Due to the particular risk of BCC infection, segregation policies were introduced 
in many CF centres separating patients based on BCC-infection status, which 
has aided in the reduction of cross-infection between patients 81. However, there 
is an argument that strict segregation of patients can have detrimental mental 
and social impacts, such as through the reducing of contact to the support that 
patients can often provide one another 82,83. Despite concerns about the negative 
impact of segregation, patient questionnaires have reported that on balance, 
patients and families strongly support segregated treatment 84,85. 
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In the UK, the most common BCC species to infect the CF airway are 
Burkholderia multivorans (formerly genomovar II) and B. cenocepacia (formerly 
genomovar III), consisting of 52 % and 27 % of BCC infections in adults 
respectively 53. Previously, B. cenocepacia was the chief cause of BCC infection 
in CF, though the prevalence of B. multivorans infection is now greater in both 
the UK and North America 86–90. Strains that have caused epidemics among CF 
populations are known to belong to several BCC species, however there are 
several notorious epidemic strains belonging specifically to B. cenocepacia – ET-
12, Midwest, PHDC and ST-32, whereas B. multivorans infections are more 
sporadic, with lower incidences of epidemic transmission between patients 22,62,91. 
While B. cenocepacia and B. multivorans are the predominant BCC species in 
CF, the vast majority of BCC species have been successfully isolated from the 
CF lung 9,86. Outside of the BCC, the phytopathogen B. gladioli is of particular 
threat relative to other non-BCC Burkholderia species, with the frequency of 
infection seemingly being greater in the USA than the UK 87,88,90.  
Infection control is the cornerstone of protecting against BCC infection, with strict 
cohort segregation reducing cross-infection in the clinic 89. However, the number 
of BCC infection cases are still considerable, and the ubiquity of the BCC in the 
environment has led to concern that the natural environment may be a source of 
infection of patients with the BCC. Evidence linking environmental BCC with 
patient infections casts a shadow on the notion of using BCC species as 
bioremediation agents 29,92. Additionally, there have been reports of BCC species 
isolated from the natural environment that are indistinguishable from those 
isolated from samples from CF patients, adding weight to the idea of acquisition 
of infection from the environment 93,94.  
Due to the intrinsic antimicrobial resistance of the BCC, eradication of infection is 
troublesome and therapeutic options are limited. There is a severe lack of 
evidence in the literature for antimicrobial treatments of the BCC; one systematic 
review found no randomised or quasi-randomised trials of antibiotic treatment for 
CF patients infected with BCC experiencing pulmonary exacerbations, another 
found no trials for eradication therapy for BCC infections in CF patients, and a 
third assessing long-term antibiotic therapy for chronic BCC infections could only 
include one study in its meta-analysis 95–97. As such there is no consensus on 
treatment regimens for BCC infection, and treatments are usually decided upon 
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using antimicrobial susceptibility data from patient samples 95,98. Trimethoprim-
sulfamethoxazole, minocycline, doxycycline, tobramycin and ceftazidime are 
reported to be the most effective treatments for BCC infection, though 
susceptibility patterns differ between isolates and between BCC species, 
highlighting the need for accurate species-level identification of BCC infection 
91,99–104.  
 
1.1.4 – The BCC and chronic granulomatous disease 
 
In addition to CF patients, the BCC poses a threat to other immunocompromised 
individuals, such as those with chronic granulomatous disease (CGD). Affecting 
around 1 in every 200,000 births globally, CGD is caused by mutations in any of 
the five subunits of phagocyte nicotinamide adenine dinucleotide phosphate 
(NADPH) oxidase, an enzyme integral to the generation of superoxide and other 
reactive oxygen species (ROS) in immune cells 105. These chemical species play 
an important role in ‘respiratory burst’, the process of using ROS in the 
degradation of internalised bacteria in immune cells. As such, patients with 
defective NADPH oxidase are particularly immunocompromised, and suffer from 
recurrent life-threatening infections throughout the body 106,107. Diagnosis of CGD 
involves patient genotyping and the measuring of NADPH oxidase activity, which 
can aid clinicians in treatment of patients, as greater residual NADPH oxidase 
activity in CGD patients is linked to a better prognosis compared to those with a 
virtually abolished NADPH oxidase activity 107,108.  
Common types of infection found in CGD populations include pneumonia, 
impetigo and abscesses of the skin and liver 106. The bacteria commonly 
associated with CGD infection include S. aureus, Serratia marcescens, 
Salmonella species, Norcadia species and the BCC, while fungal infections from 
Aspergillus and Candida species are also common 109,110. CGD treatment 
focuses on the identification of infecting microbes and the prevention and 
management of infection with antimicrobials 110. 
As with CF patients, the BCC are not as prevalent as other bacteria are in 
infecting CGD patients, though they are still considerably dangerous, with BCC 
infection having a relatively high proportion of fatal outcomes in patient cohorts, 
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often causing septicaemia 109,111,112. Contrastingly to CF, in which chronic BCC 
infection is usually caused by persistence of the same specific strain, BCC 
infection in CGD is more transient, with recurrent episodes of infection being 
caused by different BCC strains that aren’t often shared between patients 113. 
Limited data exists surrounding species-level identification of BCC infection in 
CGD compared to CF, though one analysis of patient isolates reported both B. 
cenocepacia and B. multivorans as frequent causes of BCC infection in CGD, in 
addition to some other BCC species that aren’t often present in CF causing 
infection in CGD, such as B. ambifaria and Burkholderia metallica 113.  
The BCC are particularly capable in resisting killing by the immune system; B. 
cenocepacia is known to be able to resist killing from respiratory burst and can 
produce at least one superoxide dismutase 114,115. Additionally, B. cenocepacia 
has been demonstrated to induce necrosis in neutrophils in CGD, as well as to 
possess the ability to interfere with NADPH oxidase complex formation in 
macrophages, resulting in reduced superoxide formation compared to heat-killed 
control 116–118. These factors make B. cenocepacia and the wider BCC particularly 
capable pathogens in CGD, given the already reduced capability of the immune 
system to destroy internalised bacteria. 
 
1.1.5 – The wider pathogenicity of the BCC 
 
In addition to CF and CGD patents, the BCC can pose a threat to others with a 
weakened immune system, such as those suffering from cancer, commonly 
through contaminated medical devices. Outbreaks of BCC infection often leading 
to bacteraemia have been reported in inpatient and outpatient units due to 
contamination of intravenous catheters and equipment such as ultrasound gels, 
mouthwash and gloves 119–127. Although rare, the BCC has caused infections in 
immunocompetent individuals, with cases of pneumonia, bacteraemia and 
osteomyelitis among others being attributed to the complex 128–135.  
The BCC has also caused infection in various animal hosts. Though feline 
infections have been documented due to contaminated antiseptic scrub, most 
origins of infection have not been traced to a nosocomial source, while there have 
also been cases of pyoderma in dogs, endocarditis in horses and mastitis in 
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sheep 136–140. There is little evidence of the BCC residing asymptomatically in 
animals, though the BCC has been detected in wallaby and horse faecal samples 
in northern Australia, indicating a possible role for animals in the dissemination 
of these bacteria in the environment 141. 
 
1.1.6 – The molecular basis of pathogenicity of the BCC 
 
Owing to the relatively large genome size of BCC species (approximately 7-8 Mb) 
there are a diverse range of virulence factors that are employed in initial 
colonisation and survival against both antibacterial compounds and the host’s 
immune system. The intrinsic antimicrobial resistance of BCC species renders 
any established infection difficult to clear. BCC species are particularly tolerant of 
polymyxins, with minimal inhibitory concentration (MIC) values up to 100 fold 
greater than those for P. aeruginosa or Escherichia coli 23. The basis for this 
resistance is thought to come in part from the consistent addition of the sugar 4-
amino-4-deoxy-L-arabinose (Ara4N) to lipid A of the lipopolysaccharide (LPS) 
structure in the outer membrane; the positive charge of the sugar is thought to 
reduce the net negative charge of the membrane, reducing permeability to 
cationic molecules such as polymyxin B 23,142. Additionally, inactivation of a UDP-
glucose dehydrogenase enzyme which is involved in the Ara4N synthesis 
pathway (BCAL2946) resulted in increased susceptibility to polymyxin B, 
supporting the importance of Ara4N in the BCC’s particular resistance to this 
antibiotic 23,143. Other implicated molecules in this extreme resistance include the 
core oligosaccharide of LPS and the alternative sigma factor RpoE 144,145. 
The BCC are also intrinsically resistant to a range of other antimicrobials, such 
as aminoglycosides and β-lactams, though MIC values vary even between strains 
of the same species 24. As with other Gram-negative bacteria, the presence of 
several Resistance-Nodulation-Cell Division (RND) efflux pumps is a contributory 
factor to broad antimicrobial resistance. Genome analysis of the J2315 genome 
identified 16 potential RND pumps in B. cenocepacia, of which at least 5 have 
been shown to play a role in antimicrobial resistance, though the molecular 
specificity of the majority of these RND pumps remains unclear 146–148.  
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In addition to its relatively robust antimicrobial resistance, the BCC employs a 
range of virulence factors to enhance its disease-causing ability. One example 
are bacterial secretion systems - complexes of membrane-associated proteins 
that extrude various molecules from the bacterial cell for reasons including 
nutrient scavenging, secretion of extracellular toxins and interbacterial 
communication and competition 149. Genes for six secretion systems have been 
identified in the J2315 genome, the Type I Secretion System (T1SS), T2SS, 
T3SS, T4SS, T5SS and T6SS 146. Several of these secretion systems have been 
implicated in BCC virulence. The T2SS exports two zinc metalloproteases, ZmpA 
and ZmpB, which can cleave a range of host proteins, such as immune mediators 
150,151. Mutants of the BCC T3SS have reduced virulence in the nematode model 
Caenorhabditis elegans and murine models, while genes encoding T4SSs are 
involved in cytotoxic protein secretion affecting onions, plasmid mobilisation and 
in intracellular survival within macrophages 152–156. The T6SS is important in 
delaying activation of NADPH oxidase in macrophages and in inter-species 
bacterial competition 118,157. 
Quorum sensing refers to the mechanism in which gene expression is regulated 
in response to population density, via the release and sensing of autoinducer 
molecules. Once a minimal threshold concentration of a certain autoinducer 
molecule is reached, gene expression is altered 158. BCC species are able to 
utilise multiple QS systems, such as CepIR, a well-conserved N-acyl homoserine 
lactone-dependent QS system which regulates a broad range of genes including 
those involved in virulence, motility, biofilm formation and the production of 
extracellular proteins such as siderophores and metalloproteases 159,160. Another 
QS system in the BCC involves cis-2-dodecenoic acid, also known as 
‘Burkholderia diffusible signal factor (BDSF)’, which is also implicated in the 
regulation of biofilm formation and virulence 161–164. Due to their overarching role 
in the regulation of pathogenicity in the BCC, research has been performed into 
the use of QS system inhibitors, known as diketopiperazines, as potential 
therapeutics 165,166.  
Forming part of the outer membrane of Gram-negative bacteria, the LPS is 
comprised of three components: Lipid A, the core oligosaccharide and the O-
antigen, and is involved in interactions between bacteria and host, such as 
adhesion, and is also able to induce strong immune responses from the host 167. 
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The LPS in the BCC differs from many other Gram-negatives, such as the 
presence of particular disaccharides in the core oligosaccharide and the 
presence of Ara4N in the lipid A, altering the charge of the cell surface which has 
been shown to inhibit the binding of certain antibiotics to the BCC, reducing their 
effectiveness 23,142,168. The BCC LPS is also able to stimulate murine 
macrophages to produce cytokines such as TNF-α and IL-6, contributing to host 
inflammation 169. The BCC also produce a range of exopolysaccharides (EPS), 
the most commonly isolated being cepacian, which has been demonstrated to 
interfere with the production of ROS and chemotaxis in human neutrophils, and 
also is important in virulence in mice 170–174.  
Comparative genomic analysis of clinical isolates of B. cenocepacia ST32 has 
provided insight into the adaptation of B. cenocepacia in cases of chronic CF 
infection with fatal outcomes. Indels in genes related to transition metal 
metabolism (particularly copper metabolism) and oxidative stress protection were 
frequently identified 175. As macrophages utilise both ROS and copper in their 
killing of internalised pathogens, these findings suggest that evolution of 
strategies to overcome macrophage killing of B. cenocepacia may contribute to 
worse patient outcomes in chronic CF infection 175.  
There are no clinically available vaccines to protect against the BCC, though 
knowledge of relevant virulence factors may lead to specific proteins being 
utilised in BCC vaccinations 176. Examples of these subunit vaccines include the 
vaccination of mice with the bacteriocin linocin, the membrane protein OmpW or 
a range of outer membrane proteins from BCC species which protected mice 
from BCC infection, resulting in reduction of lung bacterial load 177–179. 
Polysaccharides are also a focus of BCC vaccine research, as well as for 
vaccines of the B. pseudomallei group 176,180. One study has utilised a live vaccine 
containing a tonB mutant of B. cenocepacia, which was deficient in the active 
uptake of iron, which conferred high levels of immunisation against B. 
cenocepacia in mice 181. Bioinformatics approaches are also being utilised to aid 
in the search for vaccine candidates, the successful development of which may 
bring profound clinical benefit to a range of vulnerable individuals 182. 
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1.1.7 – The intracellular niche of the BCC 
 
The respiratory epithelium acts as a physical barrier between the host and inhaled 
pathogens and plays a critical role in the innate immune system via the production 
of antimicrobial agents, stimulation of pro-inflammatory cytokines upon bacterial 
recognition and the trapping of bacteria in the mucosal environment 183,184. 
Internalisation of respiratory pathogens by the epithelium contributes to the innate 
response of the host to infection, however hijacking of this process by bacterial 
pathogens poses a threat to the host, as certain bacteria, such as the BCC, can 
persist in these cells and even pass across the epithelium to the bloodstream, 
spreading potentially devastating infection throughout the body 185–187. The BCC 
is better able to invade the CF airway than those of healthy individuals, both 
successfully invading and migrating across epithelial cells, so an understanding 
of the molecular pathophysiology behind this phenomenon is crucial for the 
development of therapeutics, especially for the CF population 188. 
Binding of the BCC to the airway epithelium is the first step in epithelial invasion, 
and is reportedly mediated by a 22 kDa adhesin and cable pili; mutants lacking 
expression of either the adhesin or cable pili show reduced binding to cytokeratin 
13, a protein with increased expression in the CF lung, and also impaired 
migration across squamous epithelial cells 189,190. Isolates of B. cenocepacia that 
show greater binding of cable pili and the 22 kDa adhesin to a glycoprotein found 
in the lung mucus, known as mucin, are linked with a greater incidence of cepacia 
syndrome, suggesting a direct link between these binding proteins and 
pathogenicity 184,191. Additionally, the trimeric autotransporter adhesins 
BCAM0223 and BCAM0224 of B. cenocepacia K56-2 have been associated with 
adherence to (and, in the case of BCAM0224, invasion of) bronchial epithelial 
cells, as well as biofilm formation and virulence in Galleria mellonella, 
strengthening the link between adhesins and virulence in B. cenocepacia 192–194. 
Inhibition of glycolipid synthesis in an epithelial cell line reduced invasion of 
strains of both B. multivorans and B. cenocepacia, implicating glycosphingolipid 
receptors in BCC adhesion and invasion 195. A number of other factors have been 
identified as playing a role in BCC adhesion, including OmpW, linocin and the 
lipoprotein pal 179,196.  
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Invasion of the epithelium by the BCC has been demonstrated in vitro, where a 
correlation between invasion and infection of a murine model has been shown 
197. The BCC are known to employ several methods of epithelial invasion, which 
can be species-specific, for example invasion by B. multivorans appears to 
depend on access to tight junctions, whereas the same was not found for B. 
cenocepacia 198. Some species were shown to invade the epithelial layer via 
disruption of the actin cytoskeleton in a biofilm state, while other species 
penetrate the epithelium as single cells 199. Additionally, in a CF epithelial cell 
line, B. cenocepacia invaded cells via of a process of actin rearrangement 200. 
Extracellular lipase appears to play a role in invasion; application of BCC lipase 
to epithelial cell lines increased invasion by B. multivorans and B. cenocepacia in 
a tight-junction independent manner 201. Mutants in flagellar genes fliG and fliI  of 
B. cepacia showed reduced invasion of epithelial cells, suggesting motility aids 
invasion of these cells 202. Additionally, the two-component system (TCS) FixLJ 
in the BCC species Burkholderia dolosa regulates invasion of epithelial cells and 
macrophages, as well as biofilm formation and motility 203. 
The fate of the BCC following invasion into CF epithelial cells involves escaping 
from lysosomes and late endosomes of the cell and entering autophagosomes, 
where it eventually can replicate in the endoplasmic reticulum 200. The T4SS has 
been implicated in the alteration of membrane trafficking in both Legionella 
pneumophila and Brucella abortus, and a BCC T4SS has also been identified as 
playing a role in avoiding degradation and aiding survival and replication within 
epithelial cells 155,204,205.  
In addition to invading the respiratory epithelium, BCC species have been 
demonstrated to survive within macrophages. A zebrafish embryo model has 
shown B. cenocepacia surviving and replicating within macrophages, while 
deletion of an AmrAB-OprA-like efflux pump has allowed for the creation of 
aminoglycoside-sensitive derivatives of BCC species for use in the gentamicin-
protection assay, which has displayed the ability of the BCC to replicate within 
murine macrophages 206–208. The strong in vitro evidence for an intracellular niche 
of the BCC has been seen in the clinic; immunohistochemistry performed on 
lungs of CF patients undergoing transplant identified BCC bacteria generally 
being present as single cells or smaller clusters within phagocytes, while P. 
aeruginosa was identified in more biofilm-like structures 67.  
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Entry of B. cenocepacia into macrophages appears to rely on the induction of 
membrane ruffling and subsequent engulfment of bacterial cells (otherwise 
known as macropinocytosis), which is partially dependent on the T3SS 209. 
Differences in internalisation rate of different BCC strains into macrophages have 
been observed; for example three strains of B. multivorans had an internalisation 
rate of between 1.2-5.2 % into RAW264.7 murine macrophages, while B. 
cenocepacia K56-2 had a rate of 1 % 208. 
Similarly to epithelial cells, macrophages containing B. cenocepacia suffer from 
a manipulated phagosome maturation pathway. B. cenocepacia-containing 
vacuoles had significantly delayed fusion with late endosomes and lysosomes: 6 
hours following internalisation for live bacteria compared to 30 minutes for heat-
killed bacteria 210. Another study found that B. cenocepacia does not appear to 
interfere with the fusion of early endosomes with phagosomes, but impaired the 
activation of the late phagosomal marker Rab7, which may contribute to the 
reduced rate of lysosomal fusion with B. cenocepacia-containing vacuoles 211. B. 
cenocepacia can also interfere with autophagy, blocking maturation of the 
autophagosome and replicating in the cytosol 212. While the arrest in lysosomal 
fusion has been observed for B. cenocepacia, phagosomes containing B. 
multivorans experienced normal trafficking within the macrophage, with no delay 
in acidification or lysosomal fusion, suggesting that while these two species share 
the ability to cause severe infection in the immunocompromised, their intracellular 
lifestyles are different 208. Recent work using a zebrafish model suggests that 
rather than acting as a host defence mechanism against infection, macrophages 
are crucial for the spread of B. cenocepacia infection (as opposed to neutrophils, 
which played no apparent role in B. cenocepacia pathogenesis), indicating that 
targeting the intracellular stages of infection may be an avenue of exploration for 
the development of novel therapeutics for B. cenocepacia and possibly other 
BCC species 213.  
Interestingly, while CFTR-defective macrophages display normal acidification of 
the phagosome, infection of these macrophages with B. cenocepacia confers a 
greater delay in acidification and lysosomal fusion compared to normal 
macrophages 214. The reason for this may lie in the process of autophagy; 
defective CFTR reduces autophagy in macrophages, while treatment of CFTR-
defective macrophages with the autophagy-stimulating rapamycin enhanced 
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clearance of B. cenocepacia through autophagy, reducing lung inflammation 
215,216. This autophagic clearance may involve the ubiquitin-binding adaptor 
molecular SQSTM1/p62, which has differing effects on B. cenocepacia survival 
in WT and CFTR-defective macrophages 217. These findings shed light on the 
molecular mechanisms underpinning the greater ability of BCC species to infect 
CF macrophages compared to those from healthy individuals, an important 
research avenue for the CF community. 
 
1.2 – The homeostasis, toxicity and relevance of heavy metals 
 
1.2.1 – Heavy metals in bacterial physiology 
 
Heavy metals are elements that typically lie within the d-block of the periodic table 
as transition metals, some of which are highly physiologically relevant. There is 
no universally accepted definition for what constitutes a ‘heavy metal’, with 
different authors utilising different thresholds for various criteria, such as density 
and atomic mass, for which elements are included under the term 218. Alternative 
naming conventions have been suggested, such as splitting metals into Class A 
(oxygen-seeking), Class B (nitrogen/sulphur-seeking) and Borderline metals, 
although alternative terms have yet to be widely adopted in the literature 218,219. 
For the sake of simplicity, the terms ‘metal’ and ‘heavy metal’ herein will refer to 
any element found within group 3 to group 12 inclusive in the periodic table. 
Metals are fundamental to the functioning of many proteins throughout the 
kingdoms of life, and therefore underpin many different cellular processes 220. 
Iron is an essential metal which can be found in iron-sulphur clusters, an 
abundant protein cofactor that plays a role in DNA replication, metabolism and 
respiration 221,222. Zinc-fingers are abundant protein motifs in which zinc ions are 
coordinated to cysteine and histidine residues, while zinc can also be found in 
several bacterial ribosomal proteins and in extracellular metalloproteases 223–225. 
Another common metal is copper, which can be found in several protein groups 
such as cytochrome oxidases and superoxide dismutases 226–228. Other metals 
incorporated in metalloproteins include nickel, manganese and molybdenum 229. 
34 
 
In order to meet the continuous cellular demand for metals, it is necessary for 
bacteria to import metals from the extracellular environment into the cytoplasm. 
Metal transport systems import metals from the environment in a variety of ways, 
be it through passive transport through porins in the outer membrane, the 
hydrolysis of ATP in ATP binding cassette (ABC) transporters and other ATPases 
to actively import metals, the sequestration of metals via siderophores or co-
transporting metals with other compounds such as amino acids 230,231. However, 
the use of metals by organisms represents a fine balance between taking 
advantage of their chemical properties in the cell without exposure to their 
inherent toxicity at higher concentrations. If metal concentration within the cell is 
too high, regulatory mechanisms can downregulate the expression of import 
proteins and upregulate expression of efflux proteins and intracellular chelators, 
maintaining the delicate homeostasis of metal ion concentration 230,232,233.  
Metal toxicity can arise from high concentrations of both essential and non-
essential metals, which can occur if extracellular metal concentration is 
particularly high, or if homeostatic mechanisms are unable to overcome 
intracellular metal stress. In order to exhibit toxicity, metals need to accumulate 
in the cytoplasm, and thus penetrate the outer membrane, and for Gram-negative 
bacteria, the inner membrane also. While outer membrane porins are one 
proposed mechanism of metals penetrating into the periplasmic space, there is 
little clarity surrounding other potential mechanisms of passing the outer 
membrane 234. The penetration of metals through the inner membrane however 
is somewhat more understood. 
In addition to the simple mass uptake of essential metals through standard 
transport pathways when extracellular concentration is high, there are other 
mechanisms in which non-essential metals can reach the cytoplasm. One 
mechanism is ‘ionic mimicry’, in which metal transporters are able to facilitate the 
uptake of non-essential metal species that are chemically-similar to their 
‘intended’ target. For example, the zinc transporters YiiP and ZipB from E. coli 
and Bordetella bronchiseptica respectively are able to transport the non-essential 
metal cadmium, albeit at a lower rate and affinity than zinc 235,236. Siderophores 
may also play a role in non-essential metal uptake; the P. aeruginosa iron 
siderophore pyochelin is able to bind gallium which is eventually taken up by the 
FptA transporter, though at a lower rate than iron 237. With different metals having 
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fundamentally different chemical properties, as well as the variety of outer and 
cytoplasmic membrane proteins across the bacterial domain, it is likely that while 
metal-uptake mechanisms may be broadly similar between species, the 
subtleties of metal uptake are unique to each combination of metal and bacteria. 
 
1.2.2 – Mechanisms of metal toxicity to bacteria 
 
There are several empirically-characterised means by which metals exert their 
toxicity on the bacterial cell at high concentrations; some are common to many 
metals, while others may only be exhibited by a single element. One toxicity 
mechanism is the generation of short-lived ROS, which are able to interact with 
and damage lipids, DNA and proteins. Several metals are able to catalyse the 
generation of ROS through the Fenton reaction (Fig 1.2), in which the by-products 
of aerobic respiration, such as superoxide and hydrogen peroxide, are able to 
oxidise and reduce metal species. The hydroxyl radical generated through this 
process poses a particular threat to the stability of the intracellular environment, 
due to its ability to both directly damage the cell, and also interact with biological 
molecules to form other radicals, such as the thiyl and peroxyl radicals 234. 
 
 
 
 
 
Figure 1.2: ROS generation via the Fenton reaction. Iron is used as an 
example for metal-catalysed Fenton chemistry, though other metal species are 
also able to undergo these reactions. Equation 1 - Hydrogen peroxide (H2O2) is 
able to oxidise Fe2+ to produce a hydroxyl ion (OH-) and a hydroxyl radical (OH∙). 
Equation 2 - Fe3+ is reduced by superoxide (O2∙-) to form Fe2+ and O2, 
replenishing the reduced metal to react further with H2O2. Equation 3 - The net 
reaction is called the Haber-Weiss reaction.  
 
Figure 2 
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In addition to iron, other metals have been demonstrated to undergo Fenton 
chemistry in vitro, such as chromium, cobalt, copper, nickel and vanadium 238. As 
such, high intracellular concentrations of these redox-active metals may directly 
generate damaging ROS. Indeed, E. coli lacking two superoxide dismutases 
were more susceptible to nickel, cadmium and cobalt, and the mechanism of 
toxicity of chromium to E. coli was demonstrated to be hydroxyl radical-dependent 
239,240. Additionally, P. aeruginosa exposed to toxic concentrations of copper 
upregulated genes indicative of an oxidative stress response, and P. aeruginosa 
lacking superoxide dismutase or glutathione reductase had increased sensitivity 
to arsenite, implying that metal toxicity may be at least partially explained by the 
generation of ROS 241,242.  
A more indirect mechanism of metal-catalysed ROS generation involves the 
targeting of exposed iron-sulphur clusters in proteins. Various metals, such as 
cadmium, copper, mercury, silver and zinc are able to damage [4Fe-4S] clusters 
in E. coli, resulting in the release of complexed iron into the cytoplasm 243,244. Any 
release of free iron into the cytoplasm may lead to ROS generation through 
Fenton chemistry, regardless of whether the metal that attacks the cluster is itself 
redox-active. Aside from the potential generation of ROS, targeting of [4Fe-4S] 
clusters directly causes protein dysfunction; copper inactivates isopropylmalate 
dehydratase (among other proteins) in E. coli, an enzyme necessary for synthesis 
of branched-chain amino acids, leading to a growth defect 243. This toxic effect 
was also present in anaerobic conditions, supporting the notion of a ROS-
independent toxicity mechanism for the targeting of [4Fe-4S] clusters by metals 
243. Cadmium, mercury, silver and zinc are also able to inactivate various [4Fe-
4S] dehydratases in E. coli, although it has been found that rather than directly 
target iron-sulfur clusters, copper, cobalt and zinc inhibit the biogenesis of these 
clusters through binding to iron-sulfur cluster assembly proteins 244–247. As many 
metabolically-essential proteins contain [4Fe-4S] clusters, the targeting of these 
clusters, be it either directly or through their biogenesis, may also explain the toxic 
effects of these metals. 
Another way that metals exert toxicity is through the displacement of other metal 
species complexed within metalloproteins. The Irving-Williams series dictates the 
order by which proteins tend to have affinity for essential divalent metals, which 
reads Mn2+ < Fe2+ < Co2+ < Ni2+ < Cu2+ > Zn2+, in which proteins have the greatest 
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affinity for copper 229,248. As such, intoxication with an essential metal such as 
copper or nickel, or a non-essential metal with relatively high affinity for protein 
complexes may lead to displacement of crucial metal groups in metalloproteins, 
leading to protein dysfunction. For example, the yeast enzyme 5-
aminolaevulinate dehydratase is inhibited by the displacing of the bound zinc at 
its triple-cysteine site by lead, and exposure of Saccharomyces cerervisiae to 
silver led to displacement of copper bound within Cu,Zn-superoxide dismutase, 
rendering it dysfunctional 249,250. In E. coli, nickel can displace the zinc bound to 
fructose-1,6-bisphosphate aldolase, leading to inhibition of enzyme activity 251. 
Many metals, such as cadmium, copper, silver and zinc have been implicated in 
the oxidation of thiol groups, leading to disulphide bond formation in proteins and 
antioxidants such as glutathione 252–254. Combined with the ROS-generating 
capabilities of these metals, depletion of antioxidants may compound oxidative 
stress, while further protein disruption through disulphide bond formation on thiol 
groups will increase the burden of metal toxicity upon the bacteria. 
In addition to the mechanisms of metal toxicity previously mentioned, there are 
other mechanisms that have only been exhibited by one or two specific metals. It 
has been postulated that cadmium and copper are able to cause cellular damage 
through peroxidation of membrane lipids, and that this is the possible mechanism 
of copper alloy-contact killing of E. coli and B. subtilis 255–257. Silver has been 
implicated in causing proton leakage and cell death in Vibrio cholerae, and also 
in inhibition of the electron transport chain in E. coli and Vibrio harveyi 258–261. 
Metals may also be able to disrupt the assimilation of essential nutrients; 
cadmium and zinc are able to compromise the uptake of manganese in 
Streptococcus pneumoniae through binding to the lipoprotein PsaA, leading to 
heightened susceptibility to oxidative stress 262–264. In essence, there are many 
ways in which metals can be toxic to the bacterial cell, some of which are shared 
across many metals, and others which have only been empirically defined for one 
or two metal species. 
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1.2.3 – The antimicrobial potential of heavy metals 
 
Given the range of toxic effects metals can have on bacteria, it is of little surprise 
that metals have been used as successful antibacterial agents in a variety of 
ways. Examples include the use of silver nitrate to prevent gonorrhoea eye 
infections in newborns, the utilisation of copper sulphate in mixtures to control 
potato blight and the use of copper-silver ionisation in hospital water systems as 
a method of controlling for Legionella 234,265,266. Owing to their antimicrobial 
properties, metals have also been incorporated in many consumer and medical 
products. Silver is often found in wound dressings, antimicrobial creams and 
catheters, copper has been postulated as an antimicrobial surface due to its 
contact killing capabilities, while tin and zinc have been incorporated into brands 
of mouthwash and toothpaste 234,267,268. 
One avenue for the use of metals as antimicrobials comes in the form of metal 
nanoparticles. In essence, these are clusters of metal atoms below 100 nm in 
size and can take the form of many shapes, such as cubes, spheres and rods 
269,270. There has been particular focus on metal nanoparticles due to their 
particular antimicrobial properties; nanoparticles of copper oxide and zinc oxide 
induce ROS formation in E. coli and S. aureus, and silver nanoparticles are able 
to disrupt the E. coli plasma membrane, leading to cell death 271–275. Given the 
potential for nanoparticles to associate with the bacterial membrane, controlled 
design of metal nanoparticles to allow for specific delivery to particular bacterial 
species may be a lucrative avenue of investigation for novel therapeutics 276,277. 
Due to its antimicrobial properties, considerable research has been performed on 
the potential of incorporating copper in various surfaces in the clinical 
environment. Various clinically relevant bacteria, such as Listeria 
monocytogenes, Clostridium difficile, S. aureus and E. coli have significantly 
reduced survival times when grown on copper alloys compared to stainless steel 
278–281. Many trials have tested the effect of utilising copper as a hard surface in 
the clinic, which have found significant reduction in microbial recovery from 
several copper-containing surfaces, such as light switches, bed rails, taps, doors, 
toilet seats and pens 282–289. Copper has also been successfully tested as an 
antimicrobial when incorporated into socks, bed linen, towels and clothing 290–294. 
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These studies strongly suggest that copper surfaces may be an effective and 
efficient way of reducing microbial burden in the clinical environment. 
In addition to its direct toxicity to bacteria, silver is able to synergise with various 
antibiotics, enhancing bacterial killing compared to antibiotic alone. Silver has 
been shown to potentiate the toxicity of polymyxin B, vancomycin, tetracycline 
and multiple aminoglycosides, among others, to both Gram-positive and Gram-
negative bacteria 295–300. The mechanism of this synergy appears to be antibiotic-
dependent; silver can enhance the uptake of aminoglycosides into bacterial cells, 
while silver has also been correlated with the blocking of the bacterial thioredoxin 
system, which enhances the activity of several other antibiotics 299,300. 
Additionally, combinations of silver and antibiotics have been shown to be 
effective in the eradication of bacterial persister cells, as well as in the clearance 
of biofilms 295,297. Overall, various metals, particularly copper and silver, hold 
promise as antimicrobial strategies, either directly or in combination with 
antimicrobials.  
While there is potential in the use of heavy metals as antimicrobials, there is 
concern about the relationship between bacterial metal resistance and antibiotic 
resistance. Bacteria that have been isolated from metal-rich environments can 
often exhibit significant antibiotic resistance profiles, with there being a strong 
correlation between exposure to heavy metals and the presence of antibiotic 
resistance genes. Antibiotic/metal resistant bacteria have been isolated from 
many diverse environments, including drinking water systems, rivers, fields, 
settling basins and animal manure 301–310. As industrial processes continue to 
lead to the pollution of both natural and urban environments with various heavy 
metals, the connection between metal resistance and antibiotic resistance is of 
particular significance 311–313. 
There are different ways in which the link between metals and antibiotics can 
arise in the bacterial cell. Co-resistance refers to the situation where genes for 
different resistant phenotypes are located together on a genetic element, such as 
a plasmid 314. There are many examples of genetic elements harbouring 
resistance genes to both metals and antibiotics, such as a plasmid isolated from 
environmental P. aeruginosa which harboured resistance for both tetracycline 
and copper, as well the linkage between the copper resistance transporter tcrB 
and resistance genes for glycopeptides and macrolides on a plasmid from 
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Enterococcus faecium 315,316. A recent study of over 5000 bacterial genomes 
found that the linkage between the presence of metal resistant genes and 
antibiotic resistant genes was significantly stronger in human pathogens than 
environmental bacteria, reinforcing the relationship between metals and 
antibiotics 317. Cross-resistance refers to when development of resistance to one 
agent confers resistance to another, e.g. an efflux pump extruding both metals 
and antibiotics 314. For example, the MdrL efflux pump from L. monocytogenes 
confers resistance to many antibiotics, particularly cefotaxime, and the metals 
chromium, cobalt and zinc 318. Resistance genes for metals and antibiotics can 
also be coregulated by the same regulator; the P. aeruginosa zinc- and copper-
responsive transcriptional regulator CzcR can upregulate the heavy metal efflux 
pump CzcCBA and also downregulate the outer membrane porin OprD, reducing 
the permeability of the cell to carbapenems 319,320. The promise that metals hold 
as potential antimicrobial agents should be considered alongside the risk that 
metal pose in the development of antibiotic resistance, and further work should 
be done to elucidate the relationship between metals and antibiotics.    
 
1.2.4 – Manipulation of metal availability by the immune system 
 
There are numerous strategies that host immune cells employ to defend against 
intracellular pathogens. These include acidification of the phagosome, the use of 
antimicrobial peptides, ROS production, and both restriction of the availability of 
essential metal species and intoxication with high concentrations of toxic metal 
ions 321,322. Metal starvation as an antimicrobial strategy in the macrophage 
revolves around natural resistance-associated membrane protein 1 (NRAMP1), 
a metal transporter found at the phagosomal membrane which transports iron 
and manganese from the phagosome to the cytoplasm 323–326. This metal export 
from the phagosome leads to a strongly iron- and manganese-deficient 
environment, limiting the supply of these essential metals to the internalised 
bacteria. Studies have linked NRAMP1 polymorphisms to differing susceptibilities 
to tuberculosis and leprosy, both caused by intracellular bacteria of the 
Mycobacterium genus, suggesting that NRAMP1, and thus iron/manganese 
starvation, plays a role in the defence against these bacteria 327–329. Additionally, 
the role of iron in innate immunity is highlighted by the evolutionary battle between 
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human protein lipocalin 2, which is able to sequester bacterial siderophores and 
thus further restrict iron availability, and the strategies bacteria can employ to 
overcome this, such as production of lipocalin 2-antagonists or siderophores that 
evade inhibition by lipocalin 2 330–332.  
In contrast to the well-studied role of metal starvation in innate immunity, there 
have been more recent studies that elude to a role for copper and zinc intoxication 
in the defence against intracellular pathogens. For example, concentrations of 
copper and zinc were significantly increased over time in phagosomes containing 
mycobacteria, while evidence for a ‘zinc burst’ was found in phagosomes 
containing Mycobacterium tuberculosis 333,334. Additionally, transcriptional 
profiling of intracellular M. tuberculosis revealed induction of several predicted 
heavy metal-transporting P-type ATPases, suggesting that the bacteria are 
exposed to intoxicating levels of metals within phagosomes 334. Outside of 
mycobacteria, E. coli and S. pneumoniae deficient in the copper-transporting 
ATPase CopA were hypersensitive to macrophage killing, and P. aeruginosa with 
a mutated copper transporting P-type ATPase had reduced virulence in mice 335–
337. This evidence points towards a paradigm in which different metals can be 
extruded from or transported into the phagosome to aid in bacterial killing in 
various ways. Given the many mechanisms by which metals are used to kill 
intracellular pathogens, either through starvation or intoxication, it may be 
possible to produce pharmacological agents to target bacterial mechanisms of 
metal homeostasis that aid in the clearance of bacterial infection in the human 
host. 
 
1.2.5 – Mechanisms of metal resistance in bacteria 
 
As there are many instances in which bacteria may be exposed to metals, be it 
the natural environment, the clinic or within immune cells, an understanding of 
the molecular strategies that are employed to defend against toxic metal species 
is crucial. There are various mechanisms in which bacteria can resist metal 
intoxication, and many of these are similar to those employed to defend against 
antimicrobials.  
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Mirroring the use of metal transporters to take up metals when the intracellular 
concentration is too low, bacteria commonly employ efflux transporters to extrude 
ions from the cytoplasm out into the periplasmic/extracellular space when the 
concentration is too great. There are several well-characterised metal 
transporters, and metals have been shown to be effluxed by various families of 
transporters. One example are RND-family efflux pumps, tripartite complexes 
composed of an RND protein, a membrane fusion protein (MFP) and an outer 
membrane factor (OMF), which together span across both the inner and outer 
membranes of the bacterial cell, extruding ions from the cytoplasm directly out to 
the extracellular environment 338–340. Examples include the cadmium-, cobalt- and 
zinc-extruding CzcCBA pump of Alcaligenes eutrophus and P. aeruginosa and 
the copper- and silver-extruding CusABCF system of E. coli, consisting of the 
CusABC efflux pump and the periplasmic CusF chaperone, which delivers metal 
ions directly to the pump from the periplasm 319,341–344.  
Rather than span both membranes, cation diffusion facilitator (CDF) pumps 
transport substrates across a single membrane, and as such can be found in both 
Gram-negative and Gram-positive bacteria 230. The zinc-transporting ZitB from E. 
coli and CzrB from S. aureus are two examples of metal-transporting CDF pumps 
345,346. The P1B group of P-type ATPases transport metals across the cytoplasmic 
membrane in an ATP-dependent manner, and have been shown to transport a 
range of metals, such as cadmium, cobalt, copper, lead, nickel, silver and zinc 
347–349. These ATPases are able to interact with periplasmic chaperones; the 
copper-transporting ATPases CopA in E. coli can directly deliver copper to the 
chaperone CusF 350. Interestingly, certain copper-ATPases appear to not be 
directly involved with copper detoxification of the cytoplasm, but rather delivery 
of copper to the periplasm at a slower rate for incorporation into cytochrome 
oxidases 351,352. 
Aside from efflux, there are several other mechanisms at play in defence against 
metals. Metal ions can undergo chemical modification into less toxic forms, for 
example the oxidation of Cu(I) to its less toxic form Cu(II) by multicopper 
oxidases, such as the periplasmic multicopper oxidase CueO from E. coli 353,354. 
Bacteria can sequester metals within the cytoplasm through the use of storage 
proteins, for example bacterioferritins are used to tightly regulate free iron 
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concentration and prevent it from undergoing Fenton chemistry, and cysteine-rich 
metallothioneins sequester metals through binding to its thiol groups 355–357.  
Metals can also be sequestered extracellularly; the E. coli secreted siderophore 
yersiniabactin, which usually sequesters iron, can bind extracellular Cu(II) to 
prevent its reduction to the more toxic Cu(I) form 358. Additionally, yersiniabactin 
bound to Cu(II) can act as a superoxide dismutase, protecting the internalised E. 
coli from superoxide generated within the phagosome 359. Other siderophores are 
also able to bind a range of metals, albeit at a lower affinity than they bind iron, 
possibly sequestering these metals in the environment 237,360. Given the diverse 
environmental niches that bacterial species can occupy, it is likely that the 
intricacies of resistance to metal stress vary across the bacterial domain, 
rendering some species more tolerant to heavy metals than others. 
 
1.2.6 – Metal resistance in the BCC 
 
Multiple Burkholderia species have been isolated from metal-rich environment; 
Burkholderia metallidurans (now Paraburkholderia metallidurans), is particularly 
resistant to such as cadmium, copper, lead and zinc, and a Burkholderia species 
isolated from soil contaminated by a former nuclear weapons production facility 
displayed heightened resistance to nickel 8,361–363. Additionally, investigation of 
gallium as a potential therapeutic against the BCC found that the MIC of gallium 
for BCC isolates was at least four-fold greater than that for P. aeruginosa, 
concluding that the use of gallium as a therapeutic for BCC infection is limited 364. 
Understanding how the BCC defends against toxic metals would inform the 
decision about their utilisation as bioremediation agents, as well as their 
pathogenic role in the CF lung, given that the concentrations of copper, iron and 
zinc are elevated in the CF lung compared to healthy control 365–367. As such, 
characterisation of the metal response is important, though there is relatively little 
literature to date on the specific mechanisms employed by the BCC to resist 
metals. 
A screen of 5000 transposon mutants of B. cenocepacia H111 by Schwager and 
colleagues (2012) identified a mutant of the P1-type ATPase CadA, which was 
deficient in growth on cadmium 368. Deletion of CadA rendered B. cenocepacia 
44 
 
sensitive to cadmium, lead and zinc, while fusion of the cadA promoter region to 
gfp demonstrated induction of CadA in response to the same three metals 364. 
The cadA gene is conserved both within the BCC and the wider Burkholderia 
genus; the cadA gene in B. cenocepacia H111 is 85 % similar to cadA from B. 
multivorans and 81 % similar to cadA from B. pseudomallei 18. This strong 
conservation suggests that CadA plays an important role in resistance to 
cadmium, lead and zinc, and perhaps other heavy metal-resistance mechanisms 
are shared between Burkholderia species. Additionally, recent investigation of 
copper-resistance genes in B. cenocepacia H111 by transposon sequencing 
identified the presence of the copper-resistance system CopABCDE, which is 
also present in E. coli 369.  
Aside from the aforementioned studies, there is a general lack of empirical 
exploration of the molecular mechanisms underpinning the metal response in the 
BCC. P1-type ATPases such as CadA are usually regulated by metal-responsive 
transcriptional repressors, in which binding of metal directly to the repressor 
allows expression of the protein, whereas efflux pumps such as RND-family 
pumps are typically regulated by TCSs 370,371. While there are many RND-family 
pumps and TCSs in the BCC, their potential role in the metal response has not 
been described 18,146,372. The focus of this work revolves around four putative 
heavy metal-sensing TCSs in B. cenocepacia K56-2, their individual regulons and 
the potential interactions between them, which will further elucidate the details of 
the metal response in the BCC (see section 1.3.8).  
 
1.3 – Two-component systems and multikinase networks 
 
1.3.1 – Introduction to the two-component system 
 
The ability to perceive and respond to the local environment is fundamental to 
the survival of any living organism. TCSs are an essential means of connecting 
the environment to cellular homeostasis commonly employed by bacteria and 
some lower eukaryotes such as fungi and plants. Traditionally comprised of a 
membrane-bound sensor kinase (SK) and a cytoplasmic response regulator 
(RR), TCSs can sense and respond to a broad range of stimuli, such as pH, 
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temperature and the extracellular concentration of a range of compounds, and as 
such they are pivotal in the regulation of a number of cellular processes, such as 
sporulation in Bacillus subtilis and the acute/chronic infection switch in P. 
aeruginosa 373–375. They are remarkably prevalent throughout the bacterial 
domain, with the majority of species containing dozens of TCS proteins 376,377.  
Signal transduction by TCSs relies on a highly-specific phosphotransfer reaction 
between a SK and a cognate RR (cognate meaning the RR usually encoded 
directly next to the SK in the genome) (Fig 1.3). SKs are commonly bifunctional; 
in addition to their kinase activity, they also act as phosphatases for their cognate 
RRs in their basal state, ensuring that RRs are only activated upon stimulation of 
the SK. As such the ratio of kinase to phosphatase activity is crucial in the 
propagation of signal transduction, which will be affected by spatial and temporal 
factors 375,377. Despite the relatively large sequence similarity between different 
TCSs, the phosphotransfer reaction and phosphatase activity of TCSs are 
specific enough to discourage crosstalk between different TCSs. While it is 
thought that most TCSs are distributed relatively evenly throughout the bacterial 
membrane, in certain situations TCSs may also be spatially separated in the cell 
to help overcome crosstalk in the interest of processes such as chemotaxis 378,379. 
RRs contain a conserved receiver domain which, upon acceptance of the 
phosphoryl group from the kinase, confers a conformational change which allows 
for functional output to occur via the output domain. Often these domains are of 
‘Winged helix’ or ‘Helix-turn-helix’ type, and their output involves the binding of 
DNA in the form of a homodimer, which can then positively or negatively affect 
regulation of transcription 380. While DNA-binding domains account for the 
majority of RR function, there is a broad range of other reported functional 
domains of RRs, such as enzymatic domains (e.g. adenylate cyclases, c-di-GMP-
synthases and methylesterases), transport domains (e.g. Mg2+ transporters and 
sulfate transporters) and protein-binding domains 380. 
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Figure 1.3: Structure of traditional TCS signalling pathways. A) A basic TCS 
comprised of a SK and an RR. Functioning as homodimers, SKs will sense a 
signal in the periplasm and undergo autophosphorylation, adding a phosphoryl 
group to a conserved histidine residue on the DHp domain via the catalysis of 
adenosine triphosphate (ATP). The conserved SK histidine residue will then 
donate its phosphoryl group to a conserved aspartate residue on the RR. The RR 
will then perform its cellular function, commonly regulation of gene transcription. 
Following activation, dephosphorylation of the TCS will occur through a 
combination of phosphatase activity of the SK and the labile phosphoryl group 
detaching from the RR. B) Phosphorelays consist of a hybrid SK, which contains 
a receiver domain as well as the usual SK domains. Phosphotransfer will occur 
between the DHp domain and RD of the SK and will then occur again between 
the RD of the SK and a conserved histidine on a Hpt protein, which can either be 
attached as part of the hybrid SK or as a standalone protein. This leads to 
phosphotransfer between the Hpt and the cognate RR in the cytoplasm. 
Abbreviations: CA, catalytic and ATP-binding domain; DBD, DNA-binding 
domain; DHp, histidine phosphotransfer domain; HPt, histidine 
phosphotransferase; RD, receiver domain. 
Figure 3 
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As TCSs allow for the adaptation of the organism to the external environment, it 
is of little surprise that the number of TCS genes in a genome appears to correlate 
with the typical environmental habitat of a bacteria. In essence, the more diverse 
and changing the environment of the bacteria is, the more TCSs it typically 
encodes 377,380,381.  
 
1.3.2 – Evolution of the two-component system 
 
The evolutionary origin of the TCS is unknown, with limited information attainable 
from genomes analysed thus far. One suggestion arises from the shared 
homology of the ATP-binding domains between SKs and the GHKL superfamily 
of proteins, which bind ATP in ways not dissimilar to SKs, implicating a divergent 
event between these proteins somewhere in the evolutionary tree 377,382. It is 
possible that one-component systems (OCSs), where the input and output 
domains are joined on a single protein, are evolutionary ancestors of TCSs, due 
to the similarities between sensor and DNA-binding domains of OCSs and TCSs, 
as well as the fact that OCSs are more widely distributed than TCSs among 
prokaryotes 383,384. 
While TCSs are found in eukaryotes such as yeasts, fungi, amoebas and plants, 
they do not usually present as basic TCSs, rather the majority of TCSs in these 
eukaryotes are phosphorelays utilising hybrid SKs, with 90 % of plant and 100 % 
of fungal SKs being hybrids 377,385,386. The absence of TCSs from the genomes 
of higher eukaryotes may be explained by the inherent lability of the phosphoryl 
group on aspartate residues. One speculation is that as cellular homeostasis 
became more complex in eukaryotes, the need for longer and more stable signals 
created an evolutionary pressure selecting for alternative residues (or proteins 
containing residues) that provide this stability, such as serine, threonine and 
tyrosine 377. 
The strong sequence similarity between TCSs suggests that gene duplication is 
a common mechanism by which new TCSs may arise. Following a gene 
duplication event, provided that a duplicated TCS is able to carve out its own 
niche in the bacteria, thus avoiding functional redundancy and eventual deletion, 
novel TCSs may arise. This is supported by the finding that SKs and RRs are 
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some of the most common kinds of pseudogene in bacterial genomes, suggesting 
that these TCSs were duplicated but have not yet been removed from the 
genome following function-disrupting mutations 387. An analysis of SK 
phylogenetic distribution found that gene duplication was a major driver of TCS 
evolution, though horizontal gene transfer between species also contributed 
significantly, with the extent of the contribution of each mechanism varying across 
different species 381. Horizontal gene transfer can occur in a variety of ways, such 
as via plasmid conjugation or on pathogenicity islands 388–390. While SKs and RRs 
often form discrete operons with each other, thus making duplication of both 
genes in a single event quite possible, duplicated SKs have a higher propensity 
to present as orphan genes, located away from a cognate RR, when compared 
to SKs gained through horizontal gene transfer 377,381. This presents an 
interesting situation where duplicated TCS genes may retain the ability to interact 
with the original TCS. One example involves the five orphan kinases 
KinA/B/C/D/E in B. subtilis, which are all able to phosphorylate the RR Spo0F, 
which regulates sporulation 373. Additionally, TCSs acquired through duplication 
events tend to have greater levels of novel domain architecture than horizontal 
gene transfer-acquired TCSs, supporting the idea that these mechanisms have 
distinct roles to play in the dissemination and evolution of TCSs 381.  
 
1.3.3 – The therapeutic potential of targeting two-component systems 
 
The separation between the TCS’s histidine/aspartate-based phosphorylation 
and the serine/threonine and tyrosine-based phosphorylation cascades of higher 
eukaryotes presents an opportunity to develop novel antimicrobials against 
TCSs. As higher eukaryotes lack TCSs, compounds specifically targeting TCSs 
would have minimal off-target effects in the host, while the structural similarities 
between different SKs and RRs in bacteria implies that a targeting compound 
may inhibit multiple TCSs simultaneously, an ideal situation for use in clinical 
practice 391. TCSs have also emerged as common regulators of various bacterial 
stress responses and virulence factors; targeting the upstream regulators of 
these processes may present an effective antimicrobial strategy when compared 
to targeting individual factors instead 391.  
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A handful of examples exist of TCSs that have been successfully targeted by 
pharmaceutical compounds. The TCS WalK/WalR is a master regulator of cell 
wall metabolism in several species including B. subtilis and S. aureus, and as 
such is essential for bacterial growth 392–394. Walkmycin B, an inhibitor of the WalK 
SK in B. subtilis and S. aureus, significantly reduced autophosphorylation of WalK 
in both species 395. Similarly, waldiomycin and singermycin B inhibited action of 
WalK, and waldiomycin also affected other SKs in B. subtilis such as PhoR and 
ResE 396,397. A high-throughput screen for WalR inhibitors identified walrycin, 
which was bactericidal against B. subtilis and S. aureus through inhibition of cell 
division 398. The example of the WalK/WalR TCS demonstrates that TCSs can be 
a promising avenue of novel antimicrobials, targeting both SKs and RRs. 
However, examples aren’t limited to just the WalKWalR system. The PhoQ/PhoP 
TCS in Salmonella enterica senses low Mg2+ levels and acidic pH, regulating 
different genes depending on the input signal received, several of which are vital 
for virulence 399. A screen of 255 drug-like compounds looking to identify 
candidates for novel antimicrobials targeting the PhoQ/PhoP system identified 
eight compounds that disrupted the formation of the PhoP-DNA complex in a 
dose-dependent manner, thus inhibiting virulence gene regulation 400. Mutants of 
Salmonella typhimurium with disrupted PhoP/Q regulons have demonstrated 
potential as live vaccine candidates in mouse models, and a PhoP mutant strain 
of M. tuberculosis has also been used as a vaccination candidate in mice and 
guinea pigs 401–404. Due to the common regulation of virulence genes by TCSs, 
strains attenuated in particular TCS function may be promising candidates for live 
vaccines in the future.  
 
1.3.4 – Cross-regulation of two-component systems 
 
There are many situations in which TCSs can interact with one another in various 
ways, such as one TCS regulating the expression of another, or through 
phosphotransfer between non-cognate pairings of SKs and RRs. This 
physiologically relevant interaction is generally known as cross-regulation, as 
opposed to the term crosstalk, which is used to describe physiologically irrelevant 
non-cognate interactions between TCSs. Cross-regulation allows for networks of 
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TCSs to be established within the cell, providing opportunities for more intricate 
responses to environmental stimuli than the binary ‘on/off’ modality of a canonical 
TCS. 
An example of a network of TCSs revolves around the aforementioned low Mg2+-
sensing PhoQ/PhoP TCS in S. enterica and E. coli. Expression of the small 
cytoplasmic-membrane connector protein SafA is induced by stimulation of the 
low pH-sensing EvgS/EvgA, which subsequently activates PhoQ/PhoP via 
interactions of the C-terminal domain of SafA to the sensor domain of PhoQ 
394,405,406. Additionally, PhoP directly regulates the expression of the acid-
response RstB/RstA TCS through binding of its promoter, adding further 
complexity to the network linking the low Mg2+ response and the acid-response 
in these bacteria 394,407.  
 
1.3.5 – Two-component systems in multikinase networks 
 
The remainder of this section will focus on a type of cross-regulation between 
TCSs that utilises direct phosphosignalling-based interactions between SKs and 
RRs, also known as multikinase networks (MKNs). The above example of cross-
regulation demonstrates some possible connections between TCSs, namely 
through the use of small connector proteins and direct regulation of each other’s 
operons, whereas TCSs in MKNs specifically utilise the presence/absence of the 
phosphoryl group as the focus of their interactions. While the insulation between 
TCSs usually prevents unwanted crosstalk, there are many strong examples of 
non-cognate phosphorylation between TCSs that confer functional advantage to 
the cell in the form of sophisticated MKNs. Additionally, MKNs exist in which 
certain SKs can directly modulate the activity of other SKs, rather than through 
phosphorylation of a non-cognate RR. Essentially, in MKNs, rather than 
confusing different signals, the phosphosignalling-based interactions allows for 
higher level decision making in response to stimuli, often integrating multiple 
stimuli into a single, decided cellular output. 
The NarXL/NarPQ system of E. coli is a relatively simple MKN that dictates the 
choice between nitrite (NO2-) and nitrate (NO3-) as alternative electron acceptors 
in anaerobic conditions (Fig 1.4). This MKN ensures that when the preferred 
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electron acceptor, NO3-, is present, NO3- reductase is expressed, but that NO2- 
reductase is only expressed when NO2- is present and NO3- is absent 408,409. This 
MKN contains just two SKs and two RRs, yet provides the opportunity for higher-
level decision making in the bacteria, acting as a good example of the potential 
for MKNs to confer evolutionary advantage to bacteria. 
 
 
 
 
 
 
 
 
Figure 1.4: The NarXL/NarPQ MKN. NarX can phosphorylate its cognate partner 
NarL, while NarQ can phosphorylate both NarL and NarP, but has a slight kinetic 
preference for phosphorylating NarL 409. NarL upregulates NO3- reductase and 
inhibits expression of NO2- reductase, while NarP upregulates NO2- reductase. 
The presence of NO3- leads to activation of both NarL and NarP, though the 
inhibiting action of NarL on NO2- expression means that only NO3- reductase is 
expressed. This occurs with or without the presence of NO2-. It is only when NO2- 
is present without NO3- that NO2- reductase is expressed, as even though NarQ 
can activate NarL, the cognate phosphatase activity of NarX on NarL means there 
is little phosphorylated NarL present. Ultimately, this MKN allows for the 
expression of NO3- reductase whenever NO3- is present, but only allows for the 
expression of NO2- reductase in the absence of NO3-. Dashed arrows signify 
positive interactions, the blunt-end arrow signifies inhibition. Figure adapted from 
Francis and Porter (2019). 
 
 
Figure 4 
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In contrast to the relative simplicity of the NarXL/NarPQ MKN, The GacS network 
of P. aeruginosa is of considerable complexity, regulating the switch between the 
acute and chronic virulence state (Fig 1.5). This MKN consists of 7 different SKs 
which are able to modulate each other in a variety of ways. For example, there is 
extensive protein-protein interaction between the basic SK RetS and the hybrid 
SK GacS that utilises at least three distinct signalling mechanisms; RetS is able 
to receive phosphoryl groups from GacS, act as a phosphatase against the RD 
of GacS and also inhibit the autophosphorylation ability of GacS 410. The MKN 
also includes Hpt proteins, regulatory RNAs and dual-function RRs, which come 
together to produce a fascinating example of the complex decision making 
afforded through the use of MKNs. Ultimately, the GacS MKN contains a wide 
variety of ways that TCSs can interact with one another, such as direct SK-SK 
interactions, phosphorylation of SKs and HPts and multiple SKs phosphorylating 
the same RR. 
There are many more examples of MKNs; cell cycle control in Caulobacter 
crescentus requires the SK DivL for the recruitment of another SK, CckA, to the 
cell pole, and utilises multiple RRs and a HPt protein, while QS in V. harveyi 
exploits a many-to-one network of three SKs phosphorylating a single HPt protein 
375,411,412. Ultimately, while MKNs can take many forms and be of ranging 
complexity, they can confer great advantage to the host through allowing superior 
levels of decision making in response to the environment. 
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Figure 1.5: The GacS MKN of P. aeruginosa. The GacS MKN centres on the 
RR GacA, which is phosphorylated by GacS. Activated GacA promotes the 
chronic virulence phenotype through expression of the regulatory RNAs RsmY 
and RsmZ 375,413,414. As a result, phosphorylation of GacS leads to promotion of 
the chronic virulence phenotype. GacS is modulated positively and negatively by 
LadS and RetS, and RetS is turn is regulated by PA1611 375,410,415,416. PA1611, 
SagS and ErcS’ can also modulate the acute/chronic virulence switch via the Hpt 
protein HptB, which is part of a cascade of proteins that can increase RsmY levels 
to promote the chronic phenotype, or increase motility via the FlgM and FliA 
proteins, promoting the acute phenotype 375,417,418. SagS can also act on BfiS, an 
interaction necessary for biofilm formation. Dashed arrows signify positive 
interactions, blunt-ended arrows signify inhibition, bulb-ended arrows signify 
positive or negative interactions depending on the wider state of the network. 
Figure adapted from Francis and Porter (2019). 
 
 
 
 
Figure 5 
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1.3.6 – Molecular regulation of phosphotransfer specificity 
 
While there are several examples of TCSs cooperating in complex MKNs, TCSs 
traditionally act independently of one another, with phosphotransfer between 
partner SKs and RRs and minimal crosstalk occurring between different TCSs. 
This has been demonstrated by Skerker and colleagues (2005) via systematic 
phosphotransfer profiling of three E. coli SKs against 32 E. coli RRs and six C. 
crescentus SKs against 44 C. crescentus RRs, which showed that while non-
cognate phosphotransfer is possible between certain non-cognate SK-RR 
pairings, each SK had a starkly stronger kinetic preference for phosphorylating 
its cognate RR over other non-cognate RRs 419. Given that TCSs can be present 
in their tens or hundreds in the cell, understanding the molecular basis of 
specificity between SKs and RRs is crucial in fully appreciating the nuance of how 
bacteria sense and respond to their environment. 
Analysis of cognate TCSs pairings has revealed that there are several amino 
acids on SKs and RRs that coevolve together, which possibly aids in the 
generation of a new niche for a recently-duplicated TCS 377,420–422. For example, 
a mutation in the phosphotransfer domain of a SK may require a compensatory 
mutation in the cognate RR, lest the TCS lose the specificity of phosphotransfer, 
or even the ability of the SK to phosphorylate its partner RR at all. A highly-
coevolving subset of specificity residues has been identified on TCS proteins that 
are essential for the specificity of phosphotransfer, which surround the 
phosphotransfer site of TCSs; there are 6 specificity residues on SKs and 7 on 
RRs. As such, one can mutate these residues to rewire the specificity of the SK-
RR phosphotransfer reaction 377,422,423. For example, directed mutagenesis of 
three strongly coevolving specificity residues of the E. coli SKs EnvZ and RstB is 
enough to swap their phosphotransfer specificity, while the E. coli RR OmpR 
could also have its phosphotransfer specificity altered through mutagenesis of 
specificity residues 422. It has been demonstrated in TCSs of M. xanthus that 
specificity residues, in addition to the specificity of phosphotransfer, also regulate 
binding kinetics between SKs and RRs, supporting their role as essential in 
avoiding unwanted crosstalk between TCSs 424. Additionally, residues have been 
identified that mediate SK dimerisation specificity, promoting homodimerisation 
and preventing heterodimerisation 425.  
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1.3.7 – Characterised two-component systems in B. cenocepacia 
 
There are 59 predicted SKs (9 of which are hybrid SKs) and 60 predicted RRs in 
B. cenocepacia, the majority of which are uncharacterised 18,426. The number of 
TCS genes in B. cenocepacia is similar to that of other BCC members and to P. 
aeruginosa, though some environmental bacteria, such as Myxococcus xanthus, 
which has a total of 136 SKs and 127 RRs, have many more TCS genes 377,426. 
A summary of the characterised TCSs in B. cenocepacia can be found in Table 
1.1. 
 
Table 1.1 – Summary of the characterised TCSs in B. cenocepacia. 1 
Locus Name Description Ref. 
BCAL0471/2 EsaSR 
Implicated in drug efflux and integrity of 
the cell membrane. 
427 
BCAL0534/5 RqpSR 
Implicated in the regulation of quorum 
sensing and virulence. 
428 
BCAL2210/11 FixLJ 
~95 % gene identity to the low oxygen-
sensing FixLJ TCS in B. dolosa, 
implicated in virulence, biofilm 
formation and motility. 
203 
BCAL2830/31 - 
Involved with transcription of the 
virulence factor High temperature 
requirement A protease, which is 
required for growth in osmotic and 
thermal stress. 
429 
BCAM0227/8 - 
The SK BCAM0227 is involved in 
sensing of BDSF. Implicated in 
virulence in G. mellonella and mice. 
163 
BCAM0379/81 AtsRT 
Phosphorelay that negatively regulates 
biofilm formation, quorum sensing, 
motility and the T6SS. 
430–
432 
BCAM1493/4 BceS1R1 
Homologous to the GacSA TCS in P. 
aeruginosa. Implicated in the regulation 
of protease production, motility, quorum 
sensing and plant pathogenesis. 
433 
BCAM2756-8 CblSTR 
Locus of two hybrid SKs and one RR 
that is implicated in regulation of the 
cable pilus locus. 
434 
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Currently, there is one potential example of a MKN in B. cenocepacia, the cable 
pilus-regulating cblSTR locus. This locus encodes two membrane-bound hybrid 
SKs, CblS and CblT, and the DNA-binding RR CblR. Upon autophosphorylation, 
the receiver domain of CblS is thought to transfer its phosphoryl group to the Hpt 
domain of CblT, which can then phosphorylate CblR. There is no direct evidence 
for phosphotransfer between the hybrid SKs CblS and CblT, however inactivation 
of either CblS, CblT or CblR leads to a block in transcription from the cblBACD 
locus, suggesting that all three are necessary for functional activation of the cable 
pilus locus 434. Interestingly, while ectopic expression of CblS or CblR in WT B. 
cenocepacia increased the number of piliated cells, expression of CblT blocked 
expression of the cable pilus, perhaps indicating that CblT is able to both promote 
(through phosphotransfer to CblS or CblR) and inhibit (via phosphatase activity 
of either the Hpt domain of CblS or CblR) transcription of the cblBACD locus 434. 
The particular stimuli that activate CblS and CblT have yet to be elucidated, and 
it is unclear how expression of the cblBACD locus is affected by the interactions 
between these SKs. Bioinformatic analysis of the specificity residues of CblS and 
CblT show their SK domains share 4 of 6 specificity residues, and their receiver 
domains share 5 of 7, further strengthening the idea that phosphotransfer can 
occur either between these SKs, or between CblS and CblT and a shared target. 
 
1.3.8 – A potential heavy metal-sensing multikinase network in B. 
cenocepacia 
 
Given that specificity residues regulate the exclusivity of phosphotransfer in 
TCSs, it may be possible to utilise specificity residues as a prediction tool for 
novel MKNs. If the specificity residues of multiple SKs or RRs are similar in a 
bacterial species, it may indicate that non-cognate phosphotransfer between 
these TCSs is not only kinetically possible, but is also of physiological relevance. 
Provided that similarities between specificity residues allows for beneficial non-
cognate phosphotransfer between TCSs, evolutionary pressure may select for 
these similarities, and as such lead to the establishment of a physiologically 
relevant MKN. If novel MKNs can indeed be predicted using this method, it may 
lead to rapid identification of MKNs, accelerating our understanding of bacterial 
environmental regulation and possibly increase the number of potential targets 
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for novel therapeutics. As such, comparisons of the specificity residues of all SKs 
and RRs in B. cenocepacia J2315 have identified several TCS proteins that show 
specificity residue similarities, which may indicate the presence of novel MKNs 
(Table 1.2). 
 
Table 1.2 – Summary of specificity residue similarity in TCS proteins in B. 
cenocepacia. 2 
Gene names Description of specificity residue similarity 
SK similarities 
BCAL2012 + 
BCAL2605 
The predicted orthologue of the E. coli osmolarity-sensing SK EnvZ 
in B. cenocepacia, BCAL2012, shares 5 of 6 specificity residues with 
BCAL2605. 
BCAM0218 + 
BCAM0227 
The BDSF-sensing hybrid SK BCAM0227 shares all 6 SK specificity 
residues with the hybrid SK BCAM0218. Real-time PCR and 
domain-swapping experiments did not reveal any BDSF-genes to be 
regulated by BCAM0218, hence the physiological relevance this 
potential interaction may have to the BDSF system of B. 
cenocepacia remains unclear 163. 
RR similarities 
BCAL1350 + 
BCAL2011 + 
BCAL2606 + 
BCAM2175 
BCAL2011, the predicted orthologue of OmpR, shares 5 specificity 
residues with three other RRs (BCAL2606, BCAL1350 and 
BCAM2175), indicating the potential presence of an osmolarity-
sensing MKN in B. cenocepacia. 
BCAL2211 + 
BCAM0230A 
The FixJ RR and the uncharacterised BCAM0230A share 5 of 7 
specificity residues. 
BCAL2222 + 
BCAL2831 
The predicted nitrogen-sensing BCAL2222 shares 5 of 7 specificity 
residues with BCAL2831. 
BCAM0288 + 
BCAM0623 + 
BCAM1494 
The GacA homologue BceR1 shares 5 of 7 specificity residues with 
BCAM0288 and BCAM0623, potentially indicating the presence of a 
MKN similar to that in P. aeruginosa. 
BCAM0443 + 
BCAM0714 + 
BCAM1418 + 
BCAS0586 
The focus of this work. Four putative metal-sensing RRs share 
between 4-6 specificity residues with one another. 
BCAM0820 + 
BCAM1161 
The receiver domain of the hybrid SK BCAM0820 shares 5 of 7 
specificity residues with the RR BCAM1161. 
BCAM0826 + 
BCAM1162 
Two predicted chemotaxis-specific methylesterases, BCAM0826 
and BCAM1162, share 6 of 7 specificity residues. 
 
 
58 
 
The focus of this work revolves around four putative heavy metal-sensing TCSs 
in B. cenocepacia that share high levels of similarity between their RR specificity 
residues, and thus may form a novel heavy metal-sensing MKN (Fig 1.6). While 
the four SKs do not share great levels of similarity in their 6 specificity residues, 
the 7 specificity residues of the RRs are of significant similarity, particularly when 
focusing on BCAS0586, which shares 6 specificity residues with both BCAM0443 
and BCAM0714, while four specificity residues are identical across all four RRs. 
Interestingly, the overall DNA sequence similarity between these four TCSs is 
significantly greater than to other TCSs in the B. cenocepacia J2315 genome. It 
could therefore be argued that these TCSs originated from a single TCS via gene 
duplication events and have subsequently managed to establish their own 
functional niche in the genome. Evidence for this also lies in the specificity 
residues of the SKs, while not hugely similar in terms of matching residues, there 
are some residues that are identical across three SKs, such as the asparagine of 
the 2nd specificity residue, the glutamine of the 5th and the valine of the 6th.  
Contrastingly, the specificity residues of the four RRs are of much greater 
similarity to each other than of the SKs. Given that the vast majority of RRs in the 
genome share between 0-2 specificity residues with other RRs, it is likely that 
these specificity residues have maintained their similarity to each other through 
some kind of evolutionary pressure, suggesting that there is physiological 
relevance to this potential MKN. 
Previous work has established that deletion of the BCAM0714/5 TCS in B. 
cenocepacia K56-2 confers sensitivity to cadmium and zinc via disrupted 
expression of the CzcCBA efflux pump (Fig 1.7) (Robinson et al., Unpublished 
data). CzcR has been shown to regulate this CzcCBA efflux pump, its own 
BCAM0714/5 operon and a downstream gene region, BCAM0716-0721. Deletion 
of this downstream gene region confers susceptibility to zinc, albeit a lower 
susceptibility than deletion of CzcRS confers, indicating the presence of a novel 
zinc-resistance determinant in this region (Fig 1.7). Transcriptomic analysis 
showed that CzcCBA, BCAM0714/5 and BCAM0716-0721 were all significantly 
upregulated in the presence of 1.5 mM ZnCl2 in comparison to LB. In essence, 
BCAM0714/5 confers resistance to cadmium and zinc via the CzcCBA efflux 
pump, while the BCAM0716-0721 region is also involved in the zinc response. 
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Figure 1.6: A potential novel heavy metal-sensing MKN in B. cenocepacia. 
A) Diagram depicting the TCSs, comprised of four basic SKs and four RRs which 
have DNA-binding domains. All four SKs are adjacent to their partner RRs in the 
genome, forming a discrete operon. Dashed arrows signify presumed cognate 
phosphotransfer. B) Table listing the specificity residues of the four SKs (left) and 
RRs (right). There are 6 specificity residues in SKs and 7 in RRs that are of 
particular importance in regulating specificity of phosphotransfer, and those have 
been selected for comparison. Yellow boxes indicate specificity residues shared 
across all four proteins, while green boxes indicate specificity residues which 
match in two or three proteins. C) A matrix table summarising the number of 
specificity residues which match between pairs of SKs (left) and RRs (right).  
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Figure 1.7: The cadmium and zinc phenotypes of CzcRS in B. cenocepacia 
K56-2. Strains were grown in LB to stationary phase, resuspended in PBS to an 
OD590 of 1 ± 0.05 and serially diluted on LB plates containing various 
concentrations of metal compounds. Deletion of CzcRS and CzcCBA confers 
susceptibility to cadmium and zinc, but not cobalt, while deletion of BCAM0716-
0721 confers susceptibility to zinc. Experiment performed and figure generated 
by Dr Matthew Robinson. 
 
 
 
 
 
 
Figure 6 
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Aside from BCAM0714/5, there is little information in the literature that sheds light 
on the function of the remaining TCSs. A recent paper by Higgins and colleagues 
(2020) identified several copper resistance genes of B. cenocepacia H111 via 
transposon sequencing, including BCAM0442/3 and the downstream 
BCAM0444-0450 gene region 369. Indeed, the genomic neighbourhood of 
BCAM0442/3 includes apparent orthologues of the CusABCF and CopABCDE 
copper/silver-resistance systems, which may implicate BCAM0442/3 in copper 
and/or silver resistance 18,344. Interestingly, the authors also identified the 
BCAM0715 and BCAS0585 SKs, but not their cognate RRs, as being involved in 
copper resistance, perhaps suggesting that these TCSs all contribute to the 
copper response of B. cenocepacia 369.  Aside from this transposon sequencing, 
little is known about what these TCSs respond to and what their wider functional 
role in B. cenocepacia may be. 
This potential MKN is also conserved across the wider BCC. The other major CF 
BCC species, B. multivorans, has four putative metal-sensing TCSs which share 
comparable levels of specificity residue similarity in their SKs and RRs. The 
environmental B. ambifaria has three orthologous TCSs with comparable 
specificity residue similarities, with an orthologue of BCAM0714/5 absent. 
Outside of the BCC, the phytopathogen B. glumae has two potentially 
orthologous TCSs, which share four of their RR specificity residues. Both B. 
pseudomallei and B. thailandensis have two putative metal-sensing TCSs which 
share all of their SK specificity residues and 6 out of 7 RR specificity residues, 
both of which have high levels of similarity to BCAM0714/5, perhaps indicating a 
gene duplication event involving this TCS. There is evidence that a comparable 
MKN exists outside of the Burkholderia genus, as the opportunistic pathogen P. 
aeruginosa has four orthologous TCSs which also share many RR specificity 
residues (albeit at a slightly lower level of similarity to the B. cenocepacia RRs). 
Overall, these TCSs and the overall level of specificity residue similarity is 
relatively well conserved across the Burkholderia genus and possibly also in P. 
aeruginosa, which may have wide implications for the metal response of these 
bacteria, and how they respond to metal-contaminated environments and metal-
containing medical devices and surfaces. 
The notion that these TCSs are metal-responsive stems from the fact that the 
orthologue of BCAM0714/5 in P. aeruginosa (PA2523/4) has been implicated in 
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resistance to cadmium, zinc and cobalt, via upregulation of the CzcCBA RND-
family efflux pump, and has thus been designated as the CzcRS system 319. 
CzcRS in P. aeruginosa also co-regulates resistance to carbapenems via 
downregulation of the OprD porin, the main route of entry for these antibiotics 
319,320,435. The copper-sensing TCS CopRS (PA2809/10) is able to upregulate 
both CzcRS and CzcCBA, and can also downregulate OprD, linking copper, zinc, 
cadmium and cobalt resistance to resistance to carbapenems in P. aeruginosa 
320. This downregulation of OprD by both RRs has been shown to be mediated 
by the RNA chaperone Hfq 436. Additionally, CzcR in P. aeruginosa has been 
identified as a regulator of pyocanin biosynthesis, several quorum sensing genes 
and is required for full virulence in C. elegans, while the IrlRS TCS in B. 
pseudomallei, which confers resistance to cadmium and zinc, is also implicated 
in epithelial cell invasion, further underlining the CzcRS system as a key player 
in regulation of virulence in addition to the metal response 437,438.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
63 
 
1.4 – Project aims 
 
The overall aim of this project was to experimentally validate the putative novel 
heavy metal-sensing MKN in B. cenocepacia, through investigation of potential 
non-cognate phosphotransfer between TCSs of interest, and to elucidate any 
potential physiological relevancy that these interactions may hold. Validation of 
this MKN was carried out by: 
• Evaluation of non-cognate interactions between TCSs via purification of 
SKs and RRs for phosphotransfer assays [Chapter 3]. 
• Generation and phenotypic characterisation of TCS deletion mutants in 
B. cenocepacia K56-2 [Chapter 4]. 
• Exploration of the copper response of B. cenocepacia K56-2 through 
RNA-seq analysis [Chapter 5]. 
• Investigation of the BCAM0716-0721 gene region through targeted 
complementation of the ∆BCAM0716-21 deletion mutant [Chapter 6]. 
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Chapter 2: Materials and Methods 
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2.1 – General culture conditions 
 
Strains and vectors utilised in this study can be found in Table 2.1. All B. 
cenocepacia gene names are as written in the J2315 reference genome. E. coli 
and B. cenocepacia K56-2 were grown at 37 °C in either a shaking incubator (200 
rpm) or static incubator in lysogeny broth (LB) liquid medium or agar unless 
otherwise specified. A full media list can be found in Table 2.2. When suitable, 
filter-sterilised (0.2 µm filter) antibiotics which were added at the following 
concentrations and solvents: Ampicillin (Amp, 100 µg/ml, ddH2O), Gentamicin 
(Gm, 25 µg/ml for E. coli, 50 µg/ml for B. cenocepacia, ddH2O), Kanamycin (Kan, 
25 µg/ml, ddH2O), Polymyxin B (Pol, 25 µg/ml, ddH2O), Tetracycline (Tet, 25 
µg/ml for E. coli, 100 µg/ml for B. cenocepacia, 95 % EtOH), Trimethoprim (Tp, 
50 µg/ml for E. coli, 100 µg/ml for B. cenocepacia, DMSO). Long term storage of 
strains involved storage in LB broth with relevant antibiotics and 15 % glycerol 
(v/v) at -80 °C. 
 
Table 2.1: List of bacterial strains utilised in this work. 3 
Bacterial strain Explanation Source/Reference 
E. coli strains 
E. coli JM109 Calcium-competent E. coli Lab stock 
E. coli GT115 Calcium-competent E. coli Lab stock 
E. coli XL1-Blue Calcium-competent E. coli Lab stock 
E. coli pRK2013 
Helper vector for Triparental 
mating, KanR 
439 
E. coli pGPI-SceI 
(Donor) vector for 1st crossover 
for mutagenesis in B. 
cenocepacia, TpR 
440 
E. coli pDAI-SceI 
(Donor) vector for 2nd crossover 
for mutagenesis in B. 
cenocepacia, TetR 
440 
E. coli pDA17 Expression vector, TetR 429 
E. coli pSCrhaB3 Expression vector, TpR 441 
E. coli pMLS7 Expression vector, TpR 442 
E. coli pGA-G1 Promoter probe vector, GmR 
443/Leo Eberl 
group 
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E. coli M15pREP4 
Calcium-competent E. coli for 
protein expression, KanR 
Lab stock 
E. coli 
pQE80::NusA 
IPTG-inducible protein 
expression vector with 5’ NusA 
gene and 6 x His tag, AmpR 
Dr Vanessa 
Francis 
E. coli pQE80 
IPTG-inducible protein 
expression vector with 5’ 6 x His 
tag, AmpR 
Qiagen 
E. coli 
pQE60::eGFP 
IPTG-inducible protein 
expression vector with 5’ eGFP 
gene AmpR 
This work 
E. coli 
pQE80::eGFP 
IPTG-inducible protein 
expression vector with 3’ eGFP 
gene AmpR 
This work 
B. cenocepacia K56-2 strains 
B. cenocepacia 
K56-2 
WT strain Lab stock 
∆BCAM0442/3 - This work 
∆BCAM0714/5 - This work 
∆BCAM1417/8 - This work 
∆BCAS0585/6 - This work 
∆BCAM0442/3 + 
∆BCAM0714/5 
- This work 
∆BCAM0442/3 + 
∆BCAS0585/6 
- This work 
∆BCAM0714/5 + 
∆BCAS0585/6 
- This work 
∆BCAM0442/3 + 
∆BCAM0714/5 + 
∆BCAS0585/6 + 
- This work 
∆BCAM0433-0450 - This work 
∆BCAM0716-0721 - 
Dr Matthew 
Robinson 
∆czcCBA - 
Dr Matthew 
Robinson 
∆czcCB - 
Dr Matthew 
Robinson 
B. cenocepacia 
K56-2 GmS 
Gentamicin-sensitive WT 
Dr Matthew 
Robinson 
∆BCAM0442/3 GmS - This work 
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∆BCAM0714/5 GmS - This work 
∆BCAM1417/8 GmS - This work 
∆BCAS0585/6 GmS - This work 
 
Table 2.2: List of media utilised in this work. 4 
Media Details Source 
LB 
10 g/L Casein digest peptone, 10 g/L NaCl, 5 g/L Yeast 
extract 
Melford 
2YT 16 g/L Tryptone, 5 g/L NaCl, 5 g/L Yeast extract Lab stock 
M9 
6.78 g/L Na2HPO4, 3 g/L KH2PO4, 1 g/L NH4Cl, 0.5 g/L 
NaCl, 0.4 % Glucose 240.7 mg/L MgSO4, 11.1 mg/L 
CaCl2 
Lab stock 
SOB 
20 g/L Tryptone, 0.5 g/L NaCl, 5 g/L Yeast extract, 
0.75 mg/L KCl, 3.8 mg/L MgCl2 
Lab stock 
TSB 
17 g/L Pancreatic digest of casein, 3 g/L Papaic digest 
of soybean meal, 5 g/L NaCl, 2.5 g/L K2HPO4, 2.5 g/L 
Glucose 
Oxoid 
Note: Relevant agars were created by adding 1.5 % (w/v) of Agar No. 2 
Bacteriological General Purpose (Neogen) 
 
2.2 – General molecular biology techniques 
 
2.2.1 – Crude DNA extraction 
 
Extraction of DNA from individual bacterial colonies for the purposes of PCR 
involved using a 1 µl sterile loop to add a scraping of the colony to 50 µl of lysis 
solution (50 mM NaOH, 0.25 % Sodium dodecyl sulfate (SDS)) prior to incubation 
at 95 °C for 15 minutes. 180 µl of nuclease-free water was then added and the 
lysates spun for 10 minutes at 13,000 rpm. 
 
2.2.2 – Genomic DNA extraction 
 
Genomic DNA was prepared using the GenEluteTM Bacterial Genomic DNA Kit 
(Sigma-Aldrich) following manufacturer’s instructions. Briefly, 5 ml overnight 
culture was centrifuged at 13,000 rpm for 2 minutes and resuspended in lysis 
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solution, followed by RNase A treatment to eliminate residual RNA. Cells were 
then lysed and processed through a spin column. 
 
2.2.3 – Plasmid DNA extraction 
 
Overnight cultures of E. coli containing the relevant plasmid were harvested and 
plasmid DNA extracted using the GeneJET Plasmid Miniprep Kit (Thermo Fisher 
Scientific) following manufacturer’s instructions. Briefly, 5 ml overnight culture 
was centrifuged at 13,000 rpm for 10 minutes, resuspended, lysed and 
chromosomal DNA removed prior to addition to a spin column. 
 
2.2.4 – Gel electrophoresis 
 
Agarose gels of concentrations ranging from 1-1.5 % were made by microwaving 
agarose in Tris-acetate-EDTA buffer, followed by the addition of the stain Midori 
Green (Nippon Genetics) for the purpose of visualising nucleic acid. Samples 
were diluted in 6 x gel loading dye (Thermo Fisher Scientific) and loaded into 
wells alongside a relevant ladder, either 100 bp plus, 1 Kb or 1 Kb plus GeneRuler 
DNA ladder (Thermo Fisher Scientific). Gels were run at 90 V for 45 minutes, and 
visualised via UV light under the Gel Doc XR+ System (Bio-rad).  
 
2.2.5 – Gel extraction of DNA 
 
For DNA products from PCR or restriction digest that required isolating following 
gel electrophoresis, the relevant band was excised using a scalpel blade under 
UV light. The DNA was then processed using the GeneJET Gel Extraction Kit 
(Thermo Fisher Scientific) following manufacturer’s instructions. Briefly, the 
agarose was melted at 60 °C in binding buffer prior to addition to a spin column. 
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2.2.6 – Quantification of DNA and RNA concentration 
 
DNA concentration and quality were assessed via a NanoDrop 1000 (Thermo 
Fisher Scientific). RNA concentration was quantified through the QubitTM 3.0 
Fluorometer (Invitrogen), while quality was assessed using the NanoDrop 1000.  
 
2.2.7 – Polymerase Chain Reaction (PCR) 
 
PCR was carried out using either Taq DNA Polymerase (New England BioLabs) 
or Phusion High-Fidelity DNA Polymerase (using the provided High-Fidelity 
buffer, Thermo Fisher Scientific) depending on requirements. All primers were 
ordered through Eurofins Genomics. Table 2.3 lists the reaction mixture for each 
of these DNA polymerases, while Table 2.4 provides details of relevant cycling 
conditions. Following PCR, DNA was visualised via gel electrophoresis (2.2.4). 
 
Table 2.3: Reaction mixture details for PCR. 5 
Constituent Taq DNA Polymerase 
Phusion High-Fidelity 
DNA Polymerase 
Relevant buffer 1 x (from 10 x stock) 1 x (from 5 x stock) 
dNTPs 200 µM 200 µM 
Forward primer 0.2 µM 0.5 µM 
Reverse primer 0.2 µM 0.5 µM 
DNA template 1 µl 1 µl 
DNA polymerase 0.625 units 0.004 units 
Nuclease-free H2O Up to 25 µl Up to 20 µl 
Note: 3 % Dimethyl sulfoxide was commonly added when amplifying from GC-
rich DNA. 
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Table 2.4: Cycling conditions for PCR. 6 
Cycle stage Taq DNA Polymerase 
Phusion High-Fidelity 
DNA Polymerase 
Initial Denaturation 95 °C for 30 s 98 °C for 90 s 
 Followed by 30 cycles of 
Denaturation 95 °C for 30 s 98 °C for 10 s 
Annealing 
Variable temperature for 
30 s 
Variable temperature for 
30 s 
Extension 68 °C for 60 s /Kb 72 °C for 20 s /Kb 
 Followed by: 
Final Extension 68 °C for 600 s 72 °C for 600 s 
Note: Annealing temperature was dependent on the melting temperature of the 
primers used. For a complete primer list see Appendix section A5. 
 
2.2.8 – Restriction digest of DNA 
 
Restriction digestion of DNA was carried out over an hour at 37 °C with 1 µg of 
DNA using FastDigest restriction enzymes (Thermo Fisher Scientific), in a total 
volume of 40 µl. All restriction enzymes used were active in the FastDigest buffer 
provided, and as such digestions using two enzymes simultaneously were 
commonly performed. Following digestion, DNA was visualised via gel 
electrophoresis and appropriate bands excised (sections 2.2.4-2.2.5). 
 
2.2.9 – Ligation of DNA 
 
Ligation between vector and insert DNA was carried out overnight at 16 °C using 
T4 DNA ligase (New England BioLabs) in a total volume of 20 µl. Generally, a 
molar ratio of insert:vector of 3:1 was used. A vector only control was run 
alongside all ligation reactions for potential troubleshooting purposes. 
Occasionally as a troubleshooting method, FastAP Thermosensitive Alkaline 
Phosphatase (Thermo Fisher Scientific) was used as per manufacturer’s 
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instructions to dephosphorylate vector DNA prior to ligation, ensuring that no 
vector recircularisation occurred during the ligation process. 
 
2.2.10 – Generation of calcium-competent E. coli cells 
 
50 ml of LB broth was inoculated with 1 ml of overnight-grown E. coli cells (either 
JM109, GT115, M15pREP4 or XL1-Blue) and grown at 37 °C until an OD600 of 
0.5-0.6 was reached. Cells were then chilled on ice for 30 minutes, then 
centrifuged at 3,000 rpm for 10 minutes at 4 °C. Cells were resuspended in 25 ml 
of chilled 100 mM CaCl2, and rested on ice for 30 minutes. Cells were then spun 
again at 3,000 rpm for 10 minutes at 4 °C, and resuspended in 2 ml of chilled 100 
mM CaCl2 with 15 % glycerol (v/v). Cells were aliquoted out and stored at -80 °C 
until use. 
 
2.2.11 – Transformation of DNA into calcium-competent E. coli 
 
4 µl of DNA (e.g. ligation product or plasmid extracted from culture) and 50 µl of 
calcium-competent E. coli cells were added to a 1.5 ml microcentrifuge tube, 
gently mixed and chilled on ice for 30 minutes. Cells were heat-shocked at 42 °C 
for 50 s, and immediately returned to ice for 2 minutes. 250 µl of LB broth (without 
antibiotic) was added and cells were incubated at 37 °C, 200 rpm for 1 hour. 
Subsequently, 200 µl of cells were plated onto appropriate antibiotic-containing 
LB plates and grown at 37 °C overnight. Transformants were screened for uptake 
of the vector via PCR and restriction digest. 
 
2.2.12 – Sequence verification of DNA vectors and PCR products 
 
All sequence verification of vectors and PCR products from generated mutants 
was done through Eurofins Genomics (TubeSeq Service). Analysis of 
sequencing data was done using the Clone Manager Professional 9 software 
(Sci-Ed). 
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2.3 – Mutagenesis of B. cenocepacia 
 
2.3.1 – Triparental mating of vectors into B. cenocepacia 
 
Conjugation of relevant vectors into B. cenocepacia was performed using 
triparental mating through use of the pRK2013 helper vector. Donor E. coli strains 
(containing the plasmid of interest), helper E. coli containing pRK2013 and 
recipient B. cenocepacia were grown overnight in 5 ml SOB broth, harvested and 
resuspended in 5 ml SOB broth. Strains were mixed at a recipient:helper:donor 
ratio of 5:1:1 and 150 µl was plated without spreading onto a SOB plate (without 
antibiotics) and grown overnight at 37 °C.  
Pools of growth were then resuspended in 2 ml PBS and plated on SOB agar 
plates containing appropriate antibiotics. These were a combination of either 
gentamicin or polymyxin B (to kill the donor and helper E. coli, both at a 
concentration of 25 µg/ml) and the relevant antibiotic for the vector of interest’s 
resistance marker (to select for B. cenocepacia that had successfully taken up 
the vector). Plates were grown for between 24-48 hours at 37 °C. Resultant 
colonies were screened via PCR for a) confirmation that the colony was B. 
cenocepacia and b) successful conjugation of the vector of interest. 
 
2.3.2 – Generation of in-frame deletion mutants of B. cenocepacia 
 
Relevant deletion mutants of B. cenocepacia were generated using a system 
based on the homing endonuclease I-SceI 440. This involved the cloning of the 
immediate upstream and downstream regions (approximately 700 base pairs) of 
the target gene(s) into the pGPI-SceI donor suicide vector, which contained a 
recognition site for I-SceI. The pGPI-SceI vector was conjugated into B. 
cenocepacia via triparental mating (section 2.3.1) and integrated into the genome 
through homologous recombination. This first crossover was subsequently PCR 
verified. 
A second triparental mating conjugated the pDAI-SceI vector, which expressed 
the I-SceI endonuclease, into the first crossover. I-SceI would then cleave the 
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recognition site of pGPI-SceI, triggering a second recombination event in the 
genome, resulting in either a restored wildtype or an unmarked deletion. Second 
crossovers were then PCR and sequence verified through amplification of the 
region upstream and downstream of the sites of homologous recombination. 
Figure 2.1 summarises the process of mutagenesis in B. cenocepacia. 
 
 
Figure 2.1: Generation of unmarked in-frame deletion mutants in B. 
cenocepacia. Upstream (F1) and downstream (F2) flanks of genes of interest 
are cloned into pGPI-SceI, which harbours a recognition site for the homing 
endonuclease I-SceI. The R6K γ origin of replication ensures that pGPI-SceI 
cannot be replicated within B. cenocepacia, and as such successful first 
crossovers can be selected for by plating onto trimethoprim. Conjugation of pDAI-
SceI into first crossovers leads to expression of I-SceI, which will cut at the 
recognition site (5’-TAGGGATAACAGGGTAAT-3’) leading to a double-stranded 
break in the chromosome. This triggers repair machinery which results in 
recombination at one of two sites, resulting in either a wildtype revertant or an 
unmarked deletion mutant. Second crossovers can then be PCR and sequence 
verified. Figure adapted from Flannagan et al (2008). 
Figure 7 
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Following verification of the in-frame deletion mutants, pDAI-SceI was cured out 
of B. cenocepacia mutants. Mutants containing pDAI-SceI were grown overnight 
in M9 minimal media at 37 °C, with subsequent serial dilutions plated onto LB 
agar and grown overnight at 37 °C. Individual colonies were then screened for 
resistance to tetracycline to identify cured mutants, which were PCR verified for 
loss of pDAI-SceI. 
 
2.3.3 – Complementation of B. cenocepacia deletion mutants 
 
In the interest of attempting to complement deletion mutants with expression 
levels of genes similar to those found in wildtype bacteria, a modified pDA17 
vector that lacked the native dhfr promoter was generated 429. This allowed for 
the cloning of gene operons that contained the predicted upstream promoter 
region of those operons, leading to expression that was dictated by regulation of 
the promoter region, rather than an expression that was constitutively active. 
Following cloning of relevant inserts, pDA17 was conjugated into the deletion 
mutants via triparental mating (section 2.3.1). 
 
2.4 – Purification of SK and RR proteins 
 
2.4.1 – Construction of SK and RR expression vectors 
 
For the purpose of ascertaining the potential for non-cognate phosphotransfer, 
RR genes were amplified in full and cloned into the pQE80 expression vector, 
however for SKs it was necessary only to purify the intracellular portion of the 
protein, excluding the extracellular and intramembrane portions. In order to 
predict the exact point in the gene at which the intracellular region began, the 
transmembrane region predictor TMpred was used 444. Upon prediction of the 
location of the intracellular region, SK genes were amplified and cloned into the 
pQE80::NusA expression vector. RR genes were amplified and cloned into 
pQE80 (lacking the N-terminal NusA tag). Due to the similarity in size between 
RRs and the intracellular domains of SKs, the N-terminal NusA tag (54.9 kDa) 
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allowed for size discrimination on the SDS-PAGE during the phosphotransfer 
assay (section 2.5). 
In the interest of verifying whether non-cognate phosphotransfer still occurred in 
the presence of the cognate RR, RR genes were also cloned into pQE60::eGFP 
and pQE80::eGFP vectors, to allow the tagging of eGFP onto the C-terminus and 
N-terminus respectively. This increased the size of the RR by approximately 28 
kDa, allowing for an untagged RR, an eGFP-tagged RR and a NusA-tagged SK 
to be visualised on the same SDS-PAGE. 
 
2.4.2 – Purification of SK and RR proteins 
 
Following successful construction of relevant expression vectors, overnight 
culture of relevant E. coli strains underwent plasmid extraction and vectors were 
transformed into calcium-competent M15pREP4 E. coli cells and grown overnight 
in LB supplemented with 2 % glucose (v/v) to prevent leaky protein expression. 
Individual colonies were then grown in 25 ml of LB with 2 % glucose (v/v) 
overnight, and added the following morning to 500 ml of 2YT media containing 
ampicillin and kanamycin. 
Cultures were grown at 37 °C and 200 rpm to an OD600 of 0.4-0.6, at which IPTG 
was added to a final concentration of 100 µM to induce protein expression. 
Cultures were then grown overnight at 18 °C at 200 rpm. Following overnight 
growth, cultures were spun at 8000 g for 20 minutes at 4 °C, with E. coli pellets 
resuspended in 30 ml of lysis buffer (10 % glycerol, 50 mM Tris (pH 8), 150 mM 
NaCl, 10 mM Imidazole, 1 mM DTT) and stored at -20 °C until further purification. 
For the final stages of purification, E. coli cell pellets were thawed and sonicated 
on ice for 6 pulses of 20 seconds using a Vibra-Cell VCX 130 (Sonics). Lysates 
were spun at 19000 g for 30 minutes, with the resulting supernatant syringe 
filtered through a 0.4 µm filter. Around 1.5 ml of Ni-NTA Agarose slurry (Qiagen) 
was added to a column and left until separation of the ethanol and nickel solution. 
The ethanol was allowed to drip through, and following this 2 ml of lysis buffer 
was added to equilibrate the column. Subsequently supernatant was added to 
the column and allowed to drip through fully. This allowed the 6 x His tag-
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containing SKs and RRs to bind to the column. The column was then washed 
with lysis buffer for 90 minutes, when finally around 5 ml of elution buffer (10 % 
glycerol, 50 mM Tris (pH 8), 150 mM NaCl, 200 mM Imidazole, 1 mM DTT) was 
added. Protein was collected in a 1.5 ml microcentrifuge tube as it passed through 
the column, with the majority aliquoted into 100 µl volumes and stored at -20 °C 
until use. The remainder of the protein was kept for analysis through SDS-
polyacrylamide gel electrophoresis (SDS-PAGE) and the Bradford assay.  
 
2.4.3 – Analysis of proteins through SDS-PAGE 
 
Protein samples were diluted in NuPAGE LDS Sample buffer (Thermo Fisher 
Scientific) and heated for 5 minutes at 96 °C. NuPAGE 4-12 % Bis-Tris gels were 
set up in an XCell Surelock Mini-Cell tank filled with NuPAGE MES SDS Running 
Buffer. 20 µl of diluted samples were added to wells, with 5 µl of protein ladder 
added to each end of the gel. Gels were run for 30 minutes at 180 V, and 
subsequently washed three times in dH2O for 5 minutes. Approximately 20 ml of 
SimplyBlue SafeStain (Invitrogen) was poured onto the gel and left to shake 
gently for 1 hour. Gels were then destained in dH2O for at least 1 hour prior to 
viewing on an Odyssey CLx Imager (LI-COR) 
 
2.4.4 – Analysis of protein concentration using the Bradford assay 
 
The Bradford assay relies on the colour change associated with protein binding 
to Coomassie Brilliant Blue G-250, which can be quantified through 
spectrophotometry. 50 µl of various dilutions of protein sample were added to 2.5 
ml of Protein Assay Dye Reagent (BIO-RAD) which had been diluted 5 x in 
ddH2O. The solution was then vortexed and left for 5 minutes to allow colour 
change to develop, and the absorbance subsequently read at OD595. The 
absorbance reading could be used to calculate protein concentration by 
comparison of optical densities to a set of standards of known concentrations of 
Bovine Serum Albumin. 
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2.5 – Phosphotransfer assay 
 
2.5.1 – Phosphotransfer assay without pre-phosphorylated SKs 
 
Phosphorylation assays have been widely utilised to characterise the nature of 
protein phosphorylation, and has been a particularly useful method of 
investigating phosphotransfer between proteins. The phosphotransfer assays 
utilised in this work were adapted based on previously described methodologies 
445,446. All phosphotransfer reactions were carried out in TGMNKD buffer (10 % 
glycerol, 150 mM NaCl, 50 mM Tris (pH 8), 1 mM DTT, 5 mM MgCl2, 50 mM KCl). 
Assays were performed within 28 days of the activity date of the [γ-32P] ATP (3.7 
GBq/mmol, PerkinElmer), which corresponded to two half-lives of the compound. 
Proteins were added to 1.5 ml microcentrifuge tubes containing TGMNKD buffer 
at concentrations of 20 µM for SKs and 10 µM for RRs. The assay was performed 
at 20 °C in a total volume of 100 µl and started through addition of 2 mM [γ-32P] 
ATP (3.7 GBq/mmol, PerkinElmer). At appropriate timepoints, 10 µl of reaction 
mixture was removed and quenched in 20 µl of SDS loading dye (37.5 % glycerol, 
7.5 % SDS, 90 mM EDTA, 37.5 mM Tris (pH 6.8), 3 % β-mercaptoethanol) and 
kept on ice. Samples were loaded on 12 % polyacrylamide gels (previously 
prepared using the PROTEAN Multi-Casting Chamber, BIO-RAD) and run at 300 
W for 1 hour at -5 °C using an anti-freeze system. Gels were then exposed to 
pre-bleached Phospho sheets for 1 hour and subsequently imaged with a Fujifilm 
FLA-7000 viewer. Any quantification of protein gels was performed using the Multi 
Gauge software package (Fujifilm) 
 
2.5.2 – Phosphotransfer assay with pre-phosphorylated SKs 
 
Depending on the particular requirements of the assay, pre-phosphorylation of 
the SKs occurred either immediately before the commencement of the 
phosphotransfer assay, or between the initial elution from the nickel column and 
a subsequent elution from a second nickel column. In the former case, prior to 
commencement of the phosphotransfer assay, SKs were incubated with [γ-32P] 
ATP (3.7 GBq/mmol, PerkinElmer) in TGMNKD buffer for 1 hour to allow for SK 
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autophosphorylation. Pre-phosphorylated SKs were then used immediately in 
the phosphotransfer assay through addition of RRs, thus commencing the 
assay. The remainder of the assay was performed as per section 2.5.1. 
For SKs that were to be purified away from the radiolabelled ATP, following 
elution from the nickel column during the protein purification process, SKs were 
incubated with [γ-32P] ATP (3.7 GBq/mmol, PerkinElmer) in TGMNKD buffer for 
1 hour to allow for SK autophosphorylation. Pre-phosphorylated SKs were then 
washed through and eluted off a second nickel column to separate SKs from 
remaining radiolabelled ATP, and subsequently stored at -20 °C. To assess 
concentration of pre-phosphorylated SKs, pre-bleached Phospho sheets were 
exposed to card containing a dilution series of each pre-phosphorylated SK for 
1 hour, and subsequently imaged with a Fujifilm FLA-7000 viewer. The 
concentration of pre-phosphorylated SKs was then quantified against a set of 
standards of known radioactivity using the Multi Gauge software package 
(Fujifilm). 
 
2.6 – Heavy metal sensitivity assays 
 
For all heavy metal sensitivity assays, overnight cultures of B. cenocepacia 
strains were pelleted and resuspended in PBS to an OD600 1 ± 0.05. All metals 
were prepared in sterile ddH2O. 
For heavy metal-supplemented agar plates, standardised strains were serially 
diluted in PBS down to 10-5, spotted on LB plates supplemented with differing 
concentrations of heavy metals and grown overnight at 37 °C. 
For growth curves performed in 10 ml volumes, three falcons containing LB broth 
and relevant heavy metal concentrations were prepared for each concentration 
of metal per strain. 50 µl of standardised strains were added to each falcon to a 
total volume of 10 ml and grown at 37 °C at 200 rpm. 1 ml was taken at relevant 
time points and the OD600 measured. For any OD600 > 1, culture was diluted prior 
to measurement.  
For growth curves in 96-well plates, 190 µl of LB broth containing differing 
concentrations of heavy metals was added to each well of a 96-well plate. 10 µl 
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of standardised culture diluted to 10-1 was added to relevant wells. All strains 
were grown in each condition in triplicate. Growth curves were performed over 48 
hours at 37 °C in a NanoQuant Infinite M200 PRO plate reader (Tecan). Plates 
were constantly shaking at 200 rpm except for approximately 5 minutes every 30 
minutes to allow the plate reader to measure the OD600 of the wells. 
For checkerboard assays 447, 190 µl of LB broth containing differing 
concentrations of heavy metals and/or antibiotics were added to each well of a 
96-well plate. 10 µl of standardised culture diluted to 10-1 was added to all wells 
of a plate, with each strain being grown in a separate plate. An additional plate 
was generated that would have 10 µl of PBS added rather than bacteria, which 
served to generate blank values for each well. Plates were then sealed with 
parafilm and grown for 21 hours at 37 °C at 125 rpm. The OD600 of each plate 
was then measured on a NanoQuant Infinite M200 PRO plate reader (Tecan). 
 
2.7 – Investigation of promoter induction via gfp transcriptional 
fusion 
 
Promoters of interest were amplified by PCR with BamHI cut sites located on 5’ 
and 3’ ends and subsequently cloned upstream of a gfp gene in the pGA-G1 
vector (kindly provided by the Leo Eberl group, University of Zurich, Switzerland). 
pGA-G1 vectors were conjugated into B. cenocepacia gentamicin-sensitive 
mutants and PCR verified for successful uptake of pGA-G1. 
For all fluorescence assays, a 96-well black polystyrene plate (Corning) was used 
to minimise crosstalk between wells. Overnight LB cultures of strains were 
pelleted and resuspended in PBS to an OD600 1 ± 0.05. 10 µl of standardised 
culture diluted to 10-1 was added to wells containing 190 µl of unsupplemented 
LB or LB supplemented with relevant metals (either 1 mM CuCl2, 1 mM ZnCl2, 
0.25 mM CdCl2, 0.25 mM CoCl2 or 5 µM AgNO3) and 20 µg/ml gentamicin. Plates 
were sealed with parafilm and incubated for 24 hours at 37 °C shaking at 125 
rpm. All strains were grown in each condition in triplicate.  
Following 24 hour growth, the OD600 and fluorescence intensity (excitation – 485 
nm, emission – 528 nm) of each plate was read using a CLARIOstar Plus plate 
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reader (BMG Labtech). Fluorescence measurements were corrected for growth 
by division of raw fluorescence values by the OD600 reading for each well. 
 
2.8 – Biofilm assay 
 
Assessment of biofilm formation ability was based on the MBEC biofilm system, 
adapted for use with B. cenocepacia 448–451. Strains were grown on LB plates 
containing appropriate antibiotics overnight at 37 °C. Strains were then 
restreaked on TSA plates without antibiotics and grown overnight at 37 °C. 
Growth was resuspended in PBS using a sterile swab to an OD600 1 ± 0.05 and 
diluted 1:200 in TSB broth. 150 µl of diluted strains were added to the wells of a 
96-well plate (8 wells per strain/condition), and an MBEC Biofilm Inoculator 96 
peg-lid was added to the plate, sealed with parafilm and incubated for 24 hours 
at 37 °C shaking at 125 rpm. Following this, the peg-lid was added to a fresh 96-
well plate containing 150 µl of TSB broth in each well, sealed with parafilm and 
incubated for another 24 hours under similar conditions, resulting in a total 
incubation time of 48 hours. 
Following the second 24 hour incubation, the OD600 of the 96 well plate was 
measured to quantify growth, and the peg-lid added to a 96-well plate containing 
PBS for 2 minutes. The peg-lid was then left to dry at room temperature for 10 
minutes, before being baked at 65 °C for 20 minutes. The peg-lid was then added 
to a plate containing 0.1 % crystal violet for 30 minutes on a rocker to allow 
staining of the biofilm on the pegs. The peg-lid was then washed in plates 
containing PBS three times for five minutes, before being dried at room 
temperature for 10 minutes. The peg-lid was subsequently added to a 96-well 
plate containing 95 % ethanol for 20 minutes on a rocker to remove the crystal 
violet from the pegs. Finally, the OD570 of the plate was measured. Any strains 
that had an OD570 of above 1 were diluted in 95 % ethanol and remeasured to 
ensure accuracy of measurement of biofilm formation. 
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2.9 – Galleria mellonella infection assay 
 
The larvae of the greater wax moth, G. mellonella, were used as a model for 
assessing virulence of different mutants of B. cenocepacia 160,452,453. All larvae 
were sourced from UK Waxworms Ltd (Sheffield, UK). Larvae that were within 
the 200-300 mg weight range were selected for use in the assay. 10 larvae were 
used per strain, and PBS and no-stab controls were included in every assay. 
Overnight LB cultures of strains were pelleted and resuspended in 5 ml of PBS, 
before being pelleted again and resuspended to an OD600 1 ± 0.05 in PBS. Strains 
were serially diluted down to 10-5, followed by a further 1:4 dilution, i.e. to an 
approximate concentration of 2500 CFU/ml, leading to a dosage of 25 
CFU/larvae. 
A PB600 Gastight Repeating Dispenser (Hamilton) was prepared by rinsing in 
100 % ethanol, followed by 70 % ethanol and finally PBS. This sequence of 
rinsing was carried out between different strains being injected. 2 x 5 µl injections 
were given into the upper left pro-leg of the larvae. Larvae were then incubated 
at 37 °C for 120 hours, with larvae being checked every 24 hours to assess the 
numbers of alive and dead larvae. Larvae were considered to be ‘alive’ if there 
was any sign of movement following a tactile stimulus with a micropipette tip.  
 
2.10 – Establishing antibiotic MICs of B. cenocepacia mutants 
 
190 µl of LB broth containing increasing concentration of antibiotics were added 
to wells of a 96-well plate. 10 µl of standardised culture diluted to 10-1 was added 
to relevant wells of the plate, which was subsequently sealed with parafilm and 
grown for 21 hours at 37 °C at 125 rpm. The OD600 of each plate was then 
measured on a NanoQuant Infinite M200 PRO plate reader (Tecan). 
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2.11 – Tissue culture and intracellular survival assay 
 
2.11.1 – Culture of J774A.1 macrophages 
 
The murine macrophage cell line J774A.1 was used for all gentamicin-protection 
assays. Cells were cultivated in high glucose Dulbecco’s modified eagle medium 
(DMEM) supplemented with 10 % foetal bovine serum (FBS). Cells were grown 
in a T75 flask with 25 ml of DMEM media at 37 °C with 5 % CO2. Cells were split 
at 1:5 ratio every 2-3 days, by washing cells in PBS and scraping adherent cells 
into fresh DMEM. Fresh cells were regularly resuscitated from storage in liquid 
nitrogen and 5 % DMSO to ensure that only cells at a passage number of between 
5-15 were used for gentamicin-protection assays. 
 
2.11.2 – Gentamicin protection assay 
 
J774 macrophages were seeded in two 24-well plate at a density of 2.5 x 105 
cells/well, with three wells per plate prepared for each strain (plus a negative 
control). These two plates would be used for a 2 hour and 24 hour post-infection 
timepoint during the assay 463. The following day overnight culture of gentamicin-
sensitive B. cenocepacia strains were pelleted, resuspended in PBS and 
standardised to OD590 1 ± 0.05. Standardised strains were then diluted in DMEM 
supplemented with 10 % FBS to a multiplicity of infection (MOI) of 4, i.e. a total 
of 1 x 106 cells/ml infecting 2.5 x 105 macrophages.  
All media used in the assay was pre-warmed at 37 °C, while all incubations were 
done at 37 °C with 5 % CO2 buffering. Macrophages were washed twice in 1 ml 
PBS, prior to the addition of 1 ml of the relevant diluted bacterial strains (or fresh 
DMEM for the negative control). The inoculating dose was calculated by plating 
out 20 µl spots of serial dilutions of each diluted strain and counting the number 
of CFUs the following day. Bacteria were allowed to internalise into the 
macrophages through incubation for 2 hours. Macrophages were then washed 
once with 1 ml PBS, prior to the addition of 1 ml of DMEM containing 50 µg/ml 
gentamicin, in order to kill extracellular bacteria. Macrophages were then 
incubated for 2 hours. 
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Both plates were then washed three times in 1 ml PBS. Following this, the plate 
designated for the 24 hour timepoint had 1 ml DMEM containing 10 µg/ml 
gentamicin added to each well and was incubated for another 22 hours, while the 
macrophages of the plate designated for the 2 hour timepoint were lysed through 
addition and mixing of 1 ml of 0.1 % (v/v) Triton X-100 to the wells. 20 µl spots of 
serially diluted lysates were plated out, grown overnight at 37 °C and CFUs 
counted the following day. The plate designated for the 24 hour timepoint was 
similarly processed following the 22 hour incubation. 
2.12 – RNA-seq analysis of the B. cenocepacia copper response 
 
2.12.1 – Extraction of RNA from B. cenocepacia 
 
Overnight LB cultures of WT and ∆BCAM0442/3 strains of B. cenocepacia were 
standardised to OD600 1 ± 0.05, with 50 µl being added to a 50 ml falcon tube 
containing either 10 ml of LB or LB supplemented with 1 mM CuCl2. 1 mM had 
been determined to be a sufficient sub-inhibitory concentration of CuCl2 via a 
growth curve done under similar conditions. Each strain was added to each 
condition in triplicate, resulting in 12 total RNA extractions. 
After 8 hours of growth, to allow cultures to reach mid log phase, 2 ml of each 
culture was pelleted and resuspended in 10 ml of RNAlater stabilisation solution 
(Thermo Fisher Scientific) and stored at 4 °C overnight, followed by longer-term 
storage at -20 °C. 
Extraction of total RNA was performed using the RiboPure RNA Purification Kit 
(Thermo Fisher Scientific) following manufacturer’s instructions. RNaseZap 
RNase Decontamination Solution (Thermo Fisher Scientific) was applied to all 
work surfaces and equipment to ensure minimal degradation of total RNA.  
Quality of RNA was assessed through use of a 4200 TapeStation System 
(Agilent), while RNA concentration was assessed with a QubitTM 3.0 Fluorometer 
(Invitrogen). Samples that had an RNA integrity rating of 8 or greater were sent 
for RNA-seq analysis. 
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2.12.2 – mRNA enrichment and library preparation 
 
Depletion of rRNA, mRNA library preparation and mapping of reads to the B. 
cenocepacia J2315 genome were performed by the Exeter Sequencing Service. 
ERCC spike-in control mixes (Thermo) were added to each sample according to 
manufacturer’s instructions. rRNA was depleted from total RNA samples using 
the Ribo-Zero rRNA Removal Kit (Illumina), while libraries were prepared with the 
Tru-Seq RNA protocol (Illumina). Sequencing was performed on an Illumina 
HiSeq2500 platform yielding 72 million 125 bp paired end reads. Reads were 
checked for quality using FastQC and for contamination using Fastq_screen. 
Sequencing adapters and low quality bases (< Q22) were removed using 
cutadapt and reads shorter than 75 bp were discarded 454. 
Salmon was used to quantify transcript expression against the B. cenocepacia 
J2315 genome and annotation 455. DESeq2 was used to calculate likelihoods of 
differential expression between conditions and to visualise results after log 
normalisation 456. An adjusted p value of p < 0.05 and a fold change of > 2 was 
used to define significantly differentially expressed genes. 
 
2.13 – Statistical analyses 
 
All statistical analyses barring the RNA-seq analysis were performed in 
GraphPad Prism 8.0. Details of statistical analyses performed and exact number 
of replicates can be found in relevant figure legends. All error bars show standard 
error of the mean (SEM). Statistical significance was taken to be p < 0.05.  
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Chapter 3: Investigation of non-cognate 
phosphotransfer between TCSs 
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3.1 – Introduction 
 
As described in Chapter 1, there are many ways in which TCSs can interact with 
one another, such as through non-cognate phosphotransfer, kinase-kinase 
interactions, regulation of one TCS by another through intermediate proteins such 
as histidine phosphotransferases, or direct regulation of the regulon of one TCS 
by another under certain conditions. Theoretically a network of TCSs can take 
many different forms, some relying solely on non-cognate interactions 
(interactions between SKs and RRs that don’t reside in the same operon), some 
only crossing paths at the level of regulation of DNA expression, with others being 
a mix of many different modalities of interaction. 
The four putative heavy metal-sensing TCSs in B. cenocepacia share great 
similarity in the specificity residues of their RRs (Fig 1.6). While it is possible that 
these TCSs can regulate each other’s regulons, or interact at the kinase-kinase 
level, this RR specificity residue similarity points strongly towards a model of 
direct non-cognate phosphotransfer being kinetically possible between the SKs 
and RRs of these TCSs. 
The methodology employed in this chapter revolves around the phosphotransfer 
assay, essentially the use of radiolabelled [γ-32P] ATP to assess phosphorylation 
of purified SKs and RRs followed by resolving of SKs and RRs via SDS-PAGE 
and imaging of the radiolabelled proteins. This allows the determination of in vitro 
activity and phosphotransfer capabilities of different SK-RR pairings, thus giving 
an insight into whether non-cognate phosphotransfer is kinetically possible 
between different SKs and RRs.  
What the phosphotransfer assay cannot provide is an indication to how 
physiologically relevant any observed non-cognate phosphotransfer is. One can 
quantify the levels of non-cognate phosphotransfer within any SK-RR pairing, but 
this does not approach the dynamism of the cellular environment, which may 
contain tens or even hundreds of different SKs and RRs at any given time. 
Because of this, in addition to assays looking for evidence of non-cognate 
phosphotransfer between the four SKs and four RRs, assays containing a SK, its 
cognate RR and a non-cognate RR were performed with the aim of establishing 
to what extent non-cognate phosphotransfer is reduced in the presence of the 
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cognate partner. While this too has limitations, it does provide insight into which 
non-cognate interactions may be the most kinetically favourable even in the 
presence of the cognate partner, and as such may perhaps be of particular focus 
for further study. 
To facilitate these phosphotransfer assays, SKs and RRs were purified with a 6 
x His tag to allow for nickel affinity column purification. RRs were also purified in 
a His tag + eGFP-tagged form, to allow for size discrimination by SDS-PAGE 
against the His tag-purified form (herein referred to as ‘untagged’). As 
phosphotransfer is not dictated by the extracellular or transmembrane portions of 
SKs, only the intracellular portions were purified. As the SK intracellular portions 
were of similar size to untagged RRs, these SKs were then tagged with an N-
terminal NusA-tag (54.9 kDa), to ensure proteins were of different enough 
weights to observe on SDS-PAGE. 
Ultimately, this chapter aims to prove whether non-cognate phosphotransfer is 
possible between these four TCSs. Based on the specificity residue similarity 
between the RRs (Fig 1.6), one may hypothesise that at least one SK of the four 
may be able to phosphorylate multiple RRs, forming a MKN. 
 
3.2 – Results 
 
3.2.1 – Prediction of SK transmembrane portions 
 
As only the intracellular portions of SKs were required for phosphotransfer assay, 
transmembrane portions were predicted using TMpred (Fig 3.1) 444. The 
autophosphorylation and phosphotransfer domains of SKs should follow the final 
intramembrane portion, hence the region immediately following the final 
transmembrane portion was amplified.  
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Figur e 8 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.1: Prediction of transmembrane portions using TMpred. Each SK 
was inputted into the TMpred prediction tool, which provided the above four 
graphs as its output. Peaks highlighted in blue indicate likely intramembrane 
regions, while the region to the right of the red dashed line indicates the region of 
the SK which was amplified. For each SK, the cloned region begins at the 
following amino acid: BCAM0442 – S193, BCAM0714 – S192, BCAM1417 – 
A179, BCAS0585 – R208.  
 
3.2.2 – Construction of SK and RR expression vectors 
 
Primers were designed to amplify the intracellular portions of SKs and the entirety 
of RRs, to clone into pQE80::NusA and pQE80 respectively (Plasmid maps can 
be found in Figure 3.2). PCR amplification was done with Phusion High-Fidelity 
DNA Polymerase. SKs were cloned into the pQE80::NusA expression vector, 
which contained an N-terminal 55 kDa NusA tag and 6 x His tag, serving to 
BCAM0442 BCAM0715 
BCAM1417 BCAS0585 
Residue number Residue number 
Residue number Residue number 
Score 
Score 
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increase the mass of SKs to allow for size discrimination through SDS-PAGE 
against untagged RRs and for purification purposes through a nickel column 
respectively. RRs were also N-terminally tagged with a 6 x His tag through 
expression in the pQE80 vector (without a NusA tag). 
 
 
Figure 3.2: Example plasmid maps for expression of BCAM0442 and 
BCAM0443. Gene sequences for intracellular regions of SKs were cloned into 
pQE80::NusA, while RR sequences were cloned into pQE80. Relevant cloning 
sites for cloning of the SK BCAM0442 and the RR BCAM0443 and 6 x His tags 
are shown. Plasmid maps made on Clone Manager Professional 9 (Sci-Ed). 
 
Following ligation of gene inserts into relevant plasmids, plasmids were 
transformed into chemically competent XL1-Blue E. coli cells, with successful 
transformants verified through restriction digest and sequencing of gene inserts. 
 
 
 
 
 
 
Figure 9 
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3.2.3 – Expression of SKs and RRs 
 
Following sequence verification of gene inserts in expression vectors, SKs and 
RRs were expressed through growth of E. coli in 2YT media and induction with 
IPTG. Following induction E. coli culture was lysed and passed through a nickel 
column, allowing for binding and purification of the 6 x His tag-containing proteins. 
SDS-PAGE of successfully purified proteins can be found in Figure 3.3. The 
Bradford assay was performed to assess protein concentration. 
 
Figure 3.3: Example of SDS-PAGE of purified NusA-tagged SKs and 
untagged RRs. From a 1.5 ml eluate, 1 µl of protein sample was loaded in the 
left-hand gel, while 10 µl was loaded in the right-hand gel. Expected protein sizes 
(kDa): BCAM0442 (NusA) – 92.9, BCAM0443 – 26.8, BCAM0715 (NusA) – 93.2, 
BCAM0714 – 26.8, BCAS0585 (NusA) – 92.4, BCAS0586 – 26.7, BCAM1417 
(NusA) – 96.6, BCAM1418 – 27.2. 
 
All NusA-tagged SKs and untagged RRs expressed relatively well aside from 
BCAM1418, of which comparatively low yields were produced (~ 2 mg compared 
to averages of > 15 mg for the other untagged RRs for 500 ml culture). Final 
yields for NusA-tagged kinases were consistently > 10 mg. Additionally, SDS-
PAGE of purified BCAM1418 consistently showed possible cleavage products 
alongside the RR band that were not seen when assessing the purity of the other 
untagged RRs. It is possible that these bands are other proteins that eluted off 
Figure 10 
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the nickel column alongside BCAM1418, such as chaperone proteins, though 
they may also be products of cleavage and/or dimerisation of the RR. 
 
3.2.4 – Cognate phosphotransfer between SKs and RRs 
 
Once proteins were purified, the ability of each SK to autophosphorylate and 
phosphotransfer to its cognate RR was assessed through the phosphotransfer 
assay (Fig 3.4). All SKs were able to autophosphorylate and undergo 
phosphotransfer with their cognate RR. Additionally, RRs incubated alone with 
[γ-32P] ATP displayed no phosphorylation, confirming that the phosphorylation 
seen in the assay is through phosphotransfer from the cognate SK. 
The variations in the strength of the phosphorylated SK and RR bands (herein 
referred to as SK-P and RR-P respectively) suggest that the kinetics of cognate 
phosphotransfer differ in vitro for these TCSs. The lack of SK-P band for 
BCAM0442 and BCAM0715 when incubated alongside their cognate RR 
suggests that their phosphotransfer kinetics are faster than that of BCAM1417 
and BCAS0585. The varying lability of the phosphoryl group on the RRs can be 
inferred through the intensity of the RR-P band; the weaker the band, the more 
labile the phosphoryl group is presumed to be on that RR. Ultimately, while 
cognate phosphotransfer kinetics may differ in vitro for these TCSs, they all 
display the necessary activity in the phosphotransfer assay to allow investigation 
of potential non-cognate phosphotransfer between these systems. 
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Figure 3.4: Representative gels displaying cognate phosphotransfer from 
the phosphotransfer assay. Reactions were performed at 20 °C and begun 
through addition of 2 mM [γ-32P] ATP (3.7 GBq/mmol, PerkinElmer), with 
timepoints processed at 1, 5, 10 and 20 minutes. For each TCS shown, assays 
were performed containing the SK alone, the SK with its cognate RR and the RR 
alone.  
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3.2.5 – Non-cognate phosphotransfer between SKs and RRs 
 
Following verification that each SK was able to undergo autophosphorylation and 
phosphotransfer to its cognate RR in vitro, the ability of each SK to undergo non-
cognate phosphorylation was assessed. In order to assess how quickly non-
cognate phosphotransfer can occur in vitro, timepoints were taken at earlier 
stages of the phosphotransfer reaction. The SKs BCAM0442, BCAM0715 and 
BCAS0585 were all able to phosphotransfer to each other’s RRs (Fig 3.5), 
whereas BCAM1417 and BCAM1418 did not participate in any non-cognate 
phosphotransfer events (Fig 3.6). Due to continual issues with the purification of 
BCAM1417, the non-cognate phosphotransfer potential of BCAM1417/8 was 
assessed at a later date than the other three TCSs. Interestingly, the BCAM1418 
RR has both the lowest sequence similarity and the lowest specificity residue 
similarity to the other RRs of this putative MKN, with 4 of 7 specificity residues 
being shared, supporting the notion that a threshold of a specificity residue 
similarity of 5 shared residues may be able to predict non-cognate 
phosphorylation between TCS proteins (Fig 1.6). 
While non-cognate phosphotransfer was possible between the SKs BCAM0442, 
BCAM0715 and BCAS0585 and the RRs BCAM0443, BCAM0714 and 
BCAS0586, the reaction kinetics were observably different. For each cognate 
phosphotransfer interaction, the SK-P band is observably depleted across the 
timepoints, whereas for non-cognate interactions the SK-P band remains on the 
gel, getting stronger with each timepoint (Fig 3.5). This may be attributed to the 
preferential reaction kinetics of the cognate interaction; a depleted SK-P band 
indicates a faster rate of phosphotransfer reaction than a SK-P band which is 
increasing over time. Preferential cognate reaction kinetics can also be seen 
within the RR-P band; cognate interactions tend to confer a stronger RR-P band 
at earlier timepoints. Interestingly, RR-P bands appear to be considerably 
stronger for the non-cognate interactions for the BCAM0715 SK compared to the 
other two SKs, perhaps indicating that out of these SKs, BCAM0715 undergoes 
non-cognate interactions most readily. 
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Figure 3.5: Representative gels displaying non-cognate phosphotransfer 
between the SKs and RRs of BCAM0442/3, BCAM0714/5 and BCAS0585/6. 
Labels in blue denote cognate interactions, whereas red labels denote non-
cognate interactions. Within each panel, the top band represents the NusA-
tagged SK-P, while the bottom band represents the untagged RR-P. 
 
 
 
Figure 12 
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Figure 3.6: Representative gels displaying a lack of non-cognate 
phosphotransfer between BCAM1417/8 and the other three TCSs. A) While 
BCAM1417 can phosphotransfer to its cognate RR BCAM1418, no non-cognate 
phosphotransfer occurs. B) No other SKs can phosphorylate BCAM1418. A 
stacking gel error led to the 10 min timepoint of BCAM0715 + BCAM1418 not 
being loaded. Within all panels, the top band represents the NusA-tagged SK, 
while the bottom band represents the untagged RR. 
Figure 13 
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3.2.6 – Generation of eGFP-tagged RRs 
 
Following from the confirmation that three TCSs are able to undergo non-cognate 
phosphorylation with one another, the ability of a SK to phosphorylate a non-
cognate RR whilst in the presence of its cognate RR was investigated. Due to the 
size similarity between RRs and the intracellular portions of SKs, it was necessary 
to purify RRs that contained a tag with a different molecular weight to the 55 kDa 
NusA tag. eGFP was chosen due to its molecular weight of 27 kDa, which would 
allow suitable size discrimination by SDS-PAGE. Both N-terminally and C-
terminally eGFP-tagged RRs were purified through expression via pQE80 and 
pQE60 plasmids (plasmid maps can be found in Figure 3.7, and SDS-PAGE of 
purified C-terminally eGFP-tagged RRs can be found in Figure 3.8). 
 
 
Figure 3.7: Example plasmid maps for expression of both N-terminally and 
C-terminally eGFP-tagged BCAM0443. eGFP was first cloned into both pQE80 
and pQE60 for N-terminal and C-terminal tags respectively. Relevant cloning 
sites for cloning of BCAM0443 and 6 x His tags are shown. Plasmid maps made 
on Clone Manager Professional 9 (Sci-Ed). 
 
Figure 14 
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Figure 3.8: SDS-PAGE of purified C-terminally eGFP-tagged RRs. From a 1.5 
ml eluate, 10 µl of both neat and a 1:5 dilution of protein was loaded for each 
eGFP-tagged RR. Expected protein sizes (kDa): BCAM0443 (eGFP) – 53.5, 
BCAM0714 (eGFP) – 53.6, BCAM1418 (eGFP) – 53.9, BCAS0586 (eGFP) – 
53.5.  
 
3.2.7 – eGFP negatively affects phosphotransfer to RRs 
 
Following successful purification of eGFP-tagged RRs, the ability of SKs to 
undergo phosphotransfer to a non-cognate RR in the presence of their cognate 
RR was assessed. Unfortunately, the eGFP tag appeared to negatively influence 
the intensity of the RR-P band, either through reducing the ability of SKs to 
successfully phosphorylate the eGFP-tagged RR, or by increasing the lability of 
the phosphoryl group. The clearest example of this can be seen with BCAM0442, 
in which there is stronger phosphorylation of untagged BCAM0443 compared to 
eGFP-tagged BCAM0443 (Fig 3.9). 
 
 
 
 
Figure 15 
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Figure 3.9: Example gels displaying that the eGFP tag negatively affects 
phosphotransfer from BCAM0442 to BCAM0443. Both gels contain 
BCAM0442 with BCAM0443 in both an untagged and eGFP-tagged form, with 
preferential phosphotransfer kinetics to the untagged form regardless of the 
relative position of the eGFP tag. Within both panels, the top band represents the 
SK, the middle band represents the eGFP-tagged RR, and the bottom band 
represents the untagged RR. 
 
Despite the disadvantage that tagging of RRs with eGFP negatively affected their 
ability to be phosphorylated, phosphotransfer assays containing an SK and both 
its cognate RR and a non-cognate RR were carried out. Two different approaches 
were taken: one in which the cognate RR was tagged, and another in which the 
non-cognate RR was tagged. Due to the influence of the eGFP on 
phosphotransfer, this created a situation in which any non-cognate RR-P band 
was either artificially enhanced or diminished due to the eGFP tag inhibiting 
phosphotransfer to the cognate or non-cognate RR respectively. As such, it was 
not possible to gain a ‘true’ representation of the phosphotransfer kinetics 
between a SK, its cognate RR and a non-cognate RR, as the intensity of the non-
cognate RR-P band would always be strengthened or diminished depending on 
which RR contains the eGFP tag. 
 
Figure 16 
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3.2.8 – Non-cognate phosphotransfer in the presence of the cognate RR 
 
Non-cognate phosphotransfer was observed in certain permutations in the 
presence of the cognate RR. Interestingly, when the cognate RR was tagged with 
eGFP, phosphotransfer was seen between certain SKs and RRs. For example, 
non-cognate phosphorylation was observed from the SK BCAM0442 to both 
BCAM0714 and BCAS0586 after 5 minutes. There is evidence to suggest that 
non-cognate phosphorylation can also occur between other SKs and RRs, 
however the relative weakness of the bands coupled with the large amount of 
background noise seen in Figure 3.10 renders it difficult to fully observe this 
phenomenon. Nonetheless, it does appear that all three of these SKs can 
undergo some level of non-cognate phosphorylation to each other’s RRs when 
the eGFP tag is placed on the cognate RR. Interestingly, as can be observed for 
the BCAM0442 SK, even when the cognate RR is tagged with eGFP, the kinetic 
preference for cognate phosphorylation is significantly greater than for either of 
the non-cognate phosphorylation interactions, underlining the preference that 
SKs have for their cognate RR. 
Conversely, when the assay was reversed and the non-cognate RR contained 
the eGFP tag, the only non-cognate RR-P band observed was phosphorylation 
of BCAS0586 by BCAM0442 after 20 minutes (Fig 3.11). The disparity in non-
cognate RR-P bands relative to the placement of the eGFP tag highlights the 
significance of the negative influence that eGFP has on RR phosphorylation. It is 
likely that the ‘true’ level of non-cognate phosphotransfer in vitro in the presence 
of the cognate partner lies somewhere between these two points, however it is 
not currently possible to observe this directly due to the limitations of the eGFP 
tag. 
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Figure 3.10: Representative gels displaying non-cognate phosphotransfer 
in the presence of the eGFP-tagged cognate RR. There are several examples 
of non-cognate phosphotransfer in the presence of the eGFP-tagged cognate RR 
over a 20 minute reaction, particularly for the BCAM0442 SK. Contact of the 
BCAS0585 + BCAS0586 (eGFP[N]) + BCAM0714 gel with the dye front led to 
contamination with excess radiation. 
 
 
Figure 17 
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Figure 3.11: Representative gels displaying limited non-cognate 
phosphotransfer in the presence of the untagged cognate RR. The only 
observable non-cognate phosphotransfer occurs after 20 minutes between 
BCAM0442 and the eGFP-tagged BCAS0586. 
 
 
 
Figure 18 
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3.2.9 – Non-cognate phosphotransfer with pre-phosphorylated SKs 
 
While it is clear from the above data that the eGFP tag negatively influenced 
phosphorylation of RRs, and therefore rendered it difficult to ascertain the true 
rates of non-cognate phosphotransfer in the presence of the cognate RR, assays 
were repeated with the adjustment that SKs were pre-phosphorylated with 
radiolabelled ATP for 1 hour, prior to addition of RRs to begin the reaction. This 
alteration to the methodology would theoretically increase the rates of both 
cognate and non-cognate phosphotransfer, as much of the SK would be 
phosphorylated and ready to undergo phosphotransfer at the beginning of the 
reaction, reducing the impact that autophosphorylation of the SK would have on 
the speed of the phosphotransfer reaction. As the radiolabelled ATP is not 
removed from the reaction, SKs can rephosphorylate following phosphotransfer 
to RRs. This version of the phosphotransfer assay was carried out using an 
untagged cognate RR and an eGFP-tagged non-cognate RR, so that any 
observable non-cognate phosphorylation did not carry the caveat of being 
artificially enhanced by an eGFP-tagged cognate RR. 
Unexpectedly, while the intensity of SK-P and RR-P bands were stronger, pre-
phosphorylation of the SKs in this way did not particularly influence the strength 
of non-cognate RR bands (Fig 3.12). The only observable non-cognate 
phosphorylation over the 20 minute reaction time was between the SK 
BCAM0442 and the RR BCAS0586 at 20 minutes post initiation of the reaction. 
Interestingly, this resembles the results shown in the ‘standard’ phosphotransfer 
assay displayed in Figure 3.11, supporting the notion that phosphotransfer 
between BCAM0442 and BCAS0586 may be the fastest non-cognate interaction. 
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Figure 3.12: Representative gels displaying limited non-cognate 
phosphotransfer in the presence of the untagged cognate RR despite pre-
phosphorylated SKs. The only observable non-cognate phosphotransfer occurs 
after 20 minutes between BCAM0442 and the eGFP-tagged BCAS0586. The 0 
minute timepoint refers to the point just before both the cognate and the non-
cognate RRs were added to the pre-phosphorylated SK to initiate the 
phosphotransfer reaction. As ATP is still present in the reaction, SKs can undergo 
rephosphorylation following phosphotransfer to RRs.  
Figure 19 
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3.2.10 – Non-cognate phosphotransfer with pre-phosphorylated and nickel 
affinity column-purified SKs 
 
It is clear from Figure 3.12 that all three SKs autophosphorylated well and gave 
clearly visible bands throughout the 20 minute time course. This is in contrast to 
examples such as Figure 3.6 B, in which certain SK and RR bands are quite 
weak, presumably because these reactions were initiated with the addition of the 
radiolabelled ATP to SKs and RRs. As such, it was decided to use this pre-
phosphorylation approach of SKs to further quantify the reactions kinetics 
between these TCSs in a simple one SK, one RR format. 
In order to focus purely on the ability of the SKs to undergo phosphotransfer to 
the RR, following initial purification, SKs were phosphorylated for one hour with 
radiolabelled ATP, and then once again washed through and eluted off a nickel 
resin column prior to storage at -20 °C. As such, the phosphorylated SK was 
purified from any remaining ATP. This resulted in the ability to perform a 
phosphotransfer assay in which the only available phosphoryl groups for 
phosphotransfer were those that were already bound to the SKs. This would 
therefore allow elucidation of the rate at which phosphotransfer occurs between 
SKs and RRs, as the ability of the SK to rephosphorylate itself, and thus undergo 
additional phosphotransfer, has been removed. 
Similarly to when the phosphotransfer assay is performed without SK pre-
phosphorylation, SKs generally had a higher kinetic preference for their cognate 
RR than for other RRs (Fig 3.13). For the SKs BCAM0442 and BCAM1417, only 
the cognate RR-P bands are clearly visible. There is some diminished SK-P band 
when BCAM0442 is incubated alongside BCAM0714, but non-cognate RR bands 
are not visible. This is in contrast to previous phosphotransfer assays (Fig 3.5), 
in which the RRs BCAM0714 and BCAS0586 were both heavily phosphorylated 
by BCAM0442. 
As observed previously (Fig 3.5), BCAM0715 clearly phosphorylates BCAM0443 
and BCAS0586 as well as its cognate RR. Interestingly, quantification of 
phosphotransfer from BCAM0715 suggests that the rate of phosphotransfer is 
similar to both the cognate BCAM0714 and the non-cognate BCAM0443 and 
BCAS0586 (Appendix Figure A1.1). Interestingly, while SK-P bands for 
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BCAM0442 and BCAM0715 are not visible in Figure 3.5, in Figure 3.13 the SK-
P bands are clearly visible. It may be the case that in the presence of BCAM0443 
or BCAM0714, autophosphorylation of BCAM0442 and BCAM0715 respectively 
is inhibited, which would explain the discrepancy between Figure 3.5 and Figure 
3.13. Unsurprisingly, BCAM1417 does not phosphorylate any RR apart from its 
own cognate partner, BCAM1418. Finally, similar to the BCAM0442/3 system, 
BCAS0585 has quicker phosphotransfer to its cognate RR, though non-cognate 
bands are weakly visible for BCAM0443 and BCAM0714. 
Ultimately, quantification of the rate of phosphotransfer from pre-phosphorylated 
SKs to RRs reaffirms the notion that cognate phosphotransfer occurs significantly 
quicker than non-cognate phosphotransfer for BCAM0442/3 and BCAS0585/6, 
though it appears that there is little difference between cognate and non-cognate 
phosphotransfer for the BCAM0715 SK. At least in vitro, BCAM0715 appears to 
be able to donate its phosphoryl group readily to the non-cognate BCAM0443 
and BCAS0586 RRs, a phenomenon seen in both ‘standard’ and ‘pre-
phosphorylated SK’ versions of the phosphotransfer assay. This readiness for 
non-cognate phosphorylation is not shared by BCAM0442 or BCAS0585, 
perhaps suggesting that the kinetics of the BCAM0715 SK allow for non-cognate 
phosphotransfer more easily than the other SKs. This may suggest that the 
BCAM0714/5 TCS has the potential to act as a central hub for this MKN. 
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Figure 3.13: Representative gels displaying phosphotransfer from pre-
phosphorylated and subsequently purified SK. Labels in blue denote cognate 
interactions, whereas red labels denote non-cognate interactions. There is a clear 
preference for cognate phosphotransfer for the pre-phosphorylated SKs, 
although there are many instances of non-cognate phosphotransfer. The 0 
minute timepoint refers to the point just before both the cognate and the non-
cognate RRs were added to the pre-phosphorylated SK to initiate the 
phosphotransfer reaction.  
Figure 20 
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3.3 – Discussion 
 
Through successful purification of SK intracellular portions and RRs, the potential 
for non-cognate phosphotransfer between all four TCSs was determined through 
use of the phosphotransfer assay. Each SK successfully underwent 
autophosphorylation and showed the potential for cognate phosphorylation with 
its predicted cognate RR. It is clear that non-cognate phosphotransfer is 
kinetically possible between BCAM0442/3, BCAM0714/5 and BCAS0585/6, 
whereas there is no evidence to suggest that the BCAM1417/8 TCS exhibits any 
non-cognate interactions with the other three TCSs. The conclusion that 
BCAM1417/8, the closest TCS in the B. cenocepacia genome to the other three 
TCSs in both overall sequence and specificity residue similarity, does not 
undergo non-cognate phosphotransfer reinforces the significance of the non-
cognate interactions shared between BCAM0442/3, BCAM0714/5 and 
BCAS0585/6, as well as supporting the notion that 5 out of 7 shared RR 
specificity residues is an accurate threshold for predicting non-cognate 
phosphotransfer between TCSs. Though a systematic phosphotransfer profile of 
these three SKs has not been performed, in which every B. cenocepacia RR is 
purified and tested for potential phosphotransfer against the SKs, based on the 
data presented in this chapter and on the bioinformatic evidence described 
previously, it may be reasonably concluded that BCAM0442/3, BCAM0714/5 and 
BCAS0585/6 form a three-TCS MKN in B. cenocepacia. 
Aside from the fact that phosphotransfer is kinetically possible between these 
TCSs, other information can be inferred from this phosphotransfer data. Based 
on both the ‘1 SK/1 RR’ and ‘1 SK/2 RRs’ phosphotransfer assays, it is clear that 
both BCAM0442 and BCAS0585 SKs hold a strong kinetic preference for their 
cognate RR over non-cognate RRs, whereas BCAM0715 appears to be more 
promiscuous. Previous data, in which the phosphotransfer profile from several 
SKs from both E. coli and C. crescentus was characterised, suggested a general 
preference for presumed cognate RRs over other non-cognate targets 419. As 
such, the rate of both cognate and non-cognate phosphotransfer for BCAM0715 
being similar suggests that BCAM0715 may be acting as a central hub for this 
MKN.   
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The fact that non-cognate phosphotransfer can occur between these TCSs 
highlights the crucial role that specificity residues hold in determining 
phosphotransfer specificity. The number of specificity residues shared between 
each RR appears to be connected to their ability to be phosphorylated by non-
cognate SKs. BCAM1418 shares 4 of 7 specificity residues with the other three 
RRs, the lowest of all the RRs, and there is no non-cognate phosphorylation with 
the BCAM1417/8 TCS, suggesting that in this example there is not enough 
similarity to allow non-cognate interactions. The remaining RRs share either 5 or 
6 specificity residues out of 7 with one another (Fig 1.6), though there appears to 
be no observable difference in phosphotransfer rate between those that share 5 
or share 6 specificity residues. Whether 5 of 7 matching specificity residues is a 
‘threshold’ for non-cognate phosphotransfer generally between TCSs is an 
interesting question worthy of further investigation. It is not known whether there 
are particular specificity residues that hold more influence over phosphotransfer 
specificity than others; this presumably would depend on the specific proteins 
and specificity residues in question. 
The concept of specificity residue similarity between TCS proteins has focused 
thus far purely on whether individual specificity residues are or are not identical 
between proteins, without including information about specific amino acid 
properties. For these RRs specifically, where specificity residues do not match 
there is generally a large difference in their chemical properties. For example, the 
threonine specificity residue on BCAM0714 and BCAS0586 is smaller and more 
polar than the equivalent methionine on BCAM0443. However, it may be the case 
that different amino acids can take the place of a specificity residue without 
adversely impacting phosphotransfer specificity, for example it may be possible 
for a leucine specificity residue to be substituted for the similarly nonpolar 
isoleucine without affecting phosphotransfer kinetics. As such, when searching 
for similarities between specificity residue on TCS proteins, it may be 
recommended to also consider the similarities and differences between non-
matching specificity residues, as this may reduce the chance of ‘false-negatives’ 
being missed by any systematic search for specificity residue similarities and 
MKNs.  
BCAS0586 shares 6 of 7 RR specificity residues with both BCAM0443 and 
BCAM0714, suggesting that this single difference in specificity residues is key to 
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regulating phosphotransfer specificity between these TCSs. In order to ascertain 
that these specific residues are indeed the key to the kinetic preference for 
cognate phosphotransfer in these TCSs, it would be of interest to systematically 
mutate these residues so that one RR contained the specificity residues of 
another. Hypothetically, the kinetic preference for a RR would be completely 
swapped with whichever RR the specificity residues originated from. For 
example, mutation of the specificity residues on BCAM0443 to match those of 
BCAM0714 would hypothetically lead to BCAM0443 being much more readily 
phosphorylated by BCAM0715, and less readily phosphorylated by BCAM0442. 
If this swapping of kinetic preference did not occur as expected, it may suggest 
that other residues may play a role in phosphotransfer specificity between these 
TCSs. 
Given the kinetic preference for cognate RRs by all of the SKs of interest, it is 
unfortunate that due to the negative impact of the eGFP tag on the RRs, it was 
not possible to directly observe the kinetics of non-cognate phosphotransfer in 
the presence of the cognate partner. While it is clear that certain non-cognate 
interactions can occur in the presence of the cognate partner, such as from 
BCAM0442 to BCAS0586 (Fig 3.11), the ‘true’ level of non-cognate 
phosphotransfer at equimolar concentrations in vitro is unclear. It is uncertain why 
the eGFP tag causes this negative impact on phosphotransfer regardless of 
which terminus of the RR it is placed, nor whether the tag affects either the initial 
phosphorylation of the RR or the lability of the phosphoryl group on the RR. It is 
also unknown whether any tag of similar size would similarly cause this issue, or 
whether this phenomenon is eGFP-specific. One possibility would be to attempt 
to utilise a tag that is smaller than the 27 kDa eGFP, so as to hopefully remove 
the negative impact on the RR, but large enough to still allow for discrimination 
on SDS-PAGE, such as the 12 kDa E. coli thioredoxin tag 457. Successfully 
utilising a tag that does not have the same issues that eGFP does would allow 
the direct comparison of phosphotransfer from a SK to a cognate and non-
cognate RR, or even between two different non-cognate RRs, further allowing the 
determination of which non-cognate interactions are the strongest in vitro. 
One vital consideration to make when interpreting data from the phosphotransfer 
assay is that the interactions between proteins are occurring in vitro, at a constant 
concentration and temperature. While this is useful in determining what non-
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cognate interactions are kinetically possible, inferring the physiological relevancy 
of different interactions is difficult, as the conditions of the reaction do not reflect 
the dynamic nature of the cellular environment. For example, it is unlikely that 
different TCSs are expressed at identical levels throughout the cell, and given 
that activation of TCSs such as BCAM0714/5 often leads to drastic alterations in 
their expression levels (Robinson et al, Unpublished data), this adds limitations 
to the interpretation of the phosphotransfer assay results. 
Given the above constraints, one possibility for future work is to adjust the 
concentrations of SKs or RRs within the phosphotransfer assay. All ‘1 SK/2 RR’ 
phosphotransfer assays were performed with the two RRs at an equal 
concentration of 10 μM. As it has previously been established that exposure of 
B. cenocepacia to 1.5 mM ZnCl2 leads to an increase of BCAM0714 and 
BCAM0715 transcript levels by between 30-58 fold (Robinson et al, Unpublished 
data), simply doubling or tripling the concentration of a non-cognate RR or SK 
may be a reasonable way of further exploring non-cognate interactions between 
these proteins. It is not unrealistic to expect situations where the concentration of 
a non-cognate RR is significantly greater than that of a cognate partner, and while 
there are limits to the protein concentration one can achieve within the 
phosphotransfer assay, these possibilities may be a worthwhile avenue of 
exploration. 
Similar to concentration, temperature is another factor that could be changed 
within the phosphotransfer assay. Being an environmental organism that is also 
capable of infecting the human host, the niches that B. cenocepacia may be 
exposed to can be of a range of different temperatures, and it may be the case 
that these TCSs, and thereby the kinetics of phosphotransfer between them, 
differ between temperatures. For example, while there is no evidence for non-
cognate interactions between BCAM1417/8 and the other TCSs at room 
temperature, perhaps there would be evidence for such interactions at other 
temperatures. This could lead to interesting observations about the nature of this 
potential MKN in B. cenocepacia; for example any differences in phosphotransfer 
kinetics between these TCSs at 37 °C may suggest that this MKN may elicit 
different behaviours within the human host than in the environment. 
As can be seen in Figure 3.5 and Figure 3.13, the presence of the BCAM0442-P 
and BCAM0715-P bands when incubated alongside BCAM0443 and BCAM0714 
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respectively is dependent on the particular methodology employed in the 
phosphotransfer reaction. Phosphotransfer initiated through the addition of 
radiolabelled ATP results in no observable SK-P band (Fig 3.5), whereas the 
addition of RR to pre-phosphorylated SK results in a strong SK-P band (Fig 3.13). 
One potential explanation may be that the presence of the BCAM0443 or 
BCAM0714 RRs inhibits autophosphorylation of BCAM0442 and BCAM0715 
respectively through binding of unphosphorylated RR to the unphosphorylated 
SK. As such, when the SK is subsequently able to autophosphorylate, the speed 
of the phosphotransfer reaction to the cognate RR results in no observable SK-P 
band in the phosphotransfer gel. One way to explore this possibility would involve 
mutagenesis of the conserved aspartate residue of the RRs to an alanine, 
removing the ability of the RRs to be phosphorylated 458. This would allow direct 
comparison of the ability of the SKs to autophosphorylate both with and without 
the presence of the RRs in the phosphotransfer assay, as no phosphoryl groups 
could be transferred from the SKs to the RRs. 
Additionally, the generation of SK mutants may allow further use of the 
phosphotransfer assay to explore these TCSs. It has previously been established 
that mutation of an asparagine to an aspartate within the ‘N-box’ in the ATP-
binding domain renders a SK unable to undergo autophosphorylation without 
affecting its phosphatase ability 459. This would allow for ‘2 SK/1 RR’ 
phosphotransfer assays which contained a cognate SK and RR pairing alongside 
a non-cognate N-box mutated SK. Comparison of RR-P bands between the ‘2 
SK/1 RR’ assay and the cognate SK and RR alone may elucidate both whether 
SKs can act as phosphatases to non-cognate RRs, and the relative strength of 
that phosphatase activity in comparison to other SKs, both important factors in 
the understanding of this potential MKN. A SK that could phosphorylate a non-
cognate RR but not also act as a phosphatase would essentially always act as 
an activator for that RR and its downstream signalling pathway, rather than as 
the dual kinase/phosphatase protein that is standard for cognate SK/RR pairings. 
Alternatively, the mutation of a conserved threonine residue to an alanine residue 
of SKs negatively impacts its phosphatase activity, a mutation which could be 
repeated with these SKs of interest, directly allowing the visualisation of whether 
a SK could act as a phosphatase to a particular RR 460.  
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The work within this chapter has focused on exploring potential phosphotransfer-
based interactions between these TCSs, however there are other ways in which 
TCS proteins may interact with one another that do not rely on the transfer of 
phosphoryl groups from SKs to RRs. For example, the SK RetS from P. 
aeruginosa can inhibit the autophosphorylation of the SK GacS, while the E. coli 
RR RscB can heterodimerise with the RRs MatA and DctR, adding layers of 
complexity to the functioning of these TCSs 410,461. It is possible that the TCSs 
described in this work can interact in ways that are not visible from the 
phosphotransfer assay. As such, other methodologies could be employed to 
further explore the interactions between these TCSs. 
One methodology that could be employed to explore this is the bacterial 
adenylate cyclase two-hybrid system (BACTH). Two proteins of interest are fused 
to complementary fragments of an adenylate cyclase, and if the proteins of 
interest associate together, the adenylate cyclase fragments can generate cAMP, 
leading to a functional readout 462. The BACTH approach could therefore be used 
to investigate whether there is any SK-SK interaction or RR heterodimerisation 
between these three TCSs, which is not possible through this phosphotransfer 
assay. Additionally, the BACTH approach could also be used to verify the results 
described within this work; theoretically the three TCSs that form this putative 
MKN should show interaction between each SK and all three RRs. It would also 
be of interest to see whether there is any association between these TCSs and 
BCAM1417/8. Though no non-cognate phosphorylation was observed for this 
system, it does not limit the potential for BCAM1417/8 to interact with the other 
three in a non-phosphotransfer based manner. 
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3.4 – Conclusions 
 
• Expression vectors for all four TCSs of interest were generated and all 
SKs and RRs were successfully purified. 
• Three TCSs, BCAM0442/3, BCAM0714/5 and BCAS0585/6, undergo non-
cognate phosphotransfer from their SKs to each other’s RRs, whereas 
BCAM1417/8 does not, indicating that BCAM0442/3, BCAM0714/5 and 
BCAS0585/6 likely work together in a MKN. 
• While some non-cognate phosphotransfer does occur in the presence of 
the cognate RR, issues with the eGFP tag prevent further investigation. 
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Chapter 4: Characterisation of TCS deletion 
mutants 
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4.1 – Introduction 
 
As outlined in Chapter 3, of the four TCSs of interest within this potential metal-
sensing MKN, three display non-cognate phosphotransfer to one another. 
Previous investigation of BCAM0714/5 has implicated this TCS in the cadmium 
and zinc response in B. cenocepacia through regulation of the CzcCBA efflux 
pump and a downstream gene region (Robinson et al., Unpublished data). 
Additionally, the BCAM0442/3 TCS was identified in a screen of copper 
resistance genes via transposon sequencing, reinforcing the idea that this TCS 
is metal-sensing 369. As such, it is of interest to characterise both what the 
individual TCSs sense and respond to, and to what phenotypes they contribute 
to. Though BCAM1417/8 does not appear to be part of this MKN based on the 
aforementioned phosphotransfer evidence, it is still of interest to characterise its 
role in B. cenocepacia, particularly given the overall sequence similarity of 
BCAM1417/8 to the other three TCSs. 
Characterisation of these TCSs has revolved around the construction of deletion 
mutants of each TCS in a B. cenocepacia K56-2 background. As these TCSs are 
predicted to be metal-sensing, these deletion mutants have then been tested for 
susceptibility against a range of metals. Investigation of metal-dependent 
induction of putative promoters of interest relied on use of a gfp transcriptional 
fusion via the pGA-G1 vector, kindly provided by the Leo Eberl group (University 
of Zurich, Switzerland). Additionally, deletion mutants have been investigated for 
a range of phenotypes of interest, such as biofilm formation, virulence in G. 
mellonella and, via the construction of gentamicin-sensitive mutants, intracellular 
survival within murine macrophages. Given the link between the CzcRS TCS in 
P. aeruginosa and resistance to imipenem, an equivalent link between the metal-
sensing TCSs of B. cenocepacia and imipenem has also been investigated. 
Ultimately, this chapter’s aim was to characterise deletion mutants of each TCS 
and subsequently investigate any relevant phenotypes, hence providing novel 
insight into the functionality of these TCSs within B. cenocepacia. 
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4.2 – Results 
 
4.2.1 – Deletion of TCSs of interest from B. cenocepacia 
 
The generation of unmarked deletion mutants within B. cenocepacia relied upon 
the methodology described previously by Flannagan and colleagues (2008), 
which involves upstream and downstream flanks of the genes of interest being 
cloned into the pGPI-SceI suicide vector, which is then conjugated into B. 
cenocepacia, resulting in a crossover event in which pGPI-SceI is incorporated 
into the genome (Fig 2.1) 440. The pDAI-SceI vector, encoding for the I-SceI 
endonuclease, is then conjugated into these first crossovers, leading to a second 
recombination event in which I-SceI cuts a specific site on pGPI-SceI, resulting 
in the generation of either WT revertants or unmarked deletion mutants (Fig 2.1).  
To generate pGPI-SceI vectors for each TCS, upstream and downstream flanks 
were PCR amplified, spliced together and cloned into pGPI-SceI (a list of primers 
used can be found in Appendix section A5). In-frame unmarked deletion mutants 
of each TCS were then generated through the processes described in section 
2.3.2. An example plasmid map of both pGPI-SceI and pDAI-SceI can be found 
in Figure 4.1. 
 
Figure 4.1: Plasmid maps for pGPI-SceI containing BCAM0442/3 flanks and 
for pDAI-SceI. Relevant cloning sites for cloning of BCAM0442/3 flanks into 
pGPI-SceI are shown. Plasmid maps made on Clone Manager Professional 9 
(Sci-Ed). 
Figure 21 
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Following verification of successful conjugation of pDAI-SceI into first crossovers 
via PCR, several verification steps were undertaken to reveal whether candidate 
colonies of B. cenocepacia were WT revertants or unmarked deletion mutants. 
Strains were tested for sensitivity to trimethoprim and resistance to tetracycline, 
which would confirm that the pGPI-SceI vector had been lost and the pDAI-SceI 
vector gained respectively, as well as PCR screened using primers specific to the 
BCC recA gene, to verify that colonies were indeed B. cenocepacia, and not E. 
coli remaining from the mutagenesis process. Various PCR screens utilising 
primers specific to the genes of interest and primers specific to surrounding 
regions were performed (example shown in Figure 4.2). Finally, to ensure that no 
undesired mutations had occurred during the mutagenesis process, regions 
containing the whole upstream and downstream flanking sites were amplified and 
sent for sequence verification (TubeSeq Service, Eurofins Genomics) (example 
shown in Figure 4.3). Overall, single deletion mutants for each TCS, double 
deletion mutants for each TCS pairing, and a triple ∆BCAM0442/3 + 
∆BCAM0714/5 + ∆BCAS0585/6 mutant were generated (Fig 4.4). While six 
double TCS deletion mutants were generated, only those that are pertinent to the 
BCAM0442/3, BCAM0714/5 and BCAS0585/6 TCSs will be focused on, as 
Chapter 3 suggests that BCAM1417/8 is not part of this metal-sensing MKN. 
 
 
 
 
 
 
Figure 4.2: PCR verification of a ∆BCAM0442/3 deletion mutant candidate. 
Left – PCR using primers specific for BCAM0442 and BCAM0443. A negative 
band in the candidate lane suggests that these genes are not present in the 
candidate. Expected size – 509 bp. Right – PCR using primers specific for the 
flanks. A positive band in the candidate lane shows that this candidate contains 
flanking regions that are spliced together without the genes of interest between 
them. Expected size – 1201 bp.  
Figure 22 
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Figure 4.3: Sequence verification of a ∆BCAM0442/3 deletion mutant 
candidate. The genomic neighbourhood of BCAM0442/3 (top) and the unmarked 
∆BCAM0442/3 deletion mutant (middle). Sequence verification of the deletion 
mutant is also displayed (bottom). The two bases highlighted in blue depict the 
point at which the upstream and downstream flanks meet. 
 
Figure 4.4: The specific combinations and order in which TCS deletion 
mutants were generated within this work. Four single, six double and one triple 
TCS deletion mutants were generated. For double and triple TCS mutants, all 
combinations of donor pGPI-SceI plasmid and recipient TCS deletion mutant 
were tested, though not all were successful. At least one mutant for each pairing 
was successfully generated. 
Figure 23 
Figure 24 
119 
 
4.2.2 – BCAM0442/3 and BCAM0714/5 are implicated in the copper and 
cadmium/zinc response respectively 
 
Initial investigation of the TCS deletion mutants focused on whether these 
deletion mutants were sensitive to metals. Deletion mutants of each TCS were 
tested for their susceptibility to a range of metals, namely cadmium, cobalt, 
copper, silver and zinc. Spotting of TCS deletion mutants on metal-infused agar 
plates revealed that ∆BCAM0442/3 is susceptible to copper, while confirming that 
deletion of BCAM0714/5 confers susceptibility to cadmium and zinc (Fig 4.5). The 
copper and zinc phenotypes, though not the cadmium phenotype, observed for 
these two systems were also partially restored by complementation with a 
pDA17-derived vector containing the genes of interest alongside their putative 
promoter region. However, a previously-generated pSCrhaB3 vector containing 
the BCAM0714/5 genes did successfully complement both the cadmium and zinc 
phenotypes for ∆BCAM0714/5 (Data not shown). There is a clear metabolic 
burden upon B. cenocepacia harbouring the pDA17 vector which may explain the 
lack of complementation of the cadmium sensitivity of ∆BCAM0714/5 by 
pDA17::BCAM0714/5, due to the relatively subtle nature of the sensitivity 
compared to the more pronounced zinc phenotype (Fig 4.5). 
The growth kinetics of these TCSs when exposed to metals of interest were 
further investigated through use of a 48 hour growth curve within a shaking plate 
reader. This revealed metal-specific differences in growth kinetics of different 
deletion mutants (Fig 4.6). For example, ΔBCAM0714/5 showed great sensitivity 
to cadmium and zinc, whereas sensitivity of the ∆BCAM0442/3 deletion mutant 
to copper is more subtle, with it taking longer to begin exponential growth when 
exposed to 5 mM CuCl2 (Fig 4.6). This can also be seen in the MIC values for 
each single TCS deletion mutant; all strains had an MIC against CuCl2 of 8 mM, 
despite the enhanced sensitivity of ∆BCAM0442/3 to copper (Table 4.1). 
Contrastingly, ∆BCAM0714/5 was significantly more sensitive to zinc than the 
other strains, with an MIC significantly lower than WT (Fig 4.6 and Table 4.1). 
Double TCS deletion mutants, as well as the triple ∆BCAM0442/3 + 
∆BCAM0714/5 + ∆BCAS0585/6 deletion mutant were also tested against a range 
of metals, though these mutants displayed no additional metal sensitivity that was 
not already observed within the single TCS deletion mutants (Table 4.1). 
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Figure 4.5: Single TCS deletion mutants spotted on copper-, cadmium- and 
zinc-supplemented agar plates. 10-1 to 10-5 dilutions of standardised overnight 
culture were spotted left to right on the plates. ∆BCAM0442/3 is sensitive to 
copper, whereas ∆BCAM0714/5 is sensitive to cadmium and zinc. There is no 
observable sensitivity to any of the metals by ∆BCAM1417/8 or ∆BCAS0585/6. 
 
 
Figure 25 
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Figure 4.6: Growth of single TCS deletion mutants in LB supplemented with 
various heavy metals. ∆BCAM0442/3 is sensitive to copper, whereas 
∆BCAM0714/5 is sensitive to cadmium and zinc. n = 3 with 3 technical replicates 
per assay. Error bars indicate SEM. 
 
 
 
 
Figure 26 
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Table 4.1: 24 hour MICs of WT and TCS deletion mutants against doubling 
concentrations of a range of metals. 7 
Strain 
MIC (mM) 
AgNO3 CdCl2 CoCl2 CuCl2 ZnCl2 
WT 0.016 4 1 8 16 
∆BCAM0442/3 0.016 4 1 8 16 
∆BCAM0714/5 0.016 2 1 8 2 
∆BCAM1417/8 0.016 4 1 8 16 
∆BCAS0585/6 0.016 4 1 8 16 
∆BCAM0442/3 + 
∆BCAM0714/5 
0.016 2 1 8 2 
∆BCAM0442/3 + 
∆BCAS0585/6 
0.016 4 1 8 16 
∆BCAM0714/5 + 
∆BCAS0585/6 
0.016 2 1 8 2 
∆BCAM0442/3 + 
∆BCAM0714/5 + 
∆BCAS0585/6 
0.016 2 1 8 2 
Note: MICs of deletion mutants highlighted in red differ from the WT 
 
4.2.3 – Fusion of promoters of interest to gfp supports deletion mutant 
metal phenotypes 
 
Though the metal sensitivity displayed by a TCS deletion mutant implicates that 
TCS in the cellular response to that metal, it does not directly support the notion 
of direct sensing by that TCS. It is possible that deletion of a TCS can render the 
cell susceptible to a toxic agent without that system directly responding to that 
agent. As such, to explore how these TCSs are transcriptionally activated in 
response to metal exposure, putative promoters of interest were cloned upstream 
of a gfp gene in the pGA-G1 vector. While BCAM0442/3 and BCAS0585/6 have 
clearly defined upstream regions that may contain a putative promoter, 
BCAM0714/5 appears to reside in a five-gene operon with czcCBA. As such, the 
upstream region of czcC was used as the ‘BCAM0714/5 promoter’. As pGA-G1 
holds a gentamicin-resistance marker, previously generated gentamicin-sensitive 
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deletion mutants of TCSs of interest generated for use in a gentamicin-protection 
assay (see section 4.2.7) were utilised.   
Gentamicin-sensitive B. cenocepacia has been previously generated by knocking 
out an AmrAB-OprA-like efflux pump (BCAL1674-1676) which is crucial for 
resistance to aminoglycosides 207. As such, the TCSs of interest were deleted 
from a previously generated gentamicin-sensitive ∆BCAL1674-76 deletion 
mutant of B. cenocepacia as described above (section 2.3.2). B. cenocepacia 
strains lacking BCAL1674-76 are hypersensitive to gentamicin; the gentamicin 
MIC of these mutants was < 4 µg/ml, whereas the gentamicin MIC WT B. 
cenocepacia was > 256 µg/ml (Data not shown). 
To ensure that gentamicin-sensitive TCS deletion mutants had the same 
phenotype as the standard TCS deletion mutants, gentamicin-sensitive mutants 
were spotted onto metal plates, which confirmed their metal phenotypes as being 
the same as the previously generated mutants (Appendix Figure A2.1). Following 
successful verification of these mutants, pGA-G1 vectors were conjugated into 
gentamicin-sensitive WT, ΔBCAM0442/3, ΔBCAM0714/5 and ΔBCAS0585/6. 
Overnight growth of the various mutants in LB supplemented with metals of 
interest revealed that the BCAM0442/3 promoter was induced in response to 
copper, and the BCAM0714/5 promoter was induced in response to cadmium 
and zinc (Fig 4.7), supporting the metal phenotypes seen in the deletion mutants 
(Figs 4.5 and 4.6). This induction was lost in the respective deletion mutants for 
each TCS, suggesting that the metal-specific induction of these promoters is 
dependent on the TCSs to which they belong (Fig 4.7). Though the induction of 
pGA-G1::0714/5prom in response to cadmium appears to still be present in the 
ΔBCAM0714/5 deletion mutant, this is due to the lower OD600 reached by the 
ΔBCAM0714/5 deletion mutant in 0.25 mM CdCl2; the raw fluorescence values 
for this mutant were equivalent to control (Data not shown). There was no 
induction of the BCAS0585/6 promoter in response to the metals tested, further 
suggesting that BCAS0585/6 is not metal-sensing (Appendix Figure A2.2). 
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Figure 4.7: Relative fluorescence of 24 hour growth of B. cenocepacia TCS 
deletion mutants containing pGA-G1::0442/3prom or pGA-G1::0714/5prom. 
Each graph displays fluorescence of each gentamicin-sensitive deletion mutant 
containing either pGA-G1::0442/3prom or pGA-G1::0714/5prom. Control refers to 
gentamicin-sensitive WT B. cenocepacia containing pGA-G1 lacking a promoter. 
Metal concentrations are as follows: CuCl2 – 1 mM, ZnCl2 – 1 mM, CdCl2 – 0.25 
mM, AgNO3 – 5 µM, CoCl2 – 0.25 mM. n = 3 independent experiments with 3 
technical replicates per assay. * = p < 0.05, *** = p < 0.001, **** = p < 0.0001. 
Asterisks on bars refer to one-way ANOVA comparison relative to respective 
metal control. Error bars indicate SEM. 
 
As the induction of these promoters is only lost in their respective TCS deletion 
mutants, and not in any other TCS deletion mutant, it is suggestive that these 
TCSs transcriptionally regulate themselves with no observable influence from 
the other TCSs within this MKN. It does appear that the copper-dependent 
induction of the BCAM0442/3 promoter is lower in the ΔBCAM0714/5 deletion 
mutant, although a one-way ANOVA with multiple comparisons found no 
statistically significant difference between the BCAM0442/3 promoter activity in 
the ΔBCAM0714/5 background and that observed in either the WT or 
ΔBCAS0585/6 background (Fig 4.7). Conversely, while comparisons of Control 
vs WT and Control vs ΔBCAS0585/6 were statistically significant, there was no 
significant difference in the Control vs ΔBCAM0714/5 comparison (Fig 4.7). Due 
uncertainty surrounding this result, there is cause to further repeat these assays 
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in future work. Further repeats were not feasible in the course of this project due 
to COVID-19 restrictions forcing the cessation of lab-based research activity. 
 
4.2.4 – A TCS-associated mechanism links copper and zinc exposure with 
resistance to imipenem in B. cenocepacia 
 
The link between the bacterial metal response and resistance to antimicrobials 
has previously been discussed (section 1.2.3). As such, investigating whether 
these TCSs of interest had any link to how B. cenocepacia responds to 
antimicrobials was important. MIC values for B. cenocepacia grown overnight in 
different antibiotics suggest that deletion of individual TCSs does not confer 
susceptibility to different classes of antimicrobials (Table 4.2).   
 
Table 4.2: 24 hour MICs of WT and single TCS deletion mutants against a 
range of antibiotics. 8 
Strain 
MIC (µg/ml) 
CHL CIP GEN IPM TMP 
WT 32 2 >256 32 8 
∆0442/3 32 2 >256 32 8 
∆0714/5 32 2 >256 32 8 
∆1417/8 32 2 >256 32 8 
∆0585/6 32 2 >256 32 8 
CHL – Chloramphenicol, CIP – Ciprofloxacin, GEN – Gentamicin, IPM – 
Imipenem, TMP – Trimethoprim. 
 
Given that exposure of P. aeruginosa to copper and zinc confers resistance to 
carbapenems through the downregulation of the OprD porin by CopRS and 
CzcRS 319,320, the possible presence of a similar mechanism in B. cenocepacia 
was investigated through use of the checkerboard assay (Fig 4.8). These assays 
confirmed that, similarly to P. aeruginosa, exposure of B. cenocepacia to copper 
or zinc significantly reduces its susceptibility to imipenem. While deletion of 
BCAM1417/8 or BCAS0585/6 did not appear to impact this phenomenon (Data 
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not shown), there were significant changes in this metal-dependent enhanced 
imipenem resistance in the ∆BCAM0442/3 and ∆BCAM0714/5 deletion mutants. 
While not completely removing the ability of copper to reduce susceptibility to 
imipenem, deletion of BCAM0442/3 did impact the extent of this copper-
dependent imipenem resistance. Conversely, deletion of BCAM0714/5 appeared 
to completely remove the link between zinc and imipenem resistance in B. 
cenocepacia, although the heightened susceptibility of the ∆BCAM0714/5 mutant 
to zinc limited the granularity of the checkerboard assay in this instance. As a 
result, these phenotypes were further explored by performing a 48 hour growth 
curve of relevant strains in the presence of specific concentrations of imipenem 
and metals (Fig 4.9). 
As seen in Figure 4.9, while exposure of both WT and ∆BCAM0442/3 B. 
cenocepacia to 0.5 mM CuCl2 reduces susceptibility to 32 µg/ml imipenem, the 
effect is somewhat negated in ∆BCAM0442/3. There is an equivalent reduction 
in susceptibility to imipenem when B. cenocepacia is exposed to 0.25 mM ZnCl2, 
and though deletion of BCAM0714/5 negatively impacts this phenomenon, it does 
not completely remove it. The combined results of Figures 4.8 and 4.9 suggest 
that while BCAM0442/3 and BCAM0714/5 have a role to play in the link between 
imipenem susceptibility and copper and zinc respectively, they are not essential 
to the phenomenon. As seen in the bottom half of Figure 4.9, there was variability 
in the ability of WT B. cenocepacia to grow in 32 µg/ml imipenem. This variability 
appeared to correlate with different batches of imipenem, suggesting batch to 
batch variability in the use of this antibiotic. Interestingly, in replicates that did 
have WT B. cenocepacia slightly growing in 32 µg/ml imipenem, the 
∆BCAM0714/5 deletion mutant did not grow, suggesting that while the 
established MICs of both strains to imipenem over 24 hours is 32 µg/ml (Table 
4.2), the respective MIC over a longer time course may be higher for WT B. 
cenocepacia than it is for the ∆BCAM0714/5 deletion mutant. 
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Figure 4.8: Preliminary checkerboard assays of different strains of B. 
cenocepacia grown in varying concentrations of imipenem against either 
copper or zinc. There is at least an eightfold increase in the imipenem MIC of B. 
cenocepacia when exposed to certain concentrations of copper or zinc. Deletion 
of BCAM0442/3 somewhat reduces this effect when exposed to copper, whereas 
deletion of BCAM0714/5 significantly inhibits this effect when exposed to zinc. 
Numbers shown display OD600 of each well with the relative blank subtracted. 
Blue shading is directly proportionate to OD600.  
 
 
 
 
Figure 28 
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Figure 4.9: Exposure of B. cenocepacia to subinhibitory concentrations of 
copper or zinc enhances imipenem resistance. Deletion of BCAM0442/3 
somewhat reduces this effect when exposed to copper, whereas deletion of 
BCAM0714/5 significantly inhibits this effect when exposed to zinc. n = 3 with 3 
technical replicates per assay. Error bars indicate SEM. 
 
Figure 29 
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Following on from the evidence that these TCSs are involved in enhanced 
resistance to imipenem, the growth kinetics of the double and triple TCS deletion 
mutants in imipenem were similarly investigated (Figs 4.10 and 4.11). There is a 
near total abolishment of the copper- and zinc-dependent enhanced imipenem 
resistance in the ∆BCAM0442/3 + ∆BCAM0714/5 deletion mutant, strongly 
suggesting that BCAM0442/3 and BCAM0714/5 interact together to aid in the 
facilitation of the metal-dependent enhanced imipenem resistance. Though figure 
4.10 suggests that the zinc-dependent enhanced imipenem resistance is 
completely lost in the ΔBCAM0442/3 + ΔBCAM0714/5 mutant, preliminary 
checkerboard assays suggest that the effect is still present, albeit heavily 
diminished (Data not shown). Interestingly, whilst the metal-dependent enhanced 
imipenem resistance is largely abolished in the ∆BCAM0442/3 + ∆BCAM0714/5 
double mutant, it is still evident in the triple deletion mutant (∆BCAM0442/3 + 
∆BCAM0714/5 + ∆BCAS0585/6). This suggests that BCAS0585/6 also has a role 
to play in this phenomenon, possibly acting in an opposing manner to 
BCAM0442/3 and BCAM0714/5.  
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Figure 4.10: Zinc-enhanced imipenem resistance is strongly diminished in 
the ∆BCAM0442/3 + ∆BCAM0714/5 deletion mutant. n = 3 with 3 technical 
replicates per assay. Error bars indicate SEM  
Figure 30 
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Figure 4.11: Copper-enhanced imipenem resistance is strongly diminished 
in the ∆BCAM0442/3 + ∆BCAM0714/5 deletion mutant. n = 3 with 3 technical 
replicates per assay. Error bars indicate SEM. 
Figure 31 
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4.2.5 – BCAM0442/3 may be involved with biofilm formation in B. 
cenocepacia 
 
Following on from investigations into the role of these TCSs of interest in copper- 
and zinc-induced resistance to imipenem in B. cenocepacia, the role that these 
TCSs may have in other virulence-associated phenotypes was investigated. The 
∆BCAM0442/3 deletion mutant had a reduced ability to form biofilms, whereas 
deletion of any other TCS did not impact biofilm formation (Fig 4.12). However, 
attempts to complement this phenotype using the pDA17-derived vector 
containing BCAM0442/3 with its native promoter were unsuccessful (Fig 4.12).  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.12: 48 hour biofilm assay of single TCS deletion mutants. 
∆BCAM0442/3 has an attenuated ability to form biofilms, though attempts to 
complement this have been unsuccessful. Strains were grown for 48 hours on a 
MBEC Biofilm Inoculator 96 peg-lid, which was subsequently stained with crystal 
violet to quantify biofilm formation. Crystal violet staining is shown relative to 
growth after 48 hours. *** = p < 0.001, one-way ANOVA with multiple 
comparisons, n = 3 with 8 technical replicates per assay. Error bars indicate SEM.  
Figure 32 
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Double TCS mutants were also subjected to the biofilm assay, which shows that 
all double TCS deletion mutants that have lost BCAM0442/3 are unable to form 
biofilms, appearing to suggest that BCAM0442/3 is indeed implicated in biofilm 
formation despite unsuccessful complementation (Fig 4.13). However, during the 
mutagenesis process for the double TCS deletion mutants, the successful 
BCAM0442/3-lacking mutants that were generated all stemmed from the original 
∆BCAM0442/3 deletion mutant (Fig 4.4). As such, if an undesired mutation in the 
original ∆BCAM0442/3 deletion mutant was the cause of the attenuation in biofilm 
formation ability, that same mutation would be present in these double TCS 
deletion mutants. This also means that the ∆BCAM0442/3 + ∆BCAM0714/5 + 
∆BCAS0585/6 triple deletion mutant would also be affected by this issue, and 
would presumably be attenuated in its ability to form biofilms. As such, it is 
currently unclear whether BCAM0442/3 has a role to play in biofilm formation in 
B. cenocepacia. 
 
 
 
 
 
 
 
 
 
Figure 4.13: 48 hour biofilm assay of double TCS deletion mutants. All 
double TCS deletion mutants stemming from the original ∆BCAM0442/3 mutant 
have attenuated abilities to form biofilms. Strains were grown for 48 hours on a 
MBEC Biofilm Inoculator 96 peg-lid, which was subsequently stained with crystal 
violet to quantify biofilm formation. Crystal violet staining is shown relative to 
growth after 48 hours. n = 3 with 8 technical replicates per assay. Error bars 
indicate SEM.  
Figure 33 
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4.2.6 – The metal-sensing MKN is important for virulence in G. mellonella 
 
Given their simplicity and ease of use, the G. mellonella greater wax moth larva 
is a useful model organism for the investigation of bacterial virulence, and as such 
was utilised to investigate potential virulence phenotypes for each TCS deletion 
mutant of interest. The virulence of WT B. cenocepacia was consistent 
throughout the assays, with 0 % larvae survival beyond 48 hours (Fig 4.14). 
Contrastingly, both ∆BCAM0442/3 and ∆BCAM1417/8 displayed attenuated 
virulence in G. mellonella (Fig 4.14). Attempts to complement this virulence 
phenotype of ∆BCAM0442/3 have been unsuccessful (Fig 4.15). There is an 
evident fitness cost for B. cenocepacia in harbouring the pDA17 vector, as can 
be seen by the reduced virulence of WT B. cenocepacia carrying pDA17 (Fig 
4.15). 
 
Figure 4.14: Virulence of WT and single TCS deletion mutants in G. 
mellonella. Both ∆BCAM0442/3 and ∆BCAM1417/8 display attenuated virulence 
in G. mellonella larvae. **** = p < 0.0001 log-rank (Mantel-Cox) test for 
comparison of WT and ∆BCAM0442/3 and WT and ∆BCAM1417/8 survival 
curves. n = 3 with 10 technical replicates per assay.  
 
 
Figure 34 
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Figure 4.15: Attempts to complement the G. mellonella virulence phenotype 
of ∆BCAM0442/3. There is an observable cost to virulence when B. cenocepacia 
harbours the pDA17 vector. There is no observable complementation of the 
virulence phenotype of ∆BCAM0442/3. n = 3 with 10 technical replicates per 
assay.  
 
Similarly to the single TCS deletion mutants, the virulence phenotypes of the 
double and triple TCS deletion mutants were investigated. Unsurprisingly, the 
deletion mutants lacking BCAM0442/3 all display attenuation in their virulence in 
G. mellonella, whereas the ∆BCAM0714/5 + ∆BCAS0585/6 deletion mutant 
shows only a mild reduction in virulence (Fig 4.16). Interestingly, the 
∆BCAM0442/3 + ∆BCAM0714/5 + ∆BCAS0585/6 deletion mutant, i.e. a deletion 
mutant of the entire metal-sensing MKN, shows a stark attenuation in virulence, 
with 27 % of larvae surviving beyond 96 hours post-infection (Fig 4.16). This 
reduction in virulence in the triple TCS deletion mutant is stronger than in any of 
the double TCS deletion mutants, suggesting that despite the inability to 
complement the virulence phenotype of ∆BCAM0442/3, this MKN is indeed 
associated with virulence in B. cenocepacia (Fig 4.16). 
 
 
 
Figure 35 
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Figure 4.16: Virulence of double and triple TCS deletion mutants in G. 
mellonella. There is a stark attenuation in virulence of the ∆BCAM0442/3 + 
∆BCAM0714/5 + ∆BCAS0585/6 deletion mutant in G. mellonella larvae. n = 3 
with 10 technical replicates per assay. 
 
4.2.7 – Investigation of intracellular survival of B. cenocepacia TCS deletion 
mutants within murine macrophages 
 
Intracellular survival of bacteria within eukaryotic cells is commonly assessed 
through the gentamicin protection assay, which utilises the poor permeability of 
eukaryotic cells to gentamicin to kill extracellular bacteria without affecting 
bacteria that have been internalised by the cell 463. Cells can then be lysed at 
specific timepoints to assess for intracellular survival of the bacteria in question. 
For this assay, the same gentamicin-sensitive deletion mutants that were 
employed in section 4.2.3 were used.  
During the gentamicin protection assay, macrophages were lysed at two 
timepoints: 2 hours and 24 hours post-infection, with bacterial recovery quantified 
through overnight growth of serial dilutions. Bacterial recovery at 24 hours post-
infection was also normalised against that at 2 hours post-infection, which aids in 
viewing the data in which any variations in bacterial uptake by the J774 
macrophages is normalised (Fig 4.17). The bacterial load of the extracellular 
media at each timepoint was also checked, showing that no extracellular bacteria 
Figure 36 
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survived gentamicin treatment during the assay, confirming that any recovered 
bacteria from the assay originated from within the macrophage (Data not shown). 
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Figure 4.17: Gentamicin protection assay of WT and single TCS deletion 
mutants of B. cenocepacia. Macrophages were lysed at 2 hours and 24 hours 
post-infection. The bacterial recovery from 24 hours post-infection standardised 
to 2 hours post-infection is also shown. n = 3 with 3 technical replicates per assay. 
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Comparison of the bacterial recovery as a percentage of input demonstrates that 
greater amounts of B. cenocepacia are recovered at 24 hours post-infection than 
at 2 hours. While statistical analysis using a one-way ANOVA did not find any 
significant differences in bacterial recovery between strains at either 2 hours or 
24 hours post-infection, there does appear to be a consistently greater recovery 
of the ∆BCAM0442/3 mutant than other strains. It is unclear why this may be the 
case, however standardising the bacterial recovery at 24 hours post-infection to 
the bacterial recovery at 2 hours post-infection suggests that the replication of the 
∆BCAM0442/3 mutant between timepoints is no different to that of other strains. 
It may be possible that there is a difference either in uptake of these strains by 
J774 macrophages, or that the ∆BCAM0442/3 mutant is able to adapt more 
quickly in the initial stages of infection than other strains. Additionally, though not 
statistically significant, standardising bacterial recovery from 24 hours post-
infection against 2 hours post-infection suggests a mild reduction in bacterial 
recovery from certain strains, particularly the ΔBCAM0714/5 and ΔBCAM1417/8 
deletion mutants (Fig 4.17). 
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4.3 – Discussion 
 
The work presented in this chapter focused on the generation and phenotypic 
characterisation of unmarked deletion mutants of each TCS of this metal-sensing 
MKN. Investigation of the sensitivity of these deletion mutants to a range of heavy 
metals revealed that ∆BCAM0442/3 was sensitive to copper, whereas as 
previously described, ∆BCAM0714/5 was sensitive to cadmium and zinc (Fig 4.5) 
(Robinson et al., Unpublished data). The metal-sensitivity phenotypes of these 
two TCSs were successfully complemented via use of the pDA17-derived 
expression vector containing the TCS genes downstream of their presumed 
promoter region (Fig 4.5). Conversely, ∆BCAM1417/8 and ∆BCAS0585/6 
displayed no observable differences in their sensitivity to any of the heavy metals 
tested (copper, cadmium, zinc, cobalt and silver) compared to WT B. 
cenocepacia. None of the deletion mutants that had lost multiple TCSs had any 
additional sensitivity to any of the metals tested (Table 4.1). These metal 
phenotypes were supported by investigation of the induction of putative promoter 
regions via transcriptional fusion to gfp, which revealed induction of the 
BCAM0442/3 promoter by copper, and induction of the BCAM0714/5 promoter 
by cadmium and zinc (Fig 4.7). Induction of BCAM0442/3 in response to copper 
and BCAM0714/5 in response to cadmium and zinc is BCAM0442/3-dependent 
and BCAM0714/5-dependent respectively (Fig 4.7). 
If cross regulation occurred between these TCSs in response to the metals 
tested, either at the protein-protein or at the transcriptional level, one may expect 
promoter induction to be influenced in various TCS deletion mutants. Though not 
fully clear from the data presented, there may be a reduction in the induction of 
the BCAM0442/3 promoter in response to copper in the ΔBCAM0714/5 deletion 
mutant, suggesting that BCAM0714/5 has a role to play in the regulation of 
BCAM0442/3 (Fig 4.7). Given the evidence presented in Chapter 3 that the 
BCAM0715 SK has the greatest propensity for non-cognate phosphotransfer, it 
may be that BCAM0715 can directly phosphorylate the RR BCAM0443 in 
response to copper, enhancing the transcriptional activation of its downstream 
regulon. Though there is no evidence presented in this chapter for copper-
dependent activation of BCAM0714/5, section 5.2.5 explores the activation of the 
BCAM0714/5 genomic neighbourhood in response to copper, which may serve 
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as some evidence that BCAM0714/5 does indeed respond to copper. If this non-
cognate phosphorylation of BCAM0443 by BCAM0715 is indeed physiologically 
relevant in vivo, it may be expected that the BCAM0443 promoter would also be 
induced in response to cadmium and zinc, both of which activate BCAM0714/5. 
However, in the presence of cadmium or zinc, the BCAM0442 SK is not activated, 
and would therefore presumably be acting as a phosphatase to BCAM0443, 
countering any non-cognate phosphorylation of the RR by BCAM0715. This 
phosphatase activity would not occur in the presence of copper, as the SK 
BCAM0442 would be activated and therefore be primarily phosphorylating 
BCAM0443.  
Given that BCAM0442/3 and BCAM0714/5 have clear links to the metal 
response, it is interesting that the remaining two TCSs do not, particularly in the 
case of BCAS0585/6, which is a clear part of this putative MKN as described in 
Chapter 3. It is important to note that though deletion of BCAM1417/8 or 
BCAS0585/6 does not confer observable sensitivity to the metals tested, this 
does not eliminate the possibility that these TCSs are involved in the response of 
B. cenocepacia to these metals in some way. It is possible that a TCS can be 
involved in the response to a particular metal, either through direct sensing of the 
metal or through regulation by a separate metal-responsive element, without a 
deletion mutant of that TCS necessarily being sensitive to that metal. As such, 
though there is no observable evidence that BCAM1417/8 or BCAS0585/6 are 
involved in the metal response, this possibility cannot be fully excluded. Indeed, 
despite the lack of empirical evidence, both TCSs (particularly BCAS0585/6) 
show significant homology to previously characterised metal-sensing TCSs. For 
example, out of all the TCSs in B. cenocepacia, the amino acid similarity of 
BCAS0585/6 to CopRS from P. aeruginosa is the greatest (34 % similarity 
between the SK BCAS0585 and CopS, and 65 % similarity between the RR 
BCAS0586 and CopR) 146. Despite this similarity and the high level of specificity 
residue similarity between BCAS0585/6 and BCAM0442/3 and BCAM0714/5 (Fig 
1.6), there is no other evidence to suggest that BCAS0585/6 is metal sensing. 
For example, there are no clear metal-binding sites on the periplasmic domain of 
the SK BCAS0585, such as the ExxE iron-binding motif and the CxxC copper-
binding motif 146. 
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As the potential role of BCAM1417/8 and BCAS0585/6 in the metal response 
remains unknown, different possibilities exist surrounding their role in B. 
cenocepacia. Interestingly, both BCAM1417/8 and BCAS0585/6 are located next 
to an RND-family efflux pump, perhaps suggesting that these TCSs are involved 
in the extrusion of a substance from the cell. Given that both BCAM0442/3 and 
BCAM0714/5 regulate genes in their immediate proximity (see Chapter 5), it may 
also be the case that BCAM1417/8 and BCAS0585/6 regulate their neighbouring 
RND-family efflux pump (BCAM1419-21 and BCAS0582-4 respectively). The 
inner membrane component of both of these efflux pumps is annotated with 
‘AcrB/AcrD/AcrF family, Interpro Accession IPR001036’ on the Burkholderia 
genome database, an annotation which is shared by the inner membrane 
component of the CzcCBA efflux pump 18. Interestingly, while CzcA is annotated 
with ‘Heavy metal efflux pump: CzcA family, Interpro Accession IPR004763’, 
there is no annotation on the BCAM1419-21 or BCAS0582-4 efflux pump that is 
suggestive of a role in metal extrusion 18. 
The inner membrane components AcrB, AcrD and AcrF from E. coli are 
implicated in the efflux of multiple antibiotics from the cell, which given their 
annotation, may in turn implicate these B. cenocepacia efflux pumps in the 
resistance to antimicrobials 464. However, though previous investigations of RND-
family efflux pumps in B. cenocepacia implicated several in the extrusion of 
antimicrobials, no evidence was found for either BCAM1419-21 or BCAS0582-4 
being involved in the extrusion of antimicrobials in B. cenocepacia 147,148. 
Additionally, a screen of single TCS deletion mutants against a range of 
antibiotics in this work revealed no observable reduction in antibiotic MIC, 
potentially arguing against a link between these TCSs are antibiotic resistance 
(Table 4.2). However, the deletion of a TCS does not equate to the deletion of 
the efflux pump; it is feasible that these pumps can still be functionally regulated 
without the presence of the neighbouring TCS. As such, one future direction to 
investigate these TCSs may be to delete the BCAM1419-21 and BCAS0582-4 
pumps both alone and alongside their neighbouring TCSs, allowing the direct 
comparison between antibiotic MICs of these deletion mutants. 
The evidence for a link between metal exposure and enhanced resistance to 
imipenem in B. cenocepacia presented here further reinforces the connection 
between heavy metals and antimicrobial resistance as discussed previously 
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(section 1.2.3). This is the first time that bacterial metal-dependent enhanced 
imipenem resistance has been demonstrated outside of P. aeruginosa, perhaps 
suggesting that this phenomenon is more prevalent across proteobacteria than 
previously thought. Given the use of carbapenems in the clinic, the growing use 
of copper as an antimicrobial surface in the clinic and the use of other metals, 
such as zinc, in medical devices, the link between metals and carbapenem 
resistance should be further explored. This includes both further characterisation 
of this phenomenon in P. aeruginosa and B. cenocepacia and exploring whether 
metal-dependent enhanced imipenem resistance exists in other clinically-
relevant bacteria.  
In terms of B. cenocepacia, it is clear that both BCAM0442/3 and BCAM0714/5 
have a role to play in this metal-dependent enhanced imipenem resistance, 
though the specific mechanisms at play are unclear. As the ∆BCAM0442/3 + 
∆BCAM0714/5 deletion mutant has the lowest (though not totally abolished) 
growth in imipenem supplemented with copper or zinc, it is suggestive of these 
two TCSs being critical players in this phenomenon. This is in parallel with 
previous studies in P. aeruginosa, in which the CzcRS and CopRS TCSs are both 
implicated in enhanced resistance to imipenem 320. Whether, as in P. aeruginosa, 
this resistance is mediated through the downregulation of an outer membrane 
porin is unknown. It has been shown that CzcR can directly regulate OprD 
through regulation of its promoter in P. aeruginosa, though whether CopR 
similarly directly regulates OprD or indirectly regulates OprD through an 
intermediary mechanism is unknown 320,438. These possibilities are also present 
for BCAM0442/3 and BCAM0714/5 in B. cenocepacia, however it is clear that the 
presence of these two TCSs are not essential for this phenomenon, as metal-
dependent resistance can still occur in the ∆BCAM0442/3 + ∆BCAM0714/5 + 
ΔBCAS0585/6 (see section 5.2.6 for a discussion on the transcriptional regulation 
of outer membrane porins in response to copper in B. cenocepacia). 
It is of particular interest that the triple deletion mutant ∆BCAM0442/3 + 
∆BCAM0714/5 + ∆BCAS0585/6, that is a deletion mutant of the entire putative 
MKN, shows greater levels of growth in imipenem supplemented with copper or 
zinc than the ∆BCAM0442/3 + ∆BCAM0714/5 deletion mutant. Though the single 
∆BCAS0585/6 deletion mutant did not show any differences in this metal-
dependent enhanced imipenem resistance relative to the WT (Data not shown), 
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the growth of the triple TCS deletion mutant suggests that BCAS0585/6 is 
somehow involved in this phenomenon. It may be that in the presence of 
BCAM0442/3 and BCAM0714/5, any impact that the loss of BCAS0585/6 has on 
this phenomenon is unobservable, however when BCAM0442/3 and 
BCAM0714/5 are not present (i.e. in the ∆BCAM0442/3 + ∆BCAM0714/5 deletion 
mutant), the presence of BCAS0585/6 acts to inhibit this phenomenon, again 
either through direct regulation of an outer membrane porin or acting via an 
intermediary mechanism. Evidence for regulators of this phenomenon outside of 
CopR and CzcR exists in P. aeruginosa; the MexT transcriptional regulator, which 
usually positively regulates an antimicrobial resistance-linked efflux pump, 
negatively regulates OprD, while the RNA chaperone Hfq is important for the 
regulation of OprD by both CzcR and CopR 320,436,465. It is clear that this MKN has 
a role in the resistance of B. cenocepacia to carbapenems, though as in P. 
aeruginosa, the precise mechanisms by which this occurs remain unclear, and 
there are likely to be additional regulators of this phenomenon existing outside of 
this metal-sensing MKN. 
Following on from the investigation of the link between this metal-sensing MKN 
and imipenem resistance, the role that these TCSs hold in various other cellular 
processes was examined. ∆BCAM0442/3, and double deletion mutants that have 
also lost BCAM0442/3, were heavily attenuated in their ability to form biofilms, 
however attempts to complement this phenotype with the pDA17-derived vector 
were unsuccessful (Figs 4.12 and 4.13). While the notion that all deletion mutants 
that have lost BCAM0442/3 are attenuated in biofilm formation ability supports 
the notion that BCAM0442/3 has a role to play in biofilm formation, the nature of 
the mutagenesis process led to both ∆BCAM0442/3 + ∆BCAM0714/5 and 
∆BCAM0442/3 + BCAS0585/6 deletion mutants being generated from the 
∆BCAM0442/3 single deletion mutant (Fig 4.4). As such, it is difficult to be 
confident in the idea that BCAM0442/3 is involved in biofilm formation, as if an 
undesired mutation that led to loss of biofilm formation occurred in the 
mutagenesis process during the generation of ∆BCAM0442/3, this undesired 
mutation will be present in the subsequent double and triple mutants as well.  
The impact that deletion of these TCSs has on virulence was investigated through 
use of the G. mellonella larvae model. This revealed an attenuation in virulence 
in both ∆BCAM0442/3 and ∆BCAM1417/8 (Fig 4.14). While the presence of 
144 
 
pDA17 did appear to confer a fitness cost to B. cenocepacia, attempts to 
complement the virulence phenotype of ∆BCAM0442/3 were also unsuccessful 
(Fig 4.15). Interestingly, the ∆BCAM0442/3 + ∆BCAM0714/5 + ∆BCAS0585/6 
deletion mutant was considerably more attenuated in their virulence than any 
other deletion mutant, providing strong evidence that this MKN is linked to 
virulence in B. cenocepacia (Fig 4.16). The reason for a link between metal-
sensing TCSs and virulence is unknown, though this has previously been 
demonstrated in P. aeruginosa, as a CzcRS deletion mutant is attenuated in 
virulence in a C. elegans model 438. The authors postulate that this is due to the 
positive regulation that CzcR has on quorum sensing in P. aeruginosa, which is 
an important factor in bacterial virulence 438. However, previous work established 
that there is no observable quorum sensing phenotype in a ∆BCAM0714/5 
deletion mutant (Robinson et al., Unpublished data), suggesting that this TCS is 
not associated with quorum sensing in B. cenocepacia. As BCAM0714/5 is part 
of a wider metal-sensing MKN, the role that BCAM0442/3 and BCAS0585/6 have 
in quorum sensing in B. cenocepacia should be further investigated, as the 
possibility that this MKN is associated with quorum sensing cannot be excluded. 
As outlined in Chapter 5, there is no clear induction of quorum sensing genes in 
B. cenocepacia in response to copper, perhaps arguing against a role for 
BCAM0442/3 in quorum sensing. Given that these metal-sensing TCSs are 
implicated in virulence, it would also be of interest to investigate whether 
exposure of B. cenocepacia to metals of interest, such as copper and zinc, affects 
virulence in G. mellonella larvae. 
Given the manipulation of metal availability by the immune system in killing 
internalised bacteria (section 1.2.4), the link between these TCSs and survival 
within murine macrophages was explored via the use of the gentamicin protection 
assay. As such, gentamicin-sensitive single TCS deletion mutants were 
generated. Two timepoints were performed for processing of macrophages in the 
gentamicin protection assay: 2 hours and 24 hours post-infection. Comparison of 
bacterial recovery between these timepoints clearly demonstrates that B. 
cenocepacia can replicate within J774 murine macrophages (Fig 4.17), 
supporting previous studies that have demonstrated both B. cenocepacia and B. 
multivorans replicating within macrophages 206,208,466. There was no statistically 
significant difference in bacterial recovery between these timepoints, nor when 
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comparing the level of bacterial recovery at the 24 hours post-infection 
standardised to 2 hours post-infection. 
While any difference between strains did not reach the threshold for statistical 
significance, there does appear to be a mild reduction in bacterial recovery for 
several gentamicin-sensitive deletion mutants, particularly ΔBCAM0714/5, 
relative to the WT when standardising bacterial recovery from 24 hours post-
infection against 2 hours post-infection (Fig 4.17). As this particular analysis of 
the data controls for any potential difference in bacterial uptake by the 
macrophages, any difference between strains may suggests an overall reduction 
in replication ability within macrophages. Given the range of toxic insults that 
internalised bacteria can be exposed to within the macrophage, it is unclear as to 
what role metal toxicity, i.e. the influx of copper and/or zinc into the 
phagolysosome, has to play in the killing of internalised B. cenocepacia cells. 
However, if the manipulation of metal availability in the phagolysosome is indeed 
a key part of killing of internalised B. cenocepacia, it may be that this metal-
sensing MKN has some role to play in the survival of B. cenocepacia within 
macrophages. Though there was no significant difference between the single 
TCS deletion mutants in the gentamicin protection assay, it may be the case that 
double or triple deletion mutants would harbour a much greater difference in 
survival relative to the WT. Given the already established links between these 
TCSs, deletion of a single TCS may not be enough to see any observable 
reduction in bacterial survival, as the detoxification systems that are presumably 
regulated by these systems may be induced by more than one TCS. As such, the 
generation and characterisation of gentamicin-sensitive double and triple TCS 
deletion mutants should be considered, which may give a clearer picture of the 
role of this metal-sensing MKN in the intracellular survival of B. cenocepacia. 
So far, the characterisation of this MKN has focused on the use of deletion 
mutants of each TCS, i.e. of both SK and cognate RR. The generation and 
characterisation of deletion mutants of the individual SK and RR proteins may 
reveal new insight into the functions and connections of these TCSs. For 
example, if the copper sensitivity phenotype of ΔBCAM0442/3 was still present 
in a ΔBCAM0442 deletion mutant then this would argue that activation of the 
regulon of BCAM0442/3 is dependent on the presence of the SK BCAM0442, i.e. 
that the RR BCAM0443 is not activated by any other agent in response to copper. 
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It would also be of benefit to assess the induction of the promoters of interest in 
pGA-G1 promoter vectors within these mutants. For example, is the presence of 
the BCAM0442 SK essential for induction of the BCAM0442/3 promoter in 
response to copper, or can another agent activate the BCAM0443 RR? Coupling 
the characterisation of single SK and single RR deletion mutants with the mutants 
generated within this work would provide a fuller picture of the hierarchy and 
connections of the proteins within this MKN. 
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4.4 – Conclusions 
 
• Characterisation of TCS deletion mutants implicates BCAM0442/3 in the 
copper response and confirms the implication of BCAM0714/5 in the 
cadmium and zinc response. 
• Exposure of B. cenocepacia to subinhibitory copper or zinc enhances 
resistance to imipenem. This mechanism appears to be closely 
associated with this metal-sensing MKN. 
• There is evidence to suggest that this MKN is associated with both 
biofilm formation and virulence in B. cenocepacia, though 
complementation of these phenotypes has not been achieved. 
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Chapter 5: RNA-seq analysis of the copper 
response of B. cenocepacia 
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5.1 – Introduction 
 
Given the evidence presented in earlier chapters that the cadmium/zinc and 
copper responses of B. cenocepacia are linked, exploring the transcriptomic 
profile of the bacterial response to different metals is of interest. As the 
transcriptomic response of WT and ∆BCAM0714/5 strains of B. cenocepacia 
K56-2 to zinc has previously been investigated (Robinson et al, Unpublished 
data), and as there has been no study that has investigated the transcriptomic 
response of B. cenocepacia to copper, this chapter aimed to utilise RNA-seq to 
assess the response of WT and ∆BCAM0442/3 B. cenocepacia K56-2 to copper. 
Firstly, this analysis would allow the characterisation of the copper response of 
B. cenocepacia, which given the varying exposure that clinically-relevant 
pathogens have to copper, is of particular relevance. Additionally, comparison of 
the transcriptomic profiles of WT and ∆BCAM0442/3 strains would theoretically 
provide an indication as to what BCAM0442/3 directly regulates, and also other 
genes that may be indirectly affected by deletion of this TCS. Any gene that is 
differentially expressed in WT, but not in ∆BCAM0442/3 B. cenocepacia, can be 
thought to be regulated, either directly or indirectly, by BCAM0442/3. 
While the transcriptional profile of the copper response in B. cenocepacia has not 
been previously characterised, transposon sequencing has identified several 
genes implicated in copper resistance 369. This includes the BCAM0442-50 gene 
region, as well as the BCAM0715 and BCAS0585 SKs, potentially implicating this 
metal-sensing MKN in the copper response of B. cenocepacia 369. Additionally, 
RNA-seq analysis of the copper response of P. aeruginosa has been performed. 
For example, P. aeruginosa grown in CuSO4 had increased expression of efflux 
pumps and genes associated with iron homeostasis, as well as decreased 
expression of outer membrane porins 242. The PA2809/10 TCS was also 
upregulated in response to CuSO4, with subsequent further investigation 
confirming the role of PA2809/10 in copper homeostasis, and as such was 
denoted as CopRS 242. Whether the transcriptomic profile of the copper response 
is similar between B. cenocepacia and P. aeruginosa is of interest, as it may 
provide insight into the evolutionary conservation of different strategies to 
withstand copper stress, and perhaps to heavy metal stress in general. 
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5.2 – Results 
 
5.2.1 – Establishing conditions for bacterial growth for RNA-seq analysis 
 
In order to assess the transcriptional profile of the copper response, it was 
important to select a non-lethal concentration of copper that would be sufficient 
to trigger the copper response, but would not trigger a larger stress response in 
the bacteria, and would not hamper growth. Based on growth curves (Fig 5.1), it 
was observed that 1 mM CuCl2 did not inhibit growth of WT or ∆BCAM0442/3 B. 
cenocepacia during log phase, and was therefore considered a suitable 
concentration for induction of the copper response. A total growth time of 8 hours 
was chosen to ensure bacteria reached mid log phase prior to harvesting of RNA. 
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Figure 5.1: Growth of WT and ∆BCAM0442/3 B. cenocepacia in LB with or 
without 1 mM CuCl2. Growth was performed in 10 ml volumes to replicate growth 
conditions prior to RNA harvesting. Error bars indicate SEM. 
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5.2.2 – Extraction of total RNA from B. cenocepacia 
 
Total RNA from each replicate was extracted using the RiboPure RNA 
Purification Kit (Thermo Fisher Scientific). To assess quality of total RNA, 
samples were run on a 1 % agarose gel (Figure 5.2), and a BCC-specific PCR 
was performed to check for gDNA contamination (Data not shown). Total RNA 
samples were then analysed on a 4200 TapeStation System (Agilent). RNA 
integrity ratings were assigned to all samples, with samples with a rating of 8 or 
greater being carried forward for sequencing. The RNA extraction for sample 1 
of ∆BCAM0442/3 – LB failed, and was repeated at a later date.  
 
Figure 5.2: Total RNA samples run on a 1 % agarose gel. 5 µl of each sample 
was loaded onto the gel and run as standard. Bands indicate the presence of 23S 
and 16S rRNA. Due to lack of availability of an RNA-based ladder, the ladder 
shown is a DNA-ladder. Expected size (bp): 23S rRNA – 2876, 16S rRNA – 1531 
bp. 
 
 
 
 
 
 
Figure 37 
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5.2.3 – Illumina sequencing results for the B. cenocepacia copper response 
 
Following sequencing and quantification of transcript levels by the Exeter 
Sequencing Service, replicates were clustered to assess for similarity. There is 
an outlier in the ∆0442/3_LB group of replicates, which does not cluster with any 
of the other groups (The TapeStation report can be found in Figure 5.3, while 
cluster analysis of replicates can be found in Figure 5.4). Interestingly, this outlier 
is the sample that was prepared separately to the other 11 samples due to the 
extraction of total RNA from a ∆0442/3_LB replicate failing. The large difference 
between this replicate and the remaining two raises questions surrounding why 
a bacterial culture grown in standard LB broth to a similar timepoint has a 
transcriptomic profile that is different to the remaining replicates. Nonetheless, 
the Δ0442/3_LB_A outlier passed all quality control checks (Fig 5.3). The 
remaining groups cluster well together (Fig 5.4). For all statistical analysis of the 
transcriptomic dataset, the ∆0442/3_LB_A outlier was included. While the 
presence of the outlier does reduce the number of significantly differentially 
expressed genes overall, the increased confidence in the data by including all 
three replicates warrants its inclusion. Table 5.1 lists the number of significantly 
differentially expressed genes in relevant comparisons of B. cenocepacia.  
Figur e 38 
 
Figure 5.3: Quality of RNA for ∆BCAM0442/3 – LB #1. Left – 23S and 16S 
rRNA peaks alongside nucleotide markers. The 23S:16S peak area ratio serves 
as an indicator of RNA sample quality. In this example, the ratio is 1.4. Right – 
Gel displaying both 16S and 23S rRNA, alongside the RNA integrity rating of 9.4. 
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Figure 5.4: Analysis of similarity of transcriptomic replicates. A) Principal 
component analysis of individual samples. Each group of samples clusters well 
apart from 0442_LB, which contains an outlier. B) Heatmap displaying the 
hierarchical clustering of samples. 0442_LB_A does not cluster with its replicates, 
while other groups cluster together.  
Figure 39 
154 
 
Table 5.1: Number of significantly differentially expressed genes of WT 
and ∆BCAM0442/3 B. cenocepacia when grown in LB with and without 1 
mM CuCl2. 9 
Sample comparison 
Significantly differentially regulated genes 
Upregulated Downregulated Total 
WT_Copper vs. WT_LB 551 551 1102 
∆0442/3_Copper vs. 
∆0442/3_LB 
68 106 174 
∆0442/3_LB vs. WT_LB 517 478 995 
∆0442/3_Copper vs. 
WT_Copper 
83 106 189 
Note: Significantly differentially expressed genes are defined as having an 
adjusted p-value of < 0.05 and a fold change of > 2. 
 
There is a large transcriptomic response to copper in WT B. cenocepacia, with 
1102 out of 7125 genes/pseudogenes being significantly differentially expressed, 
representing 15 % of the genome. The copper response of the ∆BCAM0442/3 
mutant appears more modest, though this has been negatively influenced by the 
outlier. Excluding the outlier from the analysis increases the total number of 
significantly differentially expressed genes between ∆0442/3_Copper and 
∆0442/3_LB from 174 to 250, suggesting that there is a loss of granularity of the 
∆BCAM0442/3 copper response due to this outlier. Surprisingly, there is also a 
large difference in transcriptomic profile between WT and ∆BCAM0442/3 when 
both are grown in LB without CuCl2, suggesting that the role of BCAM0442/3 in 
B. cenocepacia extends beyond the copper response. 
Out of 1102 differentially expressed genes in the WT_Copper to WT_LB 
comparison, 942 were successfully assigned a COG value using eggNOG-
mapper v1 467. 175 of these COG-assigned genes were assigned as ‘function 
unknown’, the majority of which were annotated in the J2315 genome as 
‘conserved hypothetical protein’ or as ‘putative exported/membrane protein’, 
while an additional 9 were ambiguously assigned two COG values. The COG 
values of remaining 758 differentially expressed genes can be seen in Figure 5.5. 
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Figure 5.5: Significantly differentially expressed genes in WT B. 
cenocepacia in response to growth in LB with 1 mM CuCl2 relative to growth 
in LB. Out of 1102 differentially expressed genes, 758 were assigned single COG 
values (excluding genes assigned ‘Function unknown’). The number of genes in 
each COG category is given in brackets on the y-axis. Each bar is split into 
upregulated genes (dark grey) and downregulated genes (light grey), with the 
total number of genes in each COG category shown in brackets. 
 
As displayed in Table 5.1, there are a large number of genes that are significantly 
differentially expressed in the comparison of both WT and ∆BCAM0442/3 B. 
cenocepacia grown in LB. A total of 995 genes are significantly differentially 
expressed, representing 14 % of the genome (Table 5.1). Removal of the 
∆0442/3_LB_A outlier increases this total to 1100 genes, suggesting that the 
outlier is not the cause of this difference in transcriptional profile to growth in LB. 
Of these 995 differentially expressed genes, 669 were also significantly 
differentially expressed in the comparison between WT grown with and without 1 
mM CuCl2. Interestingly, 667 of these 669 genes were differentially expressed in 
the same ‘direction’, i.e. within these 667 genes, the genes that were upregulated 
were upregulated in both comparisons. Unsurprisingly, the remaining genes were 
BCAM0442 and BCAM0443. This similarity suggests that the transcriptional 
Figure 40 
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profile of ∆BCAM0442/3 grown in LB shares particular similarity to WT B. 
cenocepacia grown in 1 mM CuCl2. In other words, for B. cenocepacia grown in 
LB, deletion of BCAM0442/3 confers a copper response-like state to the bacteria. 
This can also be seen when comparing the COG values of differentially 
expressed genes between both comparisons, which presents a similar 
transcriptional profile of differentially expressed genes (Figures 5.5 and 5.6).  
 
 
Figure 5.6: Significantly differentially expressed genes in ∆BCAM0442/3 B. 
cenocepacia in response to growth in LB relative to growth of WT B. 
cenocepacia in LB. Out of 995 genes, 814 were assigned single COG values 
(excluding genes assigned ‘Function unknown’). The number of genes in each 
COG category is given in brackets on the y-axis. Each bar is split into upregulated 
genes (dark grey) and downregulated genes (light grey), with the total number of 
genes in each COG category shown in brackets. 
 
5.2.4 – Upregulation of the BCAM0442/3 genomic neighbourhood 
 
The genes that underwent the greatest amount of upregulation in response to 
copper are those that are downstream of the BCAM0442/3 TCS (Table 5.2). The 
Figure 41 
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genes that are upregulated in the BCAM0442/3 gene region of WT B. 
cenocepacia can generally be split into two groups: BCAM0433-0436, which are 
orthologues of the CusABCF system, and BCAM0446-0450, orthologous to the 
Cop/PcoABCDE system (Fig 5.7).  
 
Table 5.2: Fold changes of significantly differentially expressed genes in 
the neighbourhood of BCAM0442/3 in WT and ∆BCAM0442/3 B. 
cenocepacia in response to copper. 10 
Gene name 
Predicted protein 
function 
Fold change 
(Copper vs LB) 
Fold change 
(∆0442/3 vs WT) 
WT ∆0442/3 LB CuCl2 
BCAM0432 Hypothetical protein 1.53 1.32 1.31 1.12 
BCAM0433 
Outer membrane protein 
(CusC) 
33.8 15.8 3.73 1.74 
BCAM0434 
Cation efflux protein 
(CusB) 
46.5 25.5 3.25 1.78 
BCAM0435 
Cation efflux system 
(CusA) 
12.4 24.9 0.75 1.51 
BCAM0436 
Periplasmic protein 
(CusF) 
126.8 64.3 1.00 0.50 
BCAM0437 
Na+/Ca2+ exchanger 
protein 
3.01 2.14 2.03 1.44 
BCAM0438 
Conserved hypothetical 
protein 
2.18 0.91 2.10 0.88 
BCAM0439 Cation efflux protein 1.75 1.15 1.67 1.10 
BCAM0440 
Conserved hypothetical 
protein 
0.39 1.83 0.30 1.41 
BCAM0441 
Major Facilitator 
Superfamily protein 
1.38 2.99 0.52 1.12 
BCAM0442 
Response regulator 
(CopR) 
21.0 1.00 0.07 0.01 
BCAM0443 Sensor kinase (CopS) 33.2 1.00 0.01 0.00 
BCAM0444 Hypothetical protein 1030.2 1.00 1.00 0.00 
BCAM0445 Hypothetical protein 62.4 1.00 1.00 0.03 
BCAM0446 
Outer membrane efflux 
protein (CopB) 
1464.7 0.24 7.00 0.00 
BCAM0447 
Exported multicopper 
oxidase (CopA) 
1460.5 2.07 4.19 0.01 
BCAM0448 
Periplasmic protein 
(CopE) 
1754.6 0.48 3.43 0.00 
BCAM0449 
Copper-resistance 
exported protein (CopC) 
352.3 1.68 1.86 0.01 
BCAM0450 
Copper-resistance 
membrane protein (CopD) 
231.3 1.00 1.00 0.01 
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BCAM0451 
Extracellular 
endo/exonuclease 
23.0 1.23 0.59 0.03 
Note: Gene names in brackets are suggested notations based on RNA-seq and 
sequence analysis. Shaded cells indicate genes that are not significantly 
differentially expressed in that comparison. Significantly differentially expressed 
genes are defined as having an adjusted p-value of < 0.05 and a fold change of 
> 2. 
 
 
Figure 5.7: Genomic neighbourhood of BCAM0442/3. Dark red arrows denote 
genes significantly differentially expressed in response to 1 mM CuCl2 relative to 
growth in unsupplemented LB in both WT and ∆BCAM0442/3 B. cenocepacia. 
Striped light red arrows denote genes significantly differentially expressed in WT 
but not ∆BCAM0442/3 B. cenocepacia. Grey arrows denote genes that are not 
significantly differentially expressed. 
 
The CusABCF system in E. coli confers resistance to both copper and silver, 
consisting of an RND-family efflux pump and a periplasmic copper chaperone 
343,344. The CusABCF system in E. coli is regulated by the upstream CusRS TCS 
468,469. The central transport protein CusA is an inner membrane protein that 
complexes with CusB, the MFP, which in turn complexes with the OMF CusC, 
ultimately allowing the transport of copper and silver ions from the cytoplasm out 
to the extracellular environment 343,344,470. CusF is a periplasmic 
metallochaperone that is able to bind Ag(I) and Cu(I) (but not Cu(II)) and deliver 
it to CusB, aiding to reduce copper and silver levels in the periplasm 344,471–473.  
Parts of the BCAM0433-0436 region share significant similarity to this CusABCF 
system of E. coli; the protein sequences of BCAM0434 and BCAM0435 share 
31.0 % and 62.6 % similarity to CusB and CusA respectively. In contrast, 
BCAM0433 shares just 17 % protein sequence similarity to CusC. This difference 
may be explained by the finding that, in contrast to CusA, CusB and CusF, the 
Figure 42 
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crystal structure of the E. coli CusC has no detectable Cu(I) or Ag(I) binding sites, 
implying that CusC does not contribute to the substrate specificity of the CusCBA 
RND-family pump 474. This may therefore allow significant variation in protein 
sequence of the OMF without hampering the ability of the RND pump as a whole 
to extrude copper or silver. This discrepancy in sequence similarity may mean 
that BCAM0433 in B. cenocepacia serves a functional purpose that CusC in E. 
coli does not, such as alteration of substrate specificity or variation in ion 
extrusion rate. It is also possible that an OMF of greater similarity to CusC lies 
elsewhere in the genome and is recruited to BCAM0434 and BCAM0435 in 
response to copper, however the proteins of greatest similarity to CusC in B. 
cenocepacia are not upregulated in response to copper. As such, it is likely that 
BCAM0433-0435 together form a CusCBA-like RND-family efflux pump.  
The E. coli CusF shares 27 % protein sequence similarity with BCAM0436 and 
22 % with BCAM0448. Both BCAM0436 and BCAM0448 are upregulated in 
response to copper, however BCAM0448 is upregulated much more strongly 
than BCAM0436 (1754.6 vs 126.8 fold change). Additionally, BCAM0448 is not 
upregulated in the ∆BCAM0442/3 mutant, whereas BCAM0436 is. Interestingly, 
BCAM0436 and BCAM0448 share 49 % protein sequence identity and are both 
predicted to be found in the periplasm, implying that they may share a similar 
function. Due to the higher sequence similarity, being within the same operon as 
CusCBA and also being upregulated in the ∆BCAM0442/3 mutant, it is likely that 
BCAM0436 fulfils the copper chaperone role in the CusABCF-like system, 
whereas BCAM0448 is part of a separate, BCAM0442/3-regulated system. 
It is clear that the CusABCF-like system in B. cenocepacia is still upregulated in 
the ∆BCAM0442/3 mutant. While the fold change of BCAM0434 in the 
∆BCAM0442/3 mutant is approximately in line with the operon as a whole, it is 
considered not significantly differentially expressed. This is due to the number of 
normalised counts for BCAM0434 in this comparison being below the threshold 
set in analysis, and therefore the upregulation cannot be considered significant. 
Despite this, it is fair to conclude that the CusABCF-like system is not directly 
regulated by the BCAM0442/3 TCS, and must be regulated by a separate copper-
responsive system. 
The Cop/Pco system of E. coli consists of seven proteins, Cop/PcoABCDERS. 
The system was originally identified on the pRJ1004 plasmid from E. coli isolated 
160 
 
from pigs fed a copper sulphate-supplemented diet, and denoted the Pco 
(plasmid-borne copper resistance) system 475,476. The Pco and Cop systems are 
homologous, and the names can be used interchangeably (the ‘Cop’ notation will 
be used herein to refer to Cop/PcoABCDERS). CopA is a periplasmic multicopper 
oxidase that oxidises Cu(I) into its less toxic Cu(II) form, while CopB is an outer 
membrane protein channel 353,477. CopC and CopE are periplasmic copper 
chaperones, whereas CopD is an inner membrane protein 477–479. These five 
proteins are regulated by the CopRS TCS 344,477. The particular interplay between 
these proteins within copper homeostasis is not fully clear, however expression 
of CopC and CopD together without the other components of the system in 
Pseudomonas syringae led to copper hypersensitivity, implicating these proteins 
in copper uptake 480. Additionally, fusion proteins of CopC and CopD have been 
identified in Gram-positive bacteria, reinforcing the idea of their shared functional 
aim 481. It therefore may be the case that CopC and CopD play a role in import of 
copper into the cell, while CopA, CopB and CopE ensure that potentially harmful 
excess copper is sequestered and extruded from the cell.  
The BCAM0446-0450 gene region is heavily expressed in response to copper in 
the WT, and contains proteins of predicted function similar to those found in the 
CopABCDE system. There are two membrane channels, one in the outer 
membrane (BCAM0446), and one in the inner membrane (BCAM0450), that are 
similar to CopB and CopD respectively. BCAM0447 is a periplasmic multicopper 
oxidase, BCAM0448 shares 49 % protein similarity to BCAM0436 (CusF) and 
BCAM0449 also may sit in the periplasm, making these genes candidates for the 
respective roles of CopA, CopC and CopE. Unlike the CusABCF system, there is 
no great protein sequence similarity between the E. coli CopABCDE genes and 
BCAM0446-0450. CopC shares 34 % similarity to BCAM0449, with the second 
greatest similarity being between CopD and BCAM0450 at 22 %. Nonetheless, 
given that the predicted function of the genes is similar to that of other 
CopABCDE systems, their proximity to each other in the genome and strong 
upregulation in response to copper, it is reasonable to conclude that these five 
genes form a CopABCDE-like system in B. cenocepacia. 
It is clear from Table 5.2 that while the CusABCF-like system is still upregulated 
in response to copper in the ∆BCAM0442/3 mutant, the CopABCDE-like system 
is not. The fold change difference when comparing the responses of both WT and 
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∆BCAM0442/3 B. cenocepacia to 1 mM CuCl2 is stark. As there is strong 
evidence to suggest that the BCAM0442/3 TCS directly regulates the 
CopABCDE-like system in B. cenocepacia, and that there are no other 
candidates for a CopABCDE-like system in B. cenocepacia, it is proposed that 
the BCAM0442/3 TCS should be denoted as CopRS. This annotation 
complements the suggestion that the BCAM0442/3 TCS and the downstream 
CopABCDE-like system in B. cenocepacia H111 are implicated in copper 
resistance via transposon sequencing analysis, reinforcing the significance of this 
gene region in the copper response of B. cenocepacia 369. 
Aside from the CusABCF-like and CopABCDE-like systems, other genes in this 
region are upregulated in response to copper. BCAM0437 is a predicted Na+/Ca2+ 
antiporter which is upregulated 3-fold in WT B. cenocepacia, however any 
potential role this may have in copper homeostasis is unclear. BCAM0444 is a 
hypothetical protein lying between BCAM0443 and another hypothetical protein 
which is strongly upregulated in WT B. cenocepacia in response to copper, 
however there is no evidence to suggest what its function may be. Given the RR 
BCAM0443-dependent stark upregulation of its neighbouring genes, it is perhaps 
surprising that the upregulation of the hypothetical protein BCAM0445 did not 
reach significance, particularly when considering that BCAM0445 appears to 
form an operon with the strongly upregulated CopB and CopA. BCAM0451, a 
predicted endonuclease/exonuclease that sits at the downstream end of the 
BCAM0442/3 neighbourhood, is another gene that undergoes BCAM0443-
dependent upregulation in response to copper, albeit not to the same extent as 
the CopABCDE-like system. Again, the potential involvement of BCAM0451 in 
the copper response is unclear. 
In order to assess the importance of the genomic neighbourhood of BCAM0442/3 
to copper resistance in B. cenocepacia, a ΔBCAM0433-50 deletion mutant was 
generated and tested for susceptibility to copper (Fig 5.8). Surprisingly, though 
ΔBCAM0433-50 was sensitive to copper, there was no greater susceptibility than 
in the ΔBCAM0442/3 deletion mutant (Fig 5.8). Given that the transcription of 
CopABCDE is BCAM0443-dependent, the major difference between these two 
deletion mutants lies in the CusABCF system, which is still fully active in 
ΔBCAM0442/3, but deleted in ΔBCAM0433-50. This suggests that CopABCDE 
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may play a more significant role in resistance to copper than CusABCF in B. 
cenocepacia. 
 
 
Figure 5.8: ΔBCAM0433-50 shows similar copper sensitivity to 
ΔBCAM0442/3. 10-1 to 10-5 dilutions of standardised overnight culture were 
spotted left to right on the plates. 
 
Overall, it can be concluded that B. cenocepacia employs both a CusABCF-like 
and a CopABCDE-like system in response to copper, of which the latter is 
controlled by the BCAM0442/3 TCS, now denoted CopRS. There are other genes 
that may appear to be directly regulated by CopRS in B. cenocepacia, but due to 
the issues with the outlier in the ∆0442/3_LB samples, it is difficult to infer with 
great certainty that this is the case outside of the downstream CopABCDE-like 
system. 
 
5.2.5 – Upregulation of the BCAM0714/5 genomic neighbourhood 
 
Interestingly, while the BCAM1417/8 and BCAS0585/6 TCSs were not 
significantly differentially expressed in response to copper, BCAM0714/5 was 
(Table 5.3). The upregulation of BCAM0714/5 was considerably milder than the 
upregulation of the BCAM0442/3 gene region, though there was greater 
upregulation of the downstream genes BCAM0716 and BCAM0718, as well as 
the upstream BCAM0711-13 efflux pump. The magnitude of the differential 
expression of these genes is largely linked to their orientation in the genome, and 
thus point towards the potential operons that they are composed of (Fig 5.9). 
Figure 43 
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BCAM0709 displays downregulation in WT and upregulation in the 
∆BCAM0442/3 mutant, and though the differential expression of BCAM0710 
does not reach significance, the raw fold changes show a similar pattern of 
expression. The BCAM0711-13 CzcCBA efflux pump and the BCAM0714/5 
CzcRS TCS are upregulated in both WT and ΔBCAM0442/3 B. cenocepacia, 
though the fold change of the RR BCAM0714 in WT B. cenocepacia is below the 
threshold for significance. The BCAM0716-21 downstream gene region shows 
considerable variation in gene expression in response to copper; the hypothetical 
protein BCAM0716 is upregulated in response to copper in both WT and the 
∆BCAM0442/3 mutant, whereas BCAM0717 is not, suggesting they form distinct 
operons. Interestingly, BCAM0715 and BCAM0716 were identified as being 
essential to the growth of B. cenocepacia H111 in copper by transposon 
sequencing, which reinforces the notion that these genes are involved in the 
response of B. cenocepacia to copper 369. The only other gene upregulated within 
the BCAM0716-21 region in WT B. cenocepacia is BCAM0718, while BCAM0721 
is downregulated in ∆BCAM0442/3 B. cenocepacia. The physiological benefit of 
this upregulation is unclear, though it supports the findings of the copper 
response in P. aeruginosa, which also had upregulation of both CzcRS and 
CzcCBA in response to copper 242. 
 
Table 5.3: Fold changes of significantly differentially expressed genes in 
the neighbourhood of BCAM0714/5 in WT and ∆BCAM0442/3 B. 
cenocepacia in response to copper. 11 
Gene name 
Predicted protein 
function 
Fold change 
(Copper vs LB) 
Fold change 
(∆0442/3 vs WT) 
WT ∆0442/3 LB CuCl2 
BCAM0709 Hypothetical protein 0.50 2.51 0.34 1.72 
BCAM0710 Metallopeptidase 0.53 2.31 0.36 1.56 
BCAM0711 
RND-family efflux pump 
(CzcC) 
8.20 12.9 0.43 0.67 
BCAM0712 
RND-family efflux pump 
(CzcB) 
4.97 11.7 0.48 1.12 
BCAM0713 
RND-family efflux pump 
(CzcA) 
5.12 10.7 0.78 1.63 
BCAM0714 Response regulator (CzcR) 1.95 2.64 0.95 1.29 
BCAM0715 Sensor kinase (CzcS) 4.39 6.25 0.78 1.12 
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BCAM0716 Hypothetical protein 88.7 15.0 0.89 0.15 
BCAM0717 
Putative Gram-negative 
porin 
2.60 8.80 0.79 2.68 
BCAM0718 Hypothetical protein 21.3 4.91 0.49 0.11 
BCAM0719 Hypothetical protein 36.3 0.89 1.85 0.05 
BCAM0720 
Hypothetical membrane 
protein 
1.00 1.53 0.92 1.41 
BCAM0721 
O-acetylhomoserine thiol-
lyase 
0.98 0.44 1.22 0.54 
Note: Gene names in brackets are suggested notations based on RNA-seq and 
sequence analysis. Shaded cells indicate genes that are not significantly 
differentially expressed in that comparison. Significantly differentially expressed 
genes are defined as having an adjusted p-value of < 0.05 and a fold change of 
> 2. 
 
Figure 5.9: Genomic neighbourhood of BCAM0714/5. Dark red arrows denote 
genes significantly differentially expressed in response to 1 mM CuCl2 relative to 
growth in unsupplemented LB in both WT and ∆BCAM0442/3 B. cenocepacia. 
Striped light red arrows denote genes significantly differentially expressed in 
either WT or ∆BCAM0442/3 B. cenocepacia. Grey arrows denote genes that are 
not significantly differentially expressed in response to 1 mM CuCl2. 
 
5.2.6 – The expression of other genes of interest in response to copper 
 
Aside from the CusABCF and CopABCDE systems in E. coli, the Cue system is 
another characterised copper-responsive system. This is comprised of the MerR 
family cytosolic regulator CueR, which directly senses copper and activates the 
expression of an inner membrane P-type ATPase CopA (not to be confused with 
the multicopper oxidase CopA of the CopABCDE system) and a periplasmic 
multicopper oxidase CueO 482–484. It is unknown whether a similar system also 
exists in B. cenocepacia, however possible orthologues for each gene are 
present in the genome. The predicted orthologues of CueR, CueO and CopA in 
Figure 44 
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B. cenocepacia, BCAL2309, BCAL2733 and BCAM2683, share 41 %, 29 % and 
35 % protein sequence similarity respectively to their predicted E. coli 
counterparts. BCAL2309 and BCAL2733 are not significantly differentially 
expressed in response to copper, whereas the predicted orthologue of the P-type 
ATPase CopA, BCAM2683, is strongly upregulated (Table 5.4). If a similar CueR 
system to E. coli exists in B. cenocepacia, it would be expected that the entire 
system is upregulated in response to copper, rather than a single component. 
Aside from BCAM0447, no other multicopper oxidase appears to exist within the 
B. cenocepacia genome, and while two other MerR family proteins are 
upregulated in response to copper, BCAL0054 and BCAL0602, neither show any 
particular sequence similarity to CueR from E. coli, arguing against the possibility 
of other genes being playing the role of CueO and CueR in a B. cenocepacia 
Cue-like system. Despite the uncertainties surrounding the mechanisms of its 
regulation, the CopA orthologue BCAM2683 is clearly heavily induced in 
response to copper, presumably aiding in detoxification of the cell through 
extrusion of copper from the cytoplasm into the periplasm. 
Another upregulated putative copper-resistance protein is BCAM2215, which is 
annotated as a ‘copper resistance protein C precursor’. Indeed, BCAM2215 
shares 40 % protein sequence similarity with BCAM0449, suggesting it may 
indeed act as a copper chaperone similar to CopC in B. cenocepacia. BCAM2215 
also shares 52 % similarity with BCAM2696, although BCAM2696 is not 
significantly differentially expressed in response to copper (Table 5.4). The 
neighbouring protein BCAM2216 is also upregulated in response to copper, 
though there is no clear link between BCAM2216 and any other copper-
resistance protein within B. cenocepacia. As such, while BCAM2215 likely acts 
as a copper chaperone within B. cenocepacia, the role of BCAM2216 in the 
copper response remains unclear. 
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Table 5.4: Fold changes of other various genes of interest in response to 
copper. 12 
Gene name 
Predicted protein 
function 
Fold change 
(Copper vs LB) 
Fold change 
(∆0442/3 vs WT) 
WT ∆0442/3 LB CuCl2 
BCAL2309 Orthologue of CueR 0.70 1.31 0.62 1.16 
BCAL2733 Orthologue of CueO 1.90 0.64 2.99 1.01 
BCAM2683 
Orthologue of CopA P-
type ATPase 
194.1 30.3 4.29 0.67 
BCAM2215 
Copper resistance 
protein C precursor 
11.2 2.31 5.66 1.16 
BCAM2216 Hypothetical protein 14.3 2.96 21.1 4.37 
BCAL2696 
Putative copper 
resistance protein 
1.06 0.31 1.34 0.39 
BCAL0604 
Putative heavy metal 
binding protein 
102.4 58.8 0.73 0.42 
BCAL0055 
Orthologue of CadA P-
type ATPase 
2.67 1.75 3.03 1.99 
BCAM0318 
Putative cation-
transporting ATPase 
3.22 0.71 5.17 1.14 
BCAL0534 
Response regulator 
(RqpR) 
4.81 1.09 4.90 1.11 
BCAL0535 Sensor kinase (RqpS) 3.67 0.58 5.81 0.92 
BCAM1493 
Response regulator 
(BceR1) 
2.14 1.68 1.60 1.26 
BCAM1494 Sensor kinase (BceS1) 1.55 1.43 1.79 1.64 
BCAM2723 
Putative outer 
membrane porin 
0.14 0.89 0.27 1.72 
Note: Shaded cells indicate genes that are not significantly differentially 
expressed in that comparison. Significantly differentially expressed genes are 
defined as having an adjusted p-value of < 0.05 and a fold change of > 2. 
 
Surprisingly, the CadA P-type ATPase, BCAL0055, is also upregulated in 
response to copper, albeit at a level much lower than the CopA P-type ATPase 
(Table 5.4). This is in contrast to the characterisation of CadA performed by 
Schwager and colleagues (2012), which found that the expression of CadA in B. 
cenocepacia H111 was induced by the presence of cadmium, lead and zinc, but 
not copper, and that deletion of the cadA gene did not result in an observable 
sensitivity to copper 368. Given the relatively mild upregulation of CadA in 
response to copper, it is likely that it does not play a significant role in the 
detoxification of the cell to copper, and deletion of this gene does not affect overall 
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sensitivity to copper. It is possible that the upregulation of CadA in response to 
copper serves a similar purpose to the upregulation of CzcCBA, that is the 
hypothesis that general extrusion of metal ions from the cytoplasm aids to reduce 
overall metal stress, thereby increasing the ability of the cell to withstand toxic 
concentrations of single metal species, in this case copper. 
Another heavily upregulated gene in response to copper is BCAL0604, a putative 
heavy metal binding protein. BCAL0604 shares 26 % protein sequence similarity 
with CopZ from B. subtilis, a copper chaperone known to interact with the P-type 
ATPase CopA, and also shares 31 % and 42 % similarity with cytoplasmic copper 
chaperones CopZ1 and CopZ2 from P. aeruginosa 485,486. Given this similarity, 
and the strong upregulation of BCAL0604 in response to copper, it is possible 
that BCAL0604 serves to sequester copper in the cytoplasm and deliver it to the 
CopA ATPase, where it is extruded into the periplasm. In addition to CadA and 
CopA, another putative ATPase is upregulated in response to copper, 
BCAM0318 (Table 5.4). While the upregulation of BCAM0318 is relatively mild at 
a 3 fold increase in expression in response to copper, this upregulation is lost in 
the ∆BCAM0442/3 B. cenocepacia mutant, perhaps indicating that the 
BCAM0442/3 system directly or indirectly regulates the expression of this 
ATPase.  
Of the characterised TCSs in B. cenocepacia listed in Table 1.1, two undergo 
some level of differential expression in response to copper (Table 5.4). The most 
notable of these is the RqpR RR BCAL0534, which is upregulated 4.8-fold in WT 
B. cenocepacia in response to copper but is not differentially expressed in the 
∆BCAM0442/3 mutant. The upregulation of the RqpS SK BCAL0535 did not 
reach the threshold for significance, but follows a similar pattern to BCAL0534. 
Given the role that RqpSR has in quorum sensing and pathogenicity, this 
upregulation, while mild, may point toward a link between the copper and/or wider 
metal response and these phenotypes in B. cenocepacia 428.  
Several gene loci that are pertinent to a range of important pathogenic 
phenotypes in B. cenocepacia are significantly differentially expressed in 
response to copper (Appendix Table A3.1). The BCAL0337-51 gene region, 
which encodes many putative T6SS proteins, is downregulated between 2-fold 
and 4-fold in response to copper in WT but not ∆BCAM0442/3 B. cenocepacia. 
Additionally, BCAL3517 and BCAL3525-6, which encode for T2SS proteins, are 
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also downregulated to a similar degree in response to copper, though 
surrounding T2SS genes are not. There is also differential expression of genes 
involved in chemotaxis and motility; gene loci including BCAL0520-27, 
BCAL0561-72 and BCAL3501-07 contain many genes associated with flagellar 
biosynthesis that are downregulated in response to copper, whereas many 
chemotaxis-associated genes, including genes within the BCAL0126-32 gene 
region, are upregulated in response to copper. Additionally, of 14 genes 
annotated with ‘putative universal stress protein’ or similar in B. cenocepacia, four 
were upregulated (BCAM0290-92 and BCAM1829), while one was 
downregulated (BCAL2268), perhaps suggesting that these genes are involved 
in the wider stress response to copper. 
There are numerous predicted outer membrane porins in B. cenocepacia; 
analysis of the J2315 genome encodes at least 45 putative porins, of which 7 are 
downregulated and 1 upregulated in response to copper in WT B. cenocepacia 
146. Given that the presence of certain metals leads to enhanced resistance to 
carbapenems in P. aeruginosa through downregulation of the OprD porin, and 
that this metal-inducible carbapenem resistance is also present in B. cenocepacia 
(Fig 4.8), it is possible that at least one of these downregulated porins is the 
equivalent route of entry for carbapenems in B. cenocepacia, and as such is 
responsible for this resistance to imipenem 319,320. Of these 7 downregulated 
porins, only BCAM2723 displays any particular similarity to OprD in P. 
aeruginosa, sharing 32 % protein sequence similarity to OprD. BCAM2723 
undergoes a fold change of 0.14-fold in response to copper in WT, but is not 
differentially expressed in response to copper in the ∆BCAM0442/3 mutant 
(Table 5.4). Given the similarity to OprD and downregulation in response to 
copper, it is feasible to suggest that BCAM2723 serves the same role in 
carbapenem entry in B. cenocepacia as OprD does in P. aeruginosa. However, 
BCAM2723 is not differentially expressed in response to 1.5 mM ZnCl2 (Robinson 
et al, Unpublished data), a concentration that does lead to enhanced imipenem 
resistance (Fig 4.8). It is possible that a different porin serves this role that does 
not share any particular similarity to the OprD porin of P. aeruginosa, or that a 
separate mechanism that links the presence of metals with carbapenem 
resistance exists that is porin-independent.  
169 
 
Many genes within the low-oxygen-activated locus (BCAM0275a-0323), which 
contain genes associated with the viability of B. cenocepacia in low-oxygen 
environments, were upregulated in response to copper 487. Interestingly, the 
abundance of several proteins encoded by this locus was increased in sequential 
isolates from chronically infected CF patients, while deletion of this gene region 
also significantly reduces the attachment of B. cenocepacia to epithelial cells, 
suggesting that these genes are associated with adaptation of B. cenocepacia to 
the CF lung 488. Two genes within the flp type pilus-encoding BCAL1525-32 
region were also upregulated in response to copper, further linking adhesion to 
host surfaces and the copper response in B. cenocepacia. 
Perhaps unexpectedly, given the ability of copper to undergo Fenton chemistry 
and generate ROS, there is little evidence for upregulation of oxidative stress-
related genes. No putative oxidative stress-genes are differentially expressed in 
response to copper in WT or ∆BCAM0442/3 B. cenocepacia. As the growth 
condition of 1 mM CuCl2 does not negatively affect growth of B. cenocepacia (Fig 
5.1), it is possible that this copper concentration is not high enough to induce an 
oxidative stress response, as the previously discussed copper-detoxification 
systems, such as CusABCF and CopABCDE, can detoxify the cell without the 
need for the upregulation of oxidative stress-specific genes. 
Aside from genes that have been characterised at least in part in the literature, 
there are several uncharacterised genes that undergo significant upregulation or 
downregulation in response to copper in B. cenocepacia (Table 5.5). It is 
noteworthy that the genes that undergo the greatest levels of upregulation and 
downregulation in WT B. cenocepacia in response to copper often aren’t 
significantly differentially expressed in ∆BCAM0442/3 B. cenocepacia. This 
pattern is still true if the anomalous 0442_LB_A replicate is excluded from the 
relevant comparison, suggesting that this stark contrast between WT and 
∆BCAM0442/3 B. cenocepacia is a genuine phenomenon of the data. It is 
relatively unlikely that these genes are all within the direct BCAM0443 RR 
regulon, rather this data suggests that BCAM0443 acts as a global regulator for 
copper stress, both directly regulating the CopABCDE-like system and indirectly 
regulating a myriad of other genes. It is also of interest that no other genes in B. 
cenocepacia are upregulated as greatly as the BCAM0442/3 genomic 
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neighbourhood and the CopA P-type ATPase in response to copper, underlining 
their importance in copper homeostasis. 
 
Table 5.5: Fold changes of various uncharacterised genes that undergo the 
highest levels of differential expression in response to copper. 13 
Gene name Predicted protein function 
Fold change 
(Copper vs LB) 
Fold change 
(∆0442/3 vs WT) 
WT ∆0442/3 LB CuCl2 
Upregulated genes 
BCAL1458 Putative exported protein 47.6 0.46 20.9 0.2 
BCAM0626 
Putative DNA-binding 
protein 
41.0 1.49 29.5 1.08 
BCAL0883 
TetR family regulatory 
protein 
37.6 3.27 8.67 0.75 
BCAM2461 
Putative inosine-uridine 
nucleoside hydrolase 
34.7 2.02 16.4 0.96 
BCAM1669 Putative exported protein 33.7 2.17 9.47 0.61 
BCAL1921 Hypothetical protein 30.1 1.03 29.7 1.02 
BCAL3362 Putative oxidoreductase 30.1 1.37 30.7 1.41 
BCAM1259 
RNA polymerase sigma 
factor 
25.8 1.63 29.2 1.85 
Downregulated genes 
BCAM0628 
Putative phosphotyrosine 
protein phosphatase 
0.014 0.62 0.053 2.38 
BCAM1745 
Putative magnesium-
transporting ATPase 
0.025 0.67 0.094 2.52 
BCAL2352 Putative carbonic anhydrase 0.027 1.03 0.12 4.70 
BCAL1055 
Histidine transport system 
permease protein 
0.031 0.43 0.13 1.85 
BCAL3502 Flagellar biosynthetic protein 0.045 0.26 0.59 3.33 
BCAL1056 
Histidine transport system 
permease protein 
0.049 0.51 0.24 2.54 
BCAM2145 Putative GABA permease 0.059 0.78 0.16 2.2 
Note: Shaded cells indicate genes that are not significantly differentially 
expressed in that comparison. Significantly differentially expressed genes are 
defined as having an adjusted p-value of < 0.05 and a fold change of > 2.  
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5.3 – Discussion 
 
Given the presence of copper in the environment, its use in intoxicating 
internalised pathogens in the phagolysosome and as an antimicrobial surface in 
the clinic, bacteria are commonly exposed to copper in various situations, and 
understanding the mechanisms underpinning how bacteria respond to and resist 
this exposure is essential. While there have been transcriptomic analyses of the 
copper response in the environmental organism, P. aeruginosa, there is a lack of 
literature surrounding how the BCC responds to metal stress 242,486. This research 
presents the first transcriptomic profiling of the response of B. cenocepacia to 
copper, as well as the characterisation of the potential regulon of the copper-
sensing BCAM0442/3 TCS. 
Through harvesting, purification and sequencing of mRNA from both WT and 
∆BCAM0442/3 B. cenocepacia K56-2 grown to mid log phase in LB with and 
without 1 mM CuCl2, a concentration that did not negatively affect growth (Fig 
5.1), the response of B. cenocepacia to copper was characterised. In contrast to 
previous data of the response of B. cenocepacia to 1.5 mM ZnCl2, in which only 
54 genes were significantly differentially expressed (Robinson et al., Unpublished 
data), the response to 1 mM CuCl2 was much greater, with 1102 genes being 
differentially expressed, representing 15 % of the genome. In contrast, only 174 
genes were significantly differentially expressed in response to copper in the 
∆BCAM0442/3 deletion mutant, suggesting that this TCS is a key regulator in the 
B. cenocepacia copper response. However, an outlier in the LB-grown 
∆BCAM0442/3 mutant condition appeared to negatively affect the interpretation 
of the ∆BCAM0442/3 data; exclusion of the outlier from the analysis increased 
the number of significantly differentially expressed genes from 174 to 250, 
suggesting that the granularity of the data has been impacted by the presence of 
this outlier. Additionally, the comparison between the copper-exposed 
ΔBCAM0442/3 deletion mutant and copper-exposed WT only contained 189 
differentially expressed genes, which is lower than may be expected if 
BCAM0442/3 does indeed play a key role in the response of B. cenocepacia to 
copper. It is therefore difficult to ascertain to what degree the BCAM0442/3 TCS 
acts as a central regulator in response to copper in B. cenocepacia, though the 
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role it plays in regulating individual genes can still be assessed on a case by case 
basis. 
Despite the uncertainty surrounding the data arising from the ∆BCAM0442/3 
deletion mutant, a large number of genes are significantly differentially expressed 
in the comparison of the transcriptomic profiles of both the deletion mutant and 
WT B. cenocepacia grown in LB. 67 % of these significantly differentially 
expressed genes were similarly differentially expressed in the WT_Copper vs 
WT_LB comparison, suggesting that, when grown in LB, deletion of BCAM0442/3 
leads to copper response-like transcriptional changes in B. cenocepacia. This 
suggests that BCAM0442/3 appears to indeed act as a central regulator of the 
copper response in B. cenocepacia. However, the mechanism by which it fulfils 
this role is unclear. Rather than be essential for the transcriptional activation of 
many of these genes, it may be the case that the RR BCAM0443 acts to repress 
transcription. That is not to say that BCAM0443 directly represses these genes, 
it may be the case that BCAM0443 acts as an upstream player in a larger, 
unknown copper-responsive signalling pathway. One possibility is that 
phosphorylation of BCAM0443 by BCAM0442 leads to the negation of this 
repression, allowing the wider transcriptional response that is observable in the 
WT_Copper vs WT_LB comparison. If this is indeed the case, it is interesting that 
the CusABCF system and the BCAM0711-21 gene region do not seem to fall 
under this hypothetical system, as these genes are not significantly differentially 
expressed in the 0442_LB vs WT_LB comparison. 
Several copper-responsive genes that have previously been described in the 
literature in E. coli appear to also both exist and respond to copper in B. 
cenocepacia. Based on this work, nomenclature for several genes is proposed, 
namely the CusABCF system, the CopRS TCS and the CopABCDE system. The 
genes that showed the greatest upregulation constituted the CopABCDE system 
downstream of BCAM0442/3; genes within this region were upregulated between 
230-fold and 1754-fold in response to copper in WT B. cenocepacia, but were not 
significantly differentially expressed in response to copper in the ∆BCAM0442/3 
mutant or in the 0442_LB vs WT_LB comparison, suggesting that the 
BCAM0442/3 TCS directly regulates the CopABCDE system in B. cenocepacia.  
Another copper-associated system is the CusABCF system found upstream of 
BCAM0442/3, upregulated between 12-fold and 126-fold in response to copper 
173 
 
in WT B. cenocepacia. While there was some variation in the level of upregulation 
between WT and ∆BCAM0442/3 B. cenocepacia, this system was generally 
upregulated in both strains, suggesting that it is not under the direct regulation of 
BCAM0442/3.  
Outside of the BCAM0442/3 regulon, other copper-responsive genes are 
upregulated, such as the CopA P-type ATPase, CopC-like proteins and a CopZ 
orthologue. Surprisingly, the cadmium-extruding P-type ATPase CadA was mildly 
upregulated, suggesting that CadA is linked to the survival of B. cenocepacia to 
copper, perhaps through the extrusion of other heavy metals to reduce the overall 
metal stress on the cell. A summary of the major proteins associated with 
detoxification of B. cenocepacia to copper can be found in Figure 5.10. 
 
Figure 5.10:  Proteins of interest that are upregulated in response to copper 
in B. cenocepacia. Proteins are given three colours; green for those directly 
regulated by BCAM0442/3, blue for those directly regulated by BCAM0714/5, and 
grey for proteins not thought to be directly regulated by either. Protein-protein 
interactions or protein localisation that is unclear are labelled with question marks.  
 
 
 
Figure 45 
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The upregulation of the BCAM0711-13 CzcCBA efflux pump and the 
BCAM0714/5 CzcRS TCS in response to copper raises interesting questions 
surrounding their role in the copper response. As shown in Chapter 6, the 
CzcCBA efflux pump does appear to be implicated in the resistance of B. 
cenocepacia to toxic copper concentrations; one suggestion is that CzcCBA 
extrudes copper in addition to cadmium and zinc. Alternatively, the general 
extrusion of metals may benefit the cell in situations of copper stress through the 
reduction of overall metal stress, particularly in environments that contain high 
levels of multiple metals 320. It may be the case that exposure of B. cenocepacia 
to copper ‘primes’ the cell into preparing for the likely possibility of exposure to 
other toxic metals in the environment through upregulation of general 
detoxification systems. In P. aeruginosa, the expression of CzcCBA and CzcRS 
is also induced by copper, thought to be a result of the CopR RR binding to a ‘cop 
box’ upstream of the czcRS operon, thus inducing expression of the CzcRS TCS 
and the subsequent expression of CzcCBA 320. As the upregulation of CzcCBA 
and CzcRS in B. cenocepacia in response to copper remains in the 
∆BCAM0442/3 mutant, it can be concluded this upregulation in B. cenocepacia 
is not BCAM0443-dependent, and another mechanism links the copper response 
to the expression of these genes. 
The notion that upregulation of CzcCBA and BCAM0714/5 is BCAM0443-
independent raises various possibilities for how this upregulation occurs. Firstly, 
the SK BCAM0715 could directly sense the presence of copper and activate the 
RR BCAM0714, which would then upregulate the entire BCAM0711-21 gene 
region. Secondly, BCAM0714 could be phosphorylated by a non-cognate 
phosphodonor, be it a SK or a separate protein. Finally, a different transcription 
factor could bind and transcribe these genes in response to copper. The lack of 
sensitivity that the ∆BCAM0714/5 deletion mutant has to copper may argue 
against direct regulation of these genes by BCAM0714 in response to copper, 
though the relatively modest upregulation of these genes in response to copper 
may indicate that these genes are not particularly essential to the resistance of 
B. cenocepacia to copper, and deletion of BCAM0714/5 may not provide an 
observable copper-sensitive phenotype. Additionally, in response to zinc the 
upregulation of the genes within the BCAM0716-19 gene region are relatively 
similar (Robinson et al, Unpublished data), whereas there are significant 
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discrepancies in differential expression of these genes in response to copper, 
arguing against a direct regulation by BCAM0714. This latter point also suggests 
that it is unlikely that this upregulation is due to the phosphorylation of BCAM0714 
by a non-cognate donor in response to copper. This is also supported by the fact 
that no other predicted metal-sensing TCS is differentially expressed in response 
to copper. This somewhat questions the relevance of the non-cognate 
phosphotransfer observed in Chapter 3; if non-cognate phosphotransfer does 
indeed occur in vivo between BCAM0442 and BCAM0714, then it is unclear as 
to why BCAM0442/3-dependent upregulation of the regulon of BCAM0714 in 
response to copper is not observed. Perhaps the growth condition of 1 mM CuCl2 
is not great enough to stimulate the upregulation of BCAM0442 to a point in which 
phosphotransfer from BCAM0442 to BCAM0714 can overcome the presumed 
phosphatase ability of BCAM0715 to BCAM0714, and as such the BCAM0442/3-
dependent upregulation of these genes was not observed in these conditions. 
Equally, while there is upregulation of the SK BCAM0442 in response to copper, 
the RR BCAM0443 is also upregulated, meaning there are considerable levels of 
cognate RR available to sequester any phosphoryl groups from BCAM0442, 
hampering any potential non-cognate phosphotransfer to BCAM0714. 
As such, the possibility that remains is that a different transcription factor aside 
from the RRs BCAM0714 and BCAM0443 is responsible for the upregulation of 
these genes. The other RRs of interest, BCAM1418 and BCAS0586, are not 
differentially expressed in response to copper, suggesting that a transcription 
factor outside of these TCS may be responsible for this upregulation. Overall, 
while the expression of CzcCBA and CzcRS in B. cenocepacia in response to 
copper is similar to that in P. aeruginosa, these data suggest that the mechanisms 
by which this occurs are not shared between these species. 
As another environmental organism and opportunistic pathogen, it is of interest 
to compare the copper response of P. aeruginosa to the data presented above 
for B. cenocepacia. Due to differences in copper concentration and exposure 
times between previous studies exploring the copper response of P. aeruginosa 
and the work presented here, it is difficult to directly compare the transcriptional 
profiles of these bacteria in response to copper, though specific comparisons can 
still be informative. The proportion of genes that are differentially expressed 
appears to be larger in B. cenocepacia than P. aeruginosa; 7.5 % of P. 
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aeruginosa genes were differentially expressed (with a fold change of > 2) after 
2 hours of exposure to 0.5 mM CuSO4, whereas 15.5 % of B. cenocepacia genes 
were differentially expressed with a similar fold change 486. Similarly, following 
exposure of P. aeruginosa to 10 mM CuSO4 for 6 hours, 5.9 % of the genome 
was differentially expressed (with a fold change of > 3), compared to 7.6 % of the 
B. cenocepacia genome 242. While the differences in concentration and exposure 
times between these studies need to be considered, there is evidence to suggest 
that the copper response of B. cenocepacia is more extensive than that of P. 
aeruginosa. 
There are several similarities in the copper response between these bacteria, for 
example exposure to copper leads to upregulation of several efflux proteins and 
the downregulation of outer membrane porins 242,486. Interestingly, P. aeruginosa 
exposed to a ‘shock’ of 10 mM CuSO4 for 45 minutes upregulated several 
oxidative stress-associated genes, whereas P. aeruginosa which was ‘adapted’ 
to the same concentration for 6 hours did not, suggesting that induction of 
oxidative stress genes may be an acute response to the presence of high levels 
of copper, and that over time intracellular concentrations of copper decrease to 
the point at which oxidative stress genes are no longer upregulated 242. This 
notion is supported by the fact that B. cenocepacia that had been exposed to 1 
mM CuCl2 for 8 hours did not show induction of an obvious oxidative stress 
response, albeit the 10-fold lower copper concentration may alternatively suggest 
that oxidative stress response genes are not necessary at subinhibitory 
concentrations of copper. Another similarity between the copper response of P. 
aeruginosa and B. cenocepacia is the induction of PA2523/4, the orthologue of 
the BCAM0714/5 TCS, and PA2520-22, the orthologue of the CzcCBA efflux 
pump in B. cenocepacia in response to copper 242,486.  
While there are several similarities between the published P. aeruginosa copper 
response and the data presented here on B. cenocepacia, there are differences 
also. Iron homeostasis genes appear to be tightly regulated in P. aeruginosa in 
response to high levels of copper; pyoverdine biosynthesis was upregulated 
whereas genes associated with pyochelin were downregulated in response to 10 
mM CuSO4 242. Contrastingly, these genes were not differentially expressed in 
response to copper when P. aeruginosa was exposed to 0.5 mM CuSO4, 
suggesting that regulation of these genes in response to copper is concentration-
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dependent 486. While exposure of B. cenocepacia to 1 mM CuCl2 did not induce 
any differential expression of iron homeostasis genes, it is not to say that they 
would not be induced at higher levels of copper stress, though it appears that iron 
homeostasis genes do not play a critical role in the response of B. cenocepacia 
to copper. Interestingly, two genes associated with ornibactin, PvdA and OrbA, 
were upregulated in response to 1.5 mM ZnCl2 in B. cenocepacia (Robinson et 
al, Unpublished data). The reason for the discrepancy in iron homeostasis genes 
between the copper and zinc response of B. cenocepacia is unclear, though it 
does suggest that iron homeostasis has a role to play in the response to zinc, but 
not to copper, and it is of interest whether these genes would be induced by 
exposure to other metals. 
Comparing the transcriptional response of B. cenocepacia to copper and to zinc 
highlights the stark difference in magnitude of the two responses. With the same 
threshold for significance of having a fold change > 2, 15 % of the B. cenocepacia 
genome was differentially expressed in response to 1 mM CuCl2, yet only 0.76 % 
of the genome was differentially expressed in response to 1.5 mM ZnCl2 
(Robinson et al., Unpublished data). Given the general lack of transcriptomic data 
sets of the copper and zinc responses of various bacteria in the literature, it is 
unclear whether the copper response is usually considerably greater in 
magnitude than the zinc response. There is no current published transcriptomic 
data on the zinc response of P. aeruginosa, though exposure of Pseudomonas 
putida to 1.5 mM ZnSO4 led to differential expression of 10.4 % of the genome 
489. While there are likely to be interspecies differences, comparison of the zinc 
response of P. putida to the copper response of P. aeruginosa discussed above 
suggests that there is not a stark difference in the magnitude of the zinc and 
copper responses in these bacteria. If this is the case, then it raises interesting 
questions surrounding why the zinc response of B. cenocepacia is considerably 
milder than its copper response. 
Though the data presented above provides insight into both the overall response 
of B. cenocepacia to copper and the role that the BCAM0442/3 TCS has to play 
in such a response, interpretation of the data must consider that it provides a 
specific snapshot of how B. cenocepacia responds to a particular concentration 
(1 mM CuCl2) at a particular length of time (8 hours). As shown previously for P. 
aeruginosa, the transcriptomic profile in response to copper can vary significantly 
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depending on the particular conditions of growth; the concentration of copper 
used and the length of time of exposure to copper strongly influence the overall 
response and therefore the interpretation of any RNA-seq output 242,486. As such, 
it would be valuable to perform similar transcriptomic analyses at varying 
concentrations of copper. 1 mM CuCl2 was chosen as it did not confer any 
inhibitory effect on growth (Fig 5.1), thus implying that B. cenocepacia is not 
under significant levels of stress at this concentration. Alongside this data, 
observing how the transcriptomic response of B. cenocepacia changes with 
increasing levels of copper, particularly at levels which are inhibitory to the 
∆BCAM0442/3 mutant but not WT B. cenocepacia, would enhance our 
understanding of how B. cenocepacia adapts to copper-containing environments 
and the role of BCAM0442/3 in this adaptation. 
In addition to various copper concentrations, observing the early-stages of the 
transcriptomic response to copper would also be of value. As demonstrated for 
oxidative stress genes in P. aeruginosa, many genes may be differentially 
regulated in the initial stages of copper exposure, but not in the later stages of 
exposure 242. One reason for this may be that the initial regulation of these genes 
allows the cell to deal with the sudden presence of copper, while simultaneously 
enhancing the expression of specific copper-detoxification systems, such as 
CusABCF and CopABCDE. Understanding the different ‘phases’ of the copper 
response is crucial to building a greater picture of how bacteria are able to 
respond to this clinically-relevant metal, and future transcriptomic analysis of the 
copper response in B. cenocepacia should consider the utilisation of various 
copper concentrations and exposure times to account for these phases. 
Comparing the transcriptomic response of both WT and ∆BCAM0442/3 B. 
cenocepacia to copper has provided insight into the regulon of the BCAM0442/3 
TCS and the links between the copper and zinc response in B. cenocepacia. As 
such, comparing how different TCS deletion mutants respond to copper would 
provide further insight into whether individual TCSs have a role to play in the 
copper response, even if they don’t directly sense copper themselves, and to 
what degree the various metal responses of B. cenocepacia are linked. For 
example, while the BCAM0714/5 gene region is upregulated in response to 
copper in both the WT and ∆BCAM0442/3 mutant B. cenocepacia, it is uncertain 
whether that copper-induced upregulation would still be present in the 
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∆BCAM0714/5 mutant. Any upregulation of the CzcCBA efflux pump or the 
downstream BCAM0716-21 gene region in response to copper in the 
∆BCAM0714/5 mutant would suggest that these genes are under the regulation 
of a different transcription factor, possibly linking the metal response to other 
cellular processes. 
In addition to assessing the copper response, exploration of the response of 
different mutants of B. cenocepacia to various metals is also a useful avenue of 
investigation. Given the upregulation of cadmium- and zinc-detoxifying genes in 
the presence of copper in B. cenocepacia, it may be the case that a number of 
systems are upregulated in response to a range of different metals, leading to a 
general detoxification of metals within the cell in order to reduce overall metal 
stress. Given the similarities between how different metals exert their toxic effects 
on bacteria, this general detoxification may be of benefit to many different 
instances of metal exposure. 
While transcriptomic profiling is an inherently powerful technique for 
understanding how a bacteria responds to a certain stimulus, its use for the 
elucidation of the regulon of specific TCSs is limited. Genes that are upregulated 
in a bacteria which are not in a TCS deletion mutant could be described as being 
under the regulation of that TCS, however as is seen above for the copper 
response of the ∆BCAM0442/3 mutant, there are hundreds of genes that are not 
differentially expressed in the mutant which are upregulated in the WT. As such, 
it is difficult to be truly confident in claiming that certain genes are or are not under 
the direct regulation of a TCS based on transcriptomic profiling alone. 
One methodology that could be employed to address this issue is chromatin 
immunoprecipitation sequencing (ChIP-seq), which allows the investigation of the 
DNA binding sites of proteins. Cross-linking between DNA and bound proteins, 
and eventual sequencing of bound DNA, enables the characterisation of which 
particular DNA sites a protein binds to under different conditions. For TCSs, a RR 
that binds to the putative promoter region upstream of a gene can be thought to 
directly regulate that gene under the conditions that the analysis took place in. 
ChIP-seq analysis has been used previously to assess the regulon of the 
BCAM0714 RR, which demonstrated that BCAM0714 regulates the CzcCBA 
efflux pump and the downstream BCAM0716-21 gene region in response to 1.5 
mM ZnCl2 (Robinson et al, Unpublished data). A similar approach could be taken 
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with the remaining RRs of this putative metal-sensing MKN; elucidation of the 
binding sites of each RR under various conditions would allow further insight into 
the regulon of each TCS, which would be of particular interest for the yet 
uncharacterised BCAS0585/6 TCS. When coupled with the RNA-seq data 
generated here, use of ChIP-seq may be a natural next step for investigation of 
this MKN. 
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5.4 – Conclusions 
 
• The response of B. cenocepacia to copper is stark, with 15 % of the 
genome being differentially expressed in response to 1 mM CuCl2. 
• The genes that undergo the highest levels of upregulation form a 
CopABCDE-like system, which appears to be under the direct regulation 
of BCAM0442/3. 
• The CzcCBA efflux pump, BCAM0714/5 TCS and BCAM0716/18 are 
upregulated in response to copper in a BCAM0442/3-independent 
manner. 
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Chapter 6: Investigation of a novel zinc 
resistance determinant within the BCAM0716-21 
gene region 
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6.1 – Introduction 
 
In the course of assessing the transcriptomic profile of B. cenocepacia K56-2 to 
1.5 mM ZnCl2, regions both upstream and downstream of the BCAM0714/5 TCS 
were shown to be heavily upregulated in response to zinc (Robinson et al., 
Unpublished data). The genes encoding the CzcCBA efflux pump, lying upstream 
of BCAM0714/5, were upregulated between 40-72 fold, and aid in the extrusion 
of cadmium and zinc from the cell (Robinson et al., Unpublished data). 
Contrastingly, the downstream BCAM0716-21 gene region, comprised mainly of 
hypothetical proteins, was upregulated between 6-256 fold (Table 6.1) (Robinson 
et al., Unpublished data). Additionally, ChIP-seq analysis of the BCAM0714 RR 
identified enrichment of this BCAM0716-21 region, suggesting that BCAM0714 
may regulate some or all of the genes within this region (Robinson et al., 
Unpublished data). Deletion of the BCAM0716-21 gene region conferred stark 
zinc sensitivity to B. cenocepacia, suggesting that a novel BCAM0714-regulated 
zinc-resistance determinant is present within this region (Robinson et al., 
Unpublished data).  
Though the putative Gram-negative porin BCAM0717 displays the greatest level 
of upregulation in response to 1.5 mM ZnCl2 of the genes in this region, 
BCAM0717 within B. cenocepacia K56-2 contains a 2 nucleotide deletion 
approximately 28 % along the coding region relative to the B. cenocepacia J2315 
reference sequence, resulting in a considerably longer transcript (386 amino 
acids in J2315 vs 581 in K56-2) (Fig 6.1) 146. As such, it is thought that BCAM0717 
does not act as a functional porin in B. cenocepacia K56-2.  
A motif search using MEME 490 identified a distinct motif upstream of BCAM0716 
and BCAM0717/8, as well as a closely-related motif upstream of czcC (Robinson 
et al., Unpublished data) (Appendix Figure A4.1). If this motif corresponds to a 
BCAM0714 binding site, this suggests that while BCAM0714 can regulate the 
BCAM0716-19 gene region, BCAM0720 and BCAM0721 are regulated by a 
separate zinc-responsive system (Fig 6.2) (Robinson et al., Unpublished data). 
This is supported by the fact that the fold changes of BCAM0720 and BCAM0721 
in response to zinc are considerably lower than the genes within the BCAM0716-
19 gene region (Table 6.1) (Robinson et al., Unpublished data). 
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Table 6.1: Differentially expressed genes in the BCAM0711-21 region in B. 
cenocepacia in response to 1.5 mM ZnCl2 (Robinson et al., Unpublished 
data). 14 
Gene name Predicted protein function Fold change 
BCAM0711 RND-family efflux pump (CzcC) 72.3 
BCAM0712 RND-family efflux pump (CzcB) 40.5 
BCAM0713 RND-family efflux pump (CzcA) 40.4 
BCAM0714 Response regulator (CzcR) 58.1 
BCAM0715 Sensor kinase (CzcS) 29.5 
BCAM0716 Hypothetical protein 136.2 
BCAM0717 Putative Gram-negative porin 255.6 
BCAM0718 Hypothetical protein 122.3 
BCAM0719 Hypothetical protein 132.6 
BCAM0720 Hypothetical membrane protein 44.0 
BCAM0721 O-acetylhomoserine thiol-lyase 6.4 
 
 
 
 
 
Figure 6.1: Differences between BCAM0717 in B. cenocepacia J2315 and 
K56-2. A 2 bp deletion within the BCAM0717 coding region in K56-2 increases 
the length of the BCAM0717 transcript. Binding motifs identified by MEME for 
BCAM0714 are denoted in blue. See appendix Figure A4.2 for the full alignment 
of DNA sequences of BCAM0717 from both B. cenocepacia J2315 and K56-2. 
 
Figure 6.2: The BCAM0716-21 gene region of B. cenocepacia J2315. Binding 
motifs identified by MEME for BCAM0714 are denoted in blue. 
Figure 46 
Figure 47 
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The work presented within this chapter surrounds the further investigation of this 
BCAM0716-21 gene region with the aim to identify the potential novel zinc-
resistance determinant that resides within it. This encompasses complementation 
of the ∆BCAM0716-21 deletion mutant with various combinations of genes 
alongside their native promoters in an attempt to identify which genes are 
necessary for restoration of the ability of ∆BCAM0716-21 to grow on zinc. Part of 
the work presented herein, namely conjugation of pDA17 containing various pairs 
of genes within this region into the ∆BCAM0716-21 deletion mutant, and the 
subsequent validation of these complemented strains, was performed in 
conjunction with Rebecca Tooze, an undergraduate project student whose work 
aligned closely with the focus of this chapter. 
 
6.2 – Results 
 
6.2.1 – Complementation of ∆BCAM0716-21 with the BCAM0716-21 gene 
region 
 
In the aim of complementing the zinc-sensitivity phenotype of the ∆BCAM0716-
21 deletion mutant, the BCAM0716-21 gene region was amplified and 
subsequently cloned into the pDA17 vector, replacing the native dhfr promoter of 
pDA17. An agarose gel displaying a digested pDA17::BCAM0716-21 vector can 
be found in Figure 6.3. Following successful sequence verification, the 
pDA17::BCAM0716-21 vector was conjugated into the ∆BCAM0716-21 deletion 
mutant. The conjugation of pDA17::BCAM0716-21 into ∆BCAM0716-21 partially 
restored the zinc sensitivity phenotype of the deletion mutant, confirming the 
notion that a novel zinc resistance determinant resides within the BCAM0716-21 
gene region (Fig 6.4). 
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Figure 6.3: Restriction digests of two pDA17::BCAM0716-21 candidates on 
a 1 % agarose gel. Following transformation into E. coli JM109 cells, 
transformant colonies were grown overnight and subsequently underwent 
plasmid extraction. The resultant plasmids were then digested with XbaI and NheI 
for one hour. Both candidates hold pDA17, though only candidate 2 contains the 
BCAM0716-21 gene insert. Expected sizes (bp): pDA17 – 6939, BCAM0716-21 
– 5903. Ladder = GeneRuler 1 kb plus. 
 
 
Figure 6.4: Conjugation of pDA17::BCAM0716-21 into the ∆BCAM0716-21 
deletion mutant partially restores the ability to grow on zinc. 10-1 to 10-5 
dilutions of standardised overnight culture were spotted left to right on the plates.  
 
Figure 48 
Figure 49 
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6.2.2 – Complementation of ∆BCAM0716-21 with single genes within the 
BCAM0716-21 gene region 
 
Following on from the successful partial complementation of the zinc sensitivity 
phenotype of ∆BCAM0716-21, the role that the individual genes within the 
BCAM0716-21 region held in this phenotype was explored. The individual genes, 
barring BCAM0717 due to the frameshift within its coding region, were each 
cloned into pDA17 downstream of the native dhfr promoter. While the generation 
of the pDA17::BCAM0720 vector was unsuccessful, the remaining four pDA17 
vectors were successfully generated and conjugated into ∆BCAM0716-21. None 
of the pDA17 vectors containing the individual genes (BCAM0716, BCAM0718, 
BCAM0719 and BCAM0721) complemented the zinc sensitivity phenotype of 
∆BCAM0716-21 (Fig 6.5). While it may be possible that complementation with 
BCAM0720 alone could restore the ability to grow on zinc, previous insertional 
inactivation of BCAM0720 in B. cenocepacia did not confer any zinc sensitivity, 
meaning that it is unlikely that BCAM0720 alone has a major role to play in this 
novel zinc resistance determinant (Robinson et al., Unpublished data). 
Additionally, complementation with individual genes using different means of 
expression via the alternative vectors pMLS7 (containing the Ps7 promoter) and 
the rhamnose-inducible pSCrhaB3 vector (both with and without 0.2 % 
rhamnose) was attempted, though this also did not result in any restoration of the 
ability to grow on zinc (Data not shown). 
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Figure 6.5: Conjugation of pDA17 containing individual genes within the 
BCAM0716-21 gene region into the ∆BCAM0716-21 deletion mutant does 
not restore the ability to grow on zinc. 10-1 to 10-5 dilutions of standardised 
overnight culture were spotted left to right on the plates 
 
6.2.3 – Complementation of ∆BCAM0716-21 with pairings of genes within 
the BCAM0716-21 gene region 
 
As conjugation of pDA17 vectors containing individual genes into the 
ΔBCAM0716-21 deletion mutant did not restore the ability to grow on zinc, larger 
portions of the gene region were cloned into pDA17 in an attempt to identify the 
general region of the novel zinc resistance determinant. As shown in Figure 6.2, 
the BCAM0716-21 gene region can be split into three portions based on gene 
orientation: BCAM0716-17, BCAM0718-19 and BCAM0720-21. As such, these 
three portions, as well as any upstream region that may contain a putative 
promoter, were cloned into pDA17 lacking the native dhfr promoter and 
subsequently conjugated into ΔBCAM0716-21.  
Interestingly, pDA17::BCAM0716-17 successfully restored the ability of 
ΔBCAM0716-21 to grow on zinc, whereas pDA17::BCAM0718-19 and 
pDA17::BCAM0720-21 did not (Fig 6.6). Though this does not exclude the 
Figure 50 
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possibility of the BCAM0718-21 gene region holding a role in the zinc response, 
there is a strong suggestion that the novel zinc resistance determinant within 
BCAM0716-21 lies within the BCAM0716-17 gene region. 
Further investigation of the BCAM0716-17 gene region revealed inconsistencies 
in the annotation of the B. cenocepacia J2315 and the B. cenocepacia K56-2 
genomes. In addition to the 2 nucleotide deletion within BCAM0717 in the K56-2 
genome relative to the J2315 reference genome, resulting in a longer BCAM0717 
protein than is annotated (580 amino acids in K56-2 compared to 368 amino acids 
in J2315) (Fig 6.1), a gene residing between BCAM0716 and BCAM0717 is 
annotated in the K56-2 genome, but not the J2315 genome, despite this gene 
region being identical in sequence between the two strains. Additionally, though 
annotated in the K56-2 genome as a 306 bp gene beginning with a GTG codon, 
an in frame ATG codon lies further upstream of this gene, which may potentially 
act as the start site, increasing its length to 444 bp. This gene is herein referred 
to as BCAM0716A. The current annotations of both the J2315 and K56-2 
genomes, and recommended alterations to the annotation of the BCAM0716-17 
gene region, can be found in Figure 6.7. 
 
 
 
 
 
 
 
 
 
 
 
 
190 
 
 
Figure 6.6: pDA17::BCAM0716-17 successfully restores the ability of 
ΔBCAM0716-21 to grow on zinc. 10-1 to 10-5 dilutions of standardised overnight 
culture were spotted left to right on the plates 
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Figure 6.7: Current and proposed annotations of the BCAM0716-21 gene 
region. The putative gene BCAM0716A should be included between BCAM0716 
and BCAM0717 in the J2315 genome, while the length of BCAM0716A and 
BCAM0717 should be extended in the K56-2 genome. Binding motifs identified 
by ChIP-seq for BCAM0714 are denoted in blue. 
 
Given that conjugation of the BCAM0716-17 region into the ∆BCAM0716-21 
deletion mutant restored the ability to grow on zinc, the generation of pDA17 
vectors containing different portions of the BCAM0716-17 region was attempted. 
Unfortunately, while pDA17::BCAM0716A-17 was successfully generated, 
attempts to create a vector containing just BCAM0716 downstream of its native 
promoter were unsuccessful. A pDA17::BCAM0717 vector was also created, 
which due to being in the opposite orientation, also included BCAM0716A from 
its ‘original’ GTG start site (though not with the ‘new’ ATG start site). As such, it 
'is unclear whether pDA17::BCAM0717 encodes just BCAM0717 or also 
BCAM0716A. While previous conjugation of pDA17::BCAM0716 into 
∆BCAM0716-21 did not restore the ability to grow on zinc, this BCAM0716 gene 
Figure 52 
192 
 
was downstream of the native dhfr promoter rather than its upstream gene region 
(Fig 6.5).  
Interestingly, conjugation of the BCAM0716A-17 gene region into ∆BCAM0716-
21 did not restore the ability to grow on zinc. This strongly suggests that either 
BCAM0716 alone is responsible for this resistance to zinc, and that 
complementation with the previous pDA17::BCAM0716 was not successful due 
to differences in expression level, or that the entire BCAM0716-17 gene region is 
necessary to restore the ability to grow on zinc. Strikingly, conjugation of 
BCAM0716A-17 into ∆BCAM0716-21 conferred sensitivity to cadmium, a 
phenotype also seen when pDA17::BCAM0717 was conjugated into the deletion 
mutant (Fig 6.6). The fact that cadmium sensitivity is not seen when BCAM0716 
is conjugated alongside BCAM0717 into ∆BCAM0716-21 suggests that 
BCAM0716 interacts with BCAM0716A or BCAM0717 in B. cenocepacia K56-2, 
preventing the cadmium sensitivity that is seen when BCAM0716A/17 are 
expressed on their own. 
The sensitivity to cadmium that conjugation of BCAM0716A-17 into ∆BCAM0716-
21 confers led to the investigation of whether this phenomenon was unique to 
cadmium, or whether an equivalent sensitivity to zinc was also present. As 
∆BCAM0716-21 showed limited growth on 5 mM ZnCl2, thus making it difficult to 
assess whether any complemented strains were more sensitive to zinc, relevant 
strains were spotted onto a 1.25 mM ZnCl2 plate (Fig 6.8). There is a clear 
sensitivity to zinc in the ∆BCAM0716-21 deletion mutant when conjugated with 
pDA17::BCAM0716A-17 and pDA17::BCAM0717, a sensitivity which is not seen 
when conjugated with the entire BCAM0716-17 gene region (Fig 6.8). This 
strongly suggests that either BCAM0716A is involved in sensitising the cell to 
these metals or, despite the large frameshift in its coding region, BCAM0717 is 
still involved with cadmium and zinc homeostasis in B. cenocepacia K56-2, 
perhaps through facilitating the influx of cadmium and zinc through the outer 
membrane. Additionally, as pDA17::BCAM0716-17 did not confer any metal 
sensitivity, it is likely that BCAM0716 is able to counteract this BCAM0716A/0717-
induced metal sensitivity (Figs 6.6 and 6.8). 
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Figure 6.8: Conjugation of BCAM0716A-17 into ∆BCAM0716-21 confers 
stark sensitivity to zinc. 10-1 to 10-5 dilutions of standardised overnight culture 
were spotted left to right on the plates 
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6.2.4 – A potential non-coding RNA between BCAM0715 and BCAM0716 is 
not involved with zinc resistance  
 
A genomics-based search for non-coding RNAs (ncRNA) in B. cenocepacia 
J2315 by Coenye and colleagues (2007) identified a potential 85 nucleotide-long 
ncRNA spanning the intergenic region between BCAM0715 and BCAM0716 491. 
This potential ncRNA is poorly conserved across the BCC, perhaps suggesting 
that it has no particular role in cellular function 491. Nonetheless, as the 
pDA17::BCAM0716-17 and pDA17::BCAM0716-21 constructs include this 
potential ncRNA, the role that this ncRNA may hold in the zinc resistance 
conferred by these gene regions was investigated. Two equivalent constructs 
lacking the potential ncRNA (i.e. starting at the final codon of BCAM0716, rather 
than continuing until the final codon of BCAM0715) were generated, denoted 
pDA17::BCAM0716-17 -ncRNA and pDA17::BCAM0716-21 -ncRNA. Both 
vectors lacking this potential ncRNA complemented the zinc sensitivity of 
∆BCAM0716-21 with equivalent efficacy to their ncRNA-containing counterparts, 
suggesting that this potential ncRNA does not have a major role to play in the 
zinc resistance determinant within BCAM0716-17 (Fig 6.9). 
 
Figure 6.9: The potential ncRNA does not appear to affect complementation 
of the zinc sensitivity phenotype of ∆BCAM0716-21. 10-1 to 10-5 dilutions of 
standardised overnight culture were spotted left to right on the plates 
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6.2.5 - ∆czcCBA, but not ∆BCAM0716-21, is sensitive to copper 
 
Based on the upregulation of the genes in the BCAM0711-21 gene region in 
response to copper outlined in Chapter 5 (Table 5.3), the ability of various 
deletion mutants related to this gene region to grow on copper was investigated. 
Surprisingly, while ∆BCAM0714/5 and ∆BCAM0716-21 showed no reduction in 
growth on copper, the previously generated ∆czcCBA mutant was sensitive to 
copper to a similar extent as the ∆BCAM0442/3 mutant (Fig 6.10). Interestingly, 
though a previously generated ∆czcCB mutant was also sensitive to copper, the 
sensitivity of ∆czcCB was lower than that of ∆czcCBA, suggesting that CzcA can 
function without CzcC or CzcB, either by itself or alongside other proteins, to 
extrude copper (Fig 6.11). While there is no complemented strain of ∆czcCBA, a 
∆czcCB mutant conjugated with a previously generated pDA17::czcCB vector 
appears to be slightly complemented in its ability to grow on copper (Fig 6.11). 
 
Figure 6.10: ∆czcCBA has a similar copper sensitivity phenotype to 
∆BCAM0442/3. 10-1 to 10-5 dilutions of standardised overnight culture were 
spotted left to right on the plates 
 
 
 
Figure 55 
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Figure 6.11: ∆czcCBA has greater sensitivity to copper than ∆czcCB. 
Conjugation of pDA17::czcCB into ∆czcCB appears to partially complement the 
copper sensitivity phenotype. 10-1 to 10-5 dilutions of standardised overnight 
culture were spotted left to right on the plates.  
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6.3 - Discussion 
 
Previous work has established that the BCAM0714/5 TCS directly regulates parts 
of the BCAM0716-21 gene region, and that deletion of this region resulted in stark 
zinc sensitivity to B. cenocepacia (Robinson et al., Unpublished data). Through 
systematic complementation of the ∆BCAM0716-21 deletion mutant, the work 
presented in this chapter provides further insight into the novel zinc resistance 
determinant located within this gene region. 
Conjugation of pDA17 vectors containing various pairings of genes within this 
BCAM0716-21 gene region resulted in identification of the BCAM0716-17 gene 
region as being likely to hold a novel zinc resistance determinant. There are three 
genes located within this region, BCAM0716, BCAM0716A and BCAM0717, the 
latter two of which overlap in opposite orientations within the genome. As 
conjugation of BCAM0716A/BCAM0717 into ∆BCAM0716-21 did not restore the 
ability to grow on zinc (Fig 6.6), it is likely that BCAM0716 is central to the novel 
zinc resistance determinant, acting either alone or in conjunction with 
BCAM0716A and/or BCAM0717. 
Annotated within the J2315 genome as a ‘Hypothetical protein’, the potential role 
that BCAM0716 holds in the zinc response is unclear. Interestingly, BCAM0716 
shares 41 % protein sequence identity with BCAM0718, and both are predicted 
to have a ‘Domain of unknown function (DUF4148), Interpro Accession 
IPR025421’ as listed on the Burkholderia genome database 18. Two other genes 
within B. cenocepacia, BCAL1236 and BCAS0573, are predicted to contain the 
DUF4148 domain, though neither gene is differentially expressed in response to 
copper or zinc, so their potential link to the metal response is unclear. Genes with 
the DUF4148 domain appear to exist throughout the Burkholderia genus and the 
wider Burkholderiales order, though there is no evidence to suggest what role this 
domain has to play either in the zinc response or wider cellular function 492.  
Being a relatively small protein at 95 amino acids in length, one possible 
explanation for the function of BCAM0716 (and possibly BCAM0718) may be that 
it acts as a zinc metallochaperone in B. cenocepacia. However, bacterial zinc 
chaperones are considered to be involved more in the shuttling of zinc to 
metalloproteins in situations of zinc limitation, such as ZigA from Acinetobacter 
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baumannii, 493,494 rather than situations of zinc toxicity, arguing against the idea 
that zinc metallochaperones may hold a role in protection of B. cenocepacia 
against zinc. Alternatively, BCAM0716 may act as a protein-folding chaperone, 
and given its proximity to the putative outer membrane porin BCAM0717 in the 
genome, it may be the case that BCAM0716 aids in the folding of BCAM0717 
within the periplasm. Given that the 2 nucleotide deletion of BCAM0717 in B. 
cenocepacia K56-2 results in only the first 109 amino acids of BCAM0717 in B. 
cenocepacia K56-2 matching that of the J2315 genome (out of a total of 386 
amino acids in J2315), it is relatively unlikely that BCAM0717 in B. cenocepacia 
K56-2 acts as a functional outer membrane porin 146. Indeed, no conserved 
domains of BCAM0717 in B. cenocepacia K56-2 were identified bar outer 
membrane porin domains residing in the original 28 % of the protein 495. 
That being said, given the evidence in Figure 6.6 that the BCAM0716-17 gene 
region is able to restore the ability of ∆BCAM0716-21 to grow on zinc, it may be 
the case that the longer transcript of BCAM0717 in B. cenocepacia K56-2 
encodes a protein that is still able to contribute to zinc resistance provided that 
BCAM0716 is also present, even if it is non-functional as a porin. Additionally, 
given that conjugation of BCAM0716A-17 into ∆BCAM0716-21 confers cadmium 
and zinc sensitivity, it may be the case that despite the large frameshift within B. 
cenocepacia K56-2, BCAM0717 can still facilitate the influx of cadmium and zinc 
(Figs 6.6 and 6.8). As this sensitivity is not seen when BCAM0716 is also 
conjugated alongside BCAM0717 and BCAM0716A it is likely that BCAM0716 
contributes to cadmium and zinc resistance, potentially through interacting either 
directly with BCAM0716A and/or BCAM0717 or through interactions with the 
metals of which BCAM0717 presumably facilitates the influx. This supports the 
idea that BCAM0716 assists the correct folding of BCAM0717, with BCAM0717 
contributing to cadmium and zinc resistance alongside BCAM0716, though 
without BCAM0716, the presence of BCAM0717 confers sensitivity. 
The other gene within the BCAM0716-17 gene region, BCAM0716A, is not 
currently annotated within the J2315 genome, despite being annotated in the 
K56-2 genome. Additionally, the annotation of BCAM0716A in the K56-2 genome 
may be missing the initial 138 bp of the gene, as an in frame ATG codon lies 
upstream of the currently annotated GTG start codon. As such it is not particularly 
clear whether BCAM0716A is a genuine gene or rather a potential open reading 
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frame that is not actually transcribed. As seen in Figure 6.7, a BCAM0714 binding 
motif lies between BCAM0716 and BCAM0716A, potentially meaning that 
BCAM0716A could be regulated by the BCAM0714 RR. However, BLAST 
searches of the protein sequence of BCAM0716A do not indicate any similarity 
with known protein sequences, nor does the annotated BCAM0716A in the B. 
cenocepacia K56-2 genome contain any particular functional or protein motif 
predictions, potentially signifying that BCAM0716A is not a genuine, transcribed 
gene 18. If BCAM0716A were a genuine protein, its function in the zinc response 
is unclear. If BCAM0716A does indeed play a role in the response to zinc then it 
presumably must be reliant on the presence of BCAM0716, as conjugation of 
BCAM0716A and BCAM0717 does not restore the ability of ΔBCAM0716-21 to 
grow on zinc (Fig 6.6). 
While there has been much focus on the BCAM0716-17 gene region, given the 
suggestion that a novel zinc resistance determinant resides within it, there is still 
the possibility that BCAM0718-21 also has a role to play in the response to zinc. 
While conjugation of the individual genes and orientation-guided pairings into 
ΔBCAM0716-21 did not restore the ability to zinc, it is possible that these genes 
work in conjunction with one another beyond the confines of their presumed 
operons to aid in the response to zinc. As such, complementation with a pDA17 
vector containing all four genes within BCAM0718-21 should be considered in the 
future to ascertain whether these genes do in fact have any relation to the novel 
zinc resistance determinant located within the BCAM0716-21 gene region. 
The work presented in this chapter has focused on complementation of the 
ΔBCAM0716-21 deletion mutant as the primary means of investigating the novel 
zinc resistance determinant in this region. In order to confirm whether the 
BCAM0716-17 region is indeed central to this determinant, deletion mutants of 
various genes and gene regions should be generated to assess the impact that 
loss of these genes has on the ability of B. cenocepacia to grow on zinc. Coupling 
data generated from relevant deletion mutants to the work presented here would 
hopefully refine the knowledge of the zinc resistance determinant within 
BCAM0716-21, as well as the potential contribution of other genes in this region 
to wider cellular function. 
Given the upregulation of various genes within the genomic neighbourhood of the 
BCAM0714/5 TCS in response to 1 mM CuCl2, including BCAM0716 and 
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BCAM0718 (Table 5.3), the ability of the ΔBCAM0716-21 deletion mutant to grow 
on copper was tested (Fig 6.10). While deletion of the BCAM0716-21 region does 
not confer sensitivity to copper, the previously generated ΔczcCBA and ΔczcCB 
mutants were sensitive to copper (Figs 6.10 and 6.11). As discussed in section 
5.3, functional explanations for the upregulation of cadmium- and zinc-effluxing 
genes in response to copper include the general detoxification of heavy metals 
from the cell, in order to reduce general metal stress in response to the presence 
of one metal, and also to anticipate and prepare for the presence of one metal in 
an environment which contains another. However, the stark sensitivity of 
ΔczcCBA to copper suggests that the CzcCBA efflux pump plays a much more 
central role in the detoxification of B. cenocepacia to copper than previously 
thought; presumably an efflux pump that was upregulated to specifically detoxify 
cadmium and zinc, even in the aim of reducing metal stress, would not be as 
essential to resistance to copper as CzcCBA appears to be in Figure 6.10. As 
such, it may be that CzcCBA directly extrudes copper from the cell, in addition to 
cadmium and zinc. Given that the ∆czcCBA mutant appears more sensitive to 
copper than the ∆czcCB mutant, it may also be the case that the inner membrane-
bound CzcA may be able to function to extrude copper without forming the full 
RND-family efflux pump with CzcCB (Fig 6.11). 
As BCAM0714/5 is known to directly regulate CzcCBA (Robinson et al., 
Unpublished data), it is surprising that while BCAM0714/5 is indeed upregulated 
in response to 1 mM CuCl2 (Table 5.3), the ΔBCAM0714/5 deletion mutant does 
not share the sensitivity to copper that ΔczcCBA does (Fig 6.10). This suggests 
that the transcription of the czcCBA genes is not under the sole regulation of 
BCAM0714, and that a separate transcription factor enables the upregulation of 
these genes in response to copper. As the upregulation of the CzcCBA efflux 
pump in response to 1 mM CuCl2 still occurs in the ∆BCAM0442/3 deletion mutant 
(Table 5.3), and that there is no evidence that BCAS0585/6 is involved in the 
response of B. cenocepacia to copper, it is likely that this additional control of 
CzcCBA lies outside of this heavy metal-sensing MKN. 
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6.4 – Conclusions 
 
• The novel zinc resistance determinant residing within BCAM0716-21 is 
located in the BCAM0716-17 region. 
• Alterations to the annotations of BCAM0716-17 gene region within the B. 
cenocepacia J2315 and K56-2 genomes are recommended. 
• The CzcCBA efflux pump has a role to play in the response to B. 
cenocepacia to copper, and its copper-dependent regulation is controlled 
by an unknown mechanism. 
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Chapter 7: Final discussion and concluding 
remarks 
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7.1 – Final discussion and concluding remarks 
 
The work described here has surrounded four putative metal-sensing TCSs in B. 
cenocepacia, predicted to form a wider MKN based on specificity residue 
analysis. Previous work has characterised the BCAM0714/5 TCS as being 
implicated in the cadmium and zinc response (Robinson et al., Unpublished data), 
while BCAM0442/3 was identified in a screen of copper-resistance genes in B. 
cenocepacia H111 369. Various methodologies have been employed in the aim of 
identifying whether these TCSs do indeed form a MKN, and what individual role 
these TCSs have in the metal response of B. cenocepacia. A visual summary of 
the current information known about this MKN can be found in Figure 7.1. 
 
 
 
 
 
 
 
 
 
 
Figure 7.1: The current model for the metal-sensing MKN in B. cenocepacia. 
Three TCSs in which non-cognate phosphotransfer is possible form a metal-
sensing MKN in B. cenocepacia. Though this MKN links the copper, cadmium 
and zinc responses of B. cenocepacia through BCAM0442/3 and BCAM0714/5, 
the role of BCAS0585/6 is unclear. This MKN is associated with metal-enhanced 
imipenem resistance, though it appears that BCAS0585/6 acts in an opposing 
manner to the other two TCSs. Additionally, this MKN is important for virulence 
of B. cenocepacia to G. mellonella larvae. 
Figure 57 
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By purifying relevant SKs tagged with NusA and untagged RRs, the potential for 
non-cognate phosphotransfer between these TCSs was investigated using the 
phosphotransfer assay. This led to the finding that non-cognate phosphotransfer 
is kinetically possible between the SKs and RRs of three of the four TCSs, 
BCAM0442/3, BCAM0714/5 and BCAS0585/6, suggesting that these three TCSs 
form a MKN. This also validates the notion that specificity residue analysis is a 
reliable tool of predicting non-cognate phosphotransfer between SKs and RRs. 
Additionally, the BCAM0715 SK appeared to have the greatest propensity for 
non-cognate phosphotransfer, with rates of phosphotransfer being similar for 
cognate and non-cognate RRs, perhaps signifying that BCAM0714/5 may act as 
a central hub within this metal-sensing MKN. 
Following on from the identification of the three TCSs that form a MKN, single, 
double and triple TCS deletion mutants were generated. This confirmed that 
BCAM0714/5 is implicated in the cadmium and zinc response, and also identified 
that the BCAM0442/3 TCS is implicated in the copper response. Transcriptional 
fusion of TCS putative promoters to gfp identified that BCAM0442/3 and 
BCAM0714/5 are induced by copper and cadmium/zinc respectively; this 
induction was lost in their respective TCS deletion mutants. Additionally, there 
appears to be a reduction of copper-dependent induction of the BCAM0442/3 
promoter in the ΔBCAM0714/5 deletion mutant, suggesting that transcriptional 
activation of BCAM0442/3 in response to copper is partially mediated by 
BCAM0714/5. As is the case with P. aeruginosa, growth curve analysis revealed 
that exposure of B. cenocepacia to subinhibitory copper or zinc reduces 
sensitivity to imipenem, and that this MKN plays a crucial role, but is not 
absolutely necessary, in this phenomenon. It also appears to be the case that the 
TCSs within this MKN play a role in virulence in the G. mellonella larvae model, 
with a deletion mutant of the entire MKN showing a stark attenuation in virulence 
compared to other deletion mutants. 
To further explore the role of BCAM0442/3 in B. cenocepacia, RNA-seq analysis 
was conducted on WT and ΔBCAM0442/3 B. cenocepacia grown with and 
without 1 mM CuCl2. This identified a large transcriptional response to copper, 
with 15.5 % of the genome being significantly differentially expressed. While 
concentration of copper and time of exposure were not identical to this study, this 
level of transcriptional response is comparatively larger than that observed for P. 
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aeruginosa, in which two studies demonstrated a transcriptional response 
involving 6-8 % of the genome 242,486. Several genes surrounding BCAM0442/3 
that are heavily upregulated in response to copper, including a CopABCDE-like 
system, the upregulation of which appears to be BCAM0442/3-dependent. As 
such, it is recommended that BCAM0442/3 now be denoted as CopRS. Many 
other genes were identified as being upregulated in response to copper, including 
the BCAM0714/5 genomic neighbourhood, perhaps suggesting that the general 
detoxification of the cell of heavy metals may confer protection against high 
concentrations of a single metal. 
Previous work identified that deletion of the downstream gene region of the 
BCAM0714/5 TCS, BCAM0716-21, conferred stark zinc sensitivity to B. 
cenocepacia. Chapter 6 of this work focused on the complementation of the 
ΔBCAM0716-21 deletion mutant with the aim of identifying the novel zinc 
resistance determinant located within. Conjugation of the BCAM0716-17 gene 
region, which also contains the hypothetical protein BCAM0716A, into 
ΔBCAM0716-21 restored the ability to grow on zinc, suggesting that the novel 
zinc resistance determinant resides within this gene region. Additionally, it was 
identified that the previously generated ΔczcCBA mutant was sensitive to copper, 
suggesting either that CzcCBA extrudes copper in addition to cadmium or zinc, 
or that detoxification of cadmium or zinc from the cell is crucial in the response of 
B. cenocepacia to copper. Surprisingly, ΔBCAM0714/5 was not sensitive to 
copper, suggesting that the copper-dependent upregulation of czcCBA is 
BCAM0714/5-independent. Additionally, the upregulation of czcCBA was still 
observed in the ΔBCAM0442/3 deletion mutant, suggesting that this upregulation 
is also BCAM0442/3-independent. 
Though this work has provided the first evidence that a metal-sensing MKN exists 
in B. cenocepacia, there are questions surrounding what the evolutionary 
advantage is to the cell in having a network of three TCSs that are able to undergo 
non-cognate phosphorylation with each other, rather than having three discrete, 
independent TCSs. The data presented here, such as the metal phenotypes of 
the TCS deletion mutants, the induction of the promoters via gfp transcriptional 
fusion vectors, the virulence phenotypes of each TCS and the RNA-seq analysis 
of the copper response, do not provide clear evidence that alludes to why this 
network exists. It is presumably the case that the stark similarity in specificity 
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residues between the RRs of these TCSs is due to evolutionary pressure to 
maintain this non-cognate phosphotransfer. Indeed, specificity residue similarity 
between putative metal-sensing TCSs is found throughout the BCC and the wider 
Burkholderia genus, suggesting that this MKN is indeed evolutionarily conserved. 
As such, there must be some benefit to the cell in maintaining non-cognate 
phosphotransfer, rather than allowing these TCSs to drift apart, forming three 
independent systems. Though this work has uncovered the key players in this 
network, future work should primarily focus on investigating why this metal-
sensing network exists in B. cenocepacia. 
For that objective, there are several avenues of investigation that could be 
followed to refine our knowledge of this network. To further explore the non-
cognate interactions that these TCSs share, several protein mutants could be 
generated, such as SKs that lack the ability to autophosphorylate, and SKs that 
are unable to act as phosphatases to their RRs. This would allow the investigation 
of whether SKs can act as phosphatases not just to their own RRs, but also to 
non-cognate RRs through use of the phosphotransfer assay; a concept which 
would further aid our understanding of the dynamics of this MKN. Additionally, 
employment of the BACTH methodology would permit the study of whether any 
non-phosphotransfer based interactions occur between these proteins, such as 
SK or RR heterodimerisation. 
One important further focus should be the generation and characterisation of 
deletion mutants of individual SKs and RRs, to further refine what contribution 
particular proteins provide to this MKN. All assays presented here that utilise TCS 
deletion mutants should be further performed with single SK or single RR deletion 
mutants. For example, a ΔBCAM0442 SK deletion mutant that is not sensitive to 
copper would strongly suggest activation of the RR BCAM0443 in a BCAM0442-
independent manner. Additionally, double and triple TCS deletion mutants that 
are gentamicin-sensitive could be generated, to further explore what function 
these TCSs have in the survival within immune cells. ChIP-seq analysis of each 
RR would allow the definition of the specific regulon of each TCSs, which coupled 
to RNA-seq analysis and gfp transcriptional fusion of putative promoters would 
give invaluable insight into the functioning of this MKN. Ultimately, there are many 
different avenues that could be taken in the future that would aid in the 
understanding of this novel heavy metal-sensing MKN. 
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Given the environmental impact of heavy metal pollution, the use of metals as an 
antibacterial strategy by the immune system and the clinical use of metals such 
as copper, understanding the regulators and effectors of bacterial metal 
resistance is vital. Overall, this work has generated evidence for the existence of 
a novel heavy metal-sensing MKN in B. cenocepacia, which is implicated in both 
resistance to carbapenems and in virulence. 
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A1 – Figures/Tables pertinent to Chapter 3 
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Figure A1.1: Quantification of phosphotransfer from pre-phosphorylated 
and subsequently purified SK. Each graph displays phosphotransfer from a 
single SK to multiple RRs in ‘1 SK-1 RR’ phosphotransfer reactions. n = 3 
independent experiments. Error bars indicate SEM. 
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A2 – Figures/Tables pertinent to Chapter 4 
 
 
Figure A2.1: Gentamicin-sensitive single TCS deletion mutants spotted on 
copper-, cadmium- and zinc-supplemented agar plates. 10-1 to 10-5 dilutions 
of standardised overnight culture were spotted left to right on the plates. The 
metal sensitivity of the gentamicin-sensitive mutants matches that of the regular 
single TCS deletion mutants (Fig 4.5). 
 
 
 
 
 
 
Figure 58 
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Figure A2.2: Relative fluorescence of 24 hour growth of B. cenocepacia 
TCS deletion mutants containing all pGA-G1 promoter vectors. Control 
refers to gentamicin-sensitive WT B. cenocepacia containing pGA-G1 lacking a 
promoter. Metal concentrations are as follows: CuCl2 – 1 mM, ZnCl2 – 1 mM, 
CdCl2 – 0.25 mM, AgNO3 – 5 µM, CoCl2 – 0.25 mM. n = 3 independent 
experiments with 3 technical replicates per assay. Error bars indicate SEM. 
 
 
 
 
 
 
 
Figure 59 
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A3 – Figures/Tables pertinent to Chapter 5 
 
Table A3.1: Fold changes of various genes that are pertinent to a range of 
virulence phenotypes in response to copper. 15 
Gene name 
Predicted protein 
function 
Fold change 
(Copper vs LB) 
Fold change      
(∆0442/3 vs 
WT) 
WT ∆0442/3 LB CuCl2 
Bacterial secretion systems 
BCAL0337 T6SS protein (TssL) 0.26 0.55 0.59 1.26 
BCAL0338 T6SS protein (TssK) 0.34 0.71 0.60 1.25 
BCAL0339 T6SS protein (TssJ) 0.30 1.10 0.41 1.49 
BCAL0340 Putative lipoprotein 0.53 0.70 0.71 0.94 
BCAL0341 T6SS protein (TssB) 0.51 0.68 0.83 1.12 
BCAL0342 T6SS protein (TssC) 0.38 0.78 0.58 1.17 
BCAL0343 T6SS protein (TssD) 0.34 0.80 3.30 7.75 
BCAL0344 T6SS protein (TssE) 0.33 1.07 0.42 1.36 
BCAL0345 T6SS protein (TssF) 0.33 0.91 0.49 1.35 
BCAL0346 T6SS protein (TssG) 0.32 0.68 0.65 1.40 
BCAL0347 T6SS protein (TssH) 0.35 0.85 0.63 1.53 
BCAL0348 T6SS protein (TssA) 0.34 0.83 0.64 1.58 
BCAL0349 
Putative outer 
membrane protein 
0.31 1.12 0.52 1.87 
BCAL0350 Hypothetical protein 0.24 0.83 0.41 1.41 
BCAL0351 T6SS protein (TssM) 0.25 0.97 0.36 1.39 
BCAL3515 
T2SS protein N 
(GspN) 
0.55 0.59 1.42 1.52 
BCAL3516 
T2SS protein M 
(GspM) 
0.90 0.38 2.49 1.05 
BCAL3517 T2SS protein L 0.39 0.88 1.01 2.28 
BCAL3519 
T2SS protein K 
(GspK) 
0.83 0.59 1.11 0.79 
BCAL3520 T2SS protein J (GspJ) 1.30 0.12 4.19 0.39 
BCAL3521 T2SS protein I (GspI) 0.91 0.68 2.51 1.87 
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BCAL3522 
T2SS protein H 
(GspH) 
3.26 0.32 4.39 0.43 
BCAL3523 
T2SS protein G 
(GspG) 
0.73 0.51 1.48 1.03 
BCAL3524 Putative T2SS protein 0.86 0.52 2.26 1.35 
BCAL3525 
T2SS protein F 
(GspF) 
0.29 1.56 0.43 2.30 
BCAL3526 
T2SS protein E 
(GspE) 
0.34 0.98 0.66 1.90 
BCAL3527 T2SS potein D (GspD) 0.56 0.85 0.58 0.91 
Flagella-associated genes 
BCAL0520 
Flagellar hook-length 
control protein (FliK) 
0.40 0.30 1.23 0.95 
BCAL0521 Flagellar protein (FliJ) 0.60 0.65 0.84 0.91 
BCAL0522 
Flagellum-specific 
ATP synthase (FliI) 
0.22 0.73 0.35 1.13 
BCAL0523 
Flagellar assembly 
protein (FliH) 
1.07 0.27 1.83 0.46 
BCAL0524 
Flagellar motor switch 
protein (FliG) 
0.14 0.41 0.58 1.74 
BCAL0525 
Flagellar M-ring 
protein (FliF) 
0.17 0.28 0.54 0.85 
BCAL0526 
Flagellar hook-basal 
body complex protein 
(FliE) 
0.14 0.24 0.44 0.77 
BCAL0527 Flagellar protein (FliS) 3.48 0.33 2.91 0.27 
BCAL0561 
Flagella synthesis 
protein (FlgN) 
2.46 0.74 1.68 0.50 
BCAL0562 
Negative regulator of 
flagellin synthesis 
(anti-sigma-28 factor) 
3.80 0.64 2.06 0.35 
BCAL0563 
Flagellar basal body 
P-ring formation 
protein (FlgA) 
0.41 0.19 1.14 0.53 
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BCAL0564 
Flagellar basal-body 
rod protein (FlgB) 
0.18 0.26 0.54 0.76 
BCAL0565 
Flagellar basal-body 
rod protein (FlgC) 
0.13 0.24 0.61 1.14 
BCAL0566 
Basal-body rod 
modification protein 
(FlgD) 
0.086 0.35 0.45 1.80 
BCAL0567 
Flagellar hook protein 
1 (FlgE1) 
0.13 0.36 0.59 1.56 
BCAL0568 
Flagellar basal-body 
rod protein (FlgF) 
0.12 0.51 0.51 2.26 
BCAL0569 
Flagellar basal-body 
rod protein (FlgG) 
0.14 0.59 0.44 1.84 
BCAL0570 
Flagellar L-ring protein 
precursor (FlgH) 
0.16 0.65 0.56 2.28 
BCAL0571 
Flagellar P-ring 
protein precursor 
(FlgI) 
0.26 0.53 0.61 1.26 
BCAL0572 
Peptidoglycan 
hydrolase (FlgJ) 
0.47 0.68 0.68 0.99 
BCAL3501 
Flagellar biosynthetic 
protein (FliR) 
0.094 0.81 0.22 1.94 
BCAL3502 
Flagellar biosynthetic 
protein (FliQ) 
0.045 0.26 0.59 3.33 
BCAL3503 
Flagellar biosynthetic 
protein (FliP) 
0.080 0.52 0.30 1.98 
BCAL3504 Flagellar protein (FliO) 0.20 0.22 2.29 2.55 
BCAL3505 
Flagellar motor switch 
protein (FliN) 
0.14 0.24 0.50 0.86 
BCAL3506 
Flagellar motor switch 
protein (FliM) 
0.13 0.25 0.43 0.81 
BCAL3507 Flagellar protein (FliL) 0.27 0.20 0.65 0.49 
Chemotaxis-associated genes 
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BCAL0126 
Chemotaxis protein 
(MotA) 
4.67 1.10 2.54 0.60 
BCAL0127 
Chemotaxis protein 
(MotB) 
4.45 0.92 2.59 0.54 
BCAL0128 
Chemotaxis two-
component RR 
(CheY) 
6.83 0.49 3.44 0.25 
BCAL0129 
Chemotaxis two-
component SK (CheA) 
2.88 0.66 2.20 0.50 
BCAL0130 
Chemotaxis protein 
(CheW) 
1.66 0.87 1.21 0.64 
BCAL0131 
Methyl-accepting 
chemotaxis protein 
1.64 0.65 1.47 0.58 
BCAL0132 
Chemotaxis protein 
methyltransferase 
(CheR) 
1.74 1.01 1.30 0.75 
Putative universal stress proteins 
BCAM0290 
Putative universal 
stress protein 
4.20 0.46 7.72 0.84 
BCAM0291 
Putative universal 
stress protein 
3.45 0.98 4.08 1.16 
BCAM0292 
Putative universal 
stress protein 
4.29 0.65 4.97 0.75 
BCAM1829 
Putative universal 
stress protein 
3.56 1.96 1.99 1.09 
BCAL2268 Putative stress protein 0.17 1.13 0.27 1.81 
Putative outer membrane porins 
BCAL0584 
Putative outer 
membrane porin 
0.19 0.54 0.51 1.40 
BCAL2615 
Putative outer 
membrane porin 
0.24 1.60 0.19 1.28 
BCAL3008 
Putative outer 
membrane porin 
0.16 1.27 2.49 0.92 
BCAM1015 Putative porin 0.50 0.66 1.00 1.32 
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BCAM2063 
Putative carbohydrate-
selective porin 
0.10 0.39 0.43 1.77 
BCAM2462 
Putative Gram-
negative porin 
3.37 2.62 2.97 2.30 
BCAM2723 
Putative outer 
membrane porin 
0.14 0.89 0.27 1.72 
BCAS0256 Putative porin protein 0.14 1.20 0.18 1.57 
Low-oxygen-activated locus genes 
BCAM0275a Hypothetical protein 1.17 0.83 1.69 1.20 
BCAM0276 
Putative universal 
stress protein 
1.78 0.71 2.74 1.10 
BCAM0277 Hypothetical protein 4.56 0.79 5.35 0.92 
BCAM0278 
Putative heat shock 
protein 
8.08 1.59 4.69 0.92 
BCAM0279 Hypothetical protein 1.84 0.51 4.11 1.14 
BCAM0280 
Putative phospholipid-
binding protein 
4.76 1.03 5.23 1.13 
BCAM0280A 
Conserved 
hypothetical protein 
5.17 1.15 5.38 1.20 
BCAM0281 
Putative sulfate 
transporter family 
protein 
2.48 1.41 1.65 0.94 
BCAM0282 
Conserved 
hypothetical protein 
3.09 1.14 2.46 0.91 
BCAM0283 
Putative lysine 
decarboxylase 
2.29 1.19 2.46 1.29 
BCAM0284 Putative cytochrome c 2.33 0.62 4.60 1.23 
BCAM0285 Hypothetical protein 1.84 0.58 2.93 0.91 
BCAM0286 
Putative alcohol 
dehydrogenase 
3.17 0.90 2.55 0.73 
BCAM0287 
CRP family regulatory 
protein 
0.57 0.58 1.26 1.28 
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BCAM0288 
Two-component 
regulatory system, RR 
protein 
1.09 1.10 1.13 1.13 
BCAM0289 
Two-component 
regulatory system, SK 
protein 
1.43 1.27 1.26 1.12 
BCAM0290 
Putative universal 
stress protein 
4.20 0.46 7.72 0.84 
BCAM0291 
Putative universal 
stress protein 
3.45 0.98 4.08 1.16 
BCAM0292 
Putative universal 
stress protein 
4.29 0.65 4.97 0.75 
BCAM0293 
Putative acetate 
kinase 
1.95 0.75 3.32 1.28 
BCAM0294 
Putative universal 
stress protein 
1.34 0.71 2.39 1.27 
BCAM0295 Hypothetical protein 2.74 0.64 4.06 0.94 
BCAM0296 
Acetoacetyl-CoA 
reductase 
2.32 0.84 3.76 1.36 
BCAM0297 
Putative poly(3-
hydroxyalkanoate) 
polymerase 
3.03 1.13 3.17 1.19 
BCAM0298 
Putative phosphate 
acetyl/butyryl 
transferase 
4.79 1.13 4.53 1.07 
BCAM0299 
Putative zinc-binding 
alcoholdehydrogenase 
15.38 1.18 12.19 0.93 
BCAM0300 
Metallo-beta-
lactamase superfamily 
protein 
1.42 0.66 2.59 1.20 
BCAM0301 
Putative membrane 
protein 
3.37 1.17 1.95 0.68 
BCAM0302 
Putative ABC 
transporter protein 
14.22 1.15 8.64 0.70 
218 
 
BCAM0303 
ABC transporter ATP-
binding membrane 
protein 
7.01 1.33 5.73 1.08 
BCAM0304 
Transporter system 
transport protein 
6.54 0.99 8.23 1.24 
BCAM0305 
Outer membrane 
transport system 
protein 
4.57 0.74 5.60 0.90 
BCAM0306 
Putative membrane 
protein 
1.98 0.34 3.24 0.56 
BCAM0307 Hypothetical protein 3.59 0.85 4.54 1.08 
BCAM0308 Hypothetical protein 3.56 1.20 4.44 1.50 
BCAM0309 
Putative cell division-
related metallo 
peptidase 
3.62 1.43 3.65 1.44 
BCAM0310 
Putative 
ribonucleotide 
reductase 
2.08 0.57 2.47 0.67 
BCAM0311 
Putative 6-
phosphofructokinase 
2.60 0.38 5.10 0.74 
BCAM0312 
Putative 
polysaccharide 
deacetylase 
2.02 0.47 3.95 0.93 
BCAM0313 
Putative exported 
protein 
1.94 0.68 3.83 1.34 
BCAM0314 Hypothetical protein 2.34 0.19 2.33 0.19 
BCAM0315 
Putative exported 
protein 
3.47 1.45 4.49 1.87 
BCAM0316 Hypothetical protein 2.37 0.60 3.17 0.80 
BCAM0317 
Putative membrane 
protein 
1.53 0.52 2.12 0.72 
BCAM0318 
Putative cation-
transporting ATPase 
3.22 0.71 5.17 1.14 
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BCAM0319 
Putative universal 
stress protein 
0.87 0.50 2.21 1.27 
BCAM0320 
Putative cytochrome 
b561 
1.52 1.17 1.24 0.96 
BCAM0321 Hypothetical protein 1.04 0.95 0.99 0.91 
BCAM0322 
Two-component 
regulatory system, RR  
protein 
0.99 1.08 0.86 0.93 
BCAM0323 
Two-component 
regulatory system, SK 
protein 
0.78 1.09 0.85 1.19 
Flp type pilus genes 
BCAL1525 Flp type pilus subunit 1.50 1.19 0.78 0.62 
BCAL1525a 
Putative flp type pilus 
leader peptidase 
1.92 1.01 1.38 0.72 
BCAL1526 
Putative flp type pilus 
assembly protein 
1.84 1.05 1.12 0.64 
BCAL1527 
Flp type pilus 
assembly protein 
1.25 0.74 1.11 0.66 
BCAL1528 
Flp type pilus 
assembly protein 
1.80 0.78 2.07 0.91 
BCAL1529 
Flp pilus type 
assembly-related 
protein 
1.43 1.07 1.47 1.10 
BCAL1530 
Flp pilus type 
assembly protein 
1.88 0.90 1.96 0.94 
BCAL1531 
Flp type pilus 
assembly protein 
2.05 1.09 1.74 0.92 
BCAL1532 
Flp type pilus 
assembly protein 
2.28 1.02 1.56 0.70 
Note: Shaded cells indicate genes that are not significantly differentially 
expressed in that comparison. Significantly differentially expressed genes are 
defined as having an adjusted p-value of < 0.05 and a fold change of > 2.  
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A4 – Figures/Tables pertinent to Chapter 6 
 
 
 
 
 
 
 
 
 
 
 
 
Figure A4.1: A conserved motif upstream of BCAM0714-potentially 
regulated genes.  A) A fully-conserved 6 bp inverted repeat is separated by a 
non-conserved sequence of 4 bp. B) A motif upstream of czcC is similar to the 
motif upstream of both BCAM0716 and BCAM0717/8. Analysis performed and 
figure generated by Dr Matthew Robinson using MEME 490. 
 
 
 
 
 
 
 
 
 
Figure 60 
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Figure A4.2: Alignment of BCAM0717 from B. cenocepacia J2315 and K56-
2. The two bp deletion within BCAM0717 from B. cenocepacia K56-2 is denoted 
with red bars. While BCAM0717 from B. cenocepacia J2315 is 1161 bp in length, 
BCAM0717 in B. cenocepacia K56-2 continues to the next in frame stop codon, 
resulting in an open reading frame of 1745 bp in length. Alignment created using 
Clustal Omega 1.2.4 496. 
 
 
 
 
 
 
Figure 61 
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A5 – List of primers 
 
Table A5.1 – List of primers pertinent to Chapter 3. 16 
Name Sequence (5’ – 3’) Enzyme 
site 
BCAM0442 F acgcggatcctcgcgcggcctgcgcccg BamHI 
BCAM0442 R acgcaagcttctaacgatcggcgccgcgcgga HindIII 
BCAM0443 F acgcggatcccggatactgatagtcgaagacg BamHI 
BCAM0443 R acgcaagctttcacgaacgatcctcgagcac HindIII 
BCAM0714 F acgcggatcccgaattctgattgtcgaggatg BamHI 
BCAM0714 R acgcaagctttcatgcggccgcgcc HindIII 
BCAM0715 F acgcggatccagcccgctgcggcggttcgc BamHI 
BCAM0715 R acgcaagctttcaggtgctgatggcggccgg HindIII 
BCAM1417 F acgcagatctgcgcgcttcgggctcg BglII 
BCAM1417 R acgcaagctttcagtgcagcgcgcgc HindIII 
BCAM1418 F acgcggatccaaagtgctgatcgtcgaagac BamHI 
BCAM1418 R acgcaagctttcatgcgcgccgctccg HindIII 
BCAS0585 F acgcggatcccgcacggcgctcgcgccg BamHI 
BCAS0585 R acgcaagctttcacgcagccggcggccggt HindIII 
BCAS0586 F acgcagatctcgcatcctgatagtcgaag BglII 
BCAS0586 R acgcaagctttcatgcgtcgtccttcgg HindIII 
BCAM0443 eGFP F acgcggtaccggtcggatactgatagtcgaagacg KpnI 
BCAM0443 eGFP R acgcaagctttcacgaacgatcctcgagcac HindIII 
BCAM0714 eGFP F acgcggtaccggtcgaattctgattgtcgaggatg KpnI 
BCAM0714 eGFP R acgcaagctttcatgcggccgcgcc HindIII 
BCAM1418 eGFP F acgcggtaccggtaaagtgctgatcgtcgaagac KpnI 
BCAM1418 eGFP R acgcaagctttcatgcgcgccgctccg HindIII 
BCAS0586 eGFP F acgcggtaccggtcgcatcctgatagtcgaag KpnI 
BCAS0586 eGFP R acgcaagctttcatgcgtcgtccttcgg HindIII 
eGFP F acgcggatccgtgagcaagggcgaggag BamHI 
eGFP R acgcggtacccttgtacagctcgtccatgc KpnI 
NusA F gaacgccagcacatggac - 
pQE80 F atcgggagaaattaactatgagaggatcgc - 
pQE80 R atcgctggatctatcaacaggagtccaag - 
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Note: Restriction site sequences are underlined. 
 
Table A5.2 – List of primers pertinent to Chapter 4. 17 
Name Sequence (5’ – 3’) Enzyme 
site 
Flanking primers utilised for generation of pGPI-SceI vectors 
BCAM0442/3 F1 agcttctagagagccgcgcgtcaatccgatccg XbaI 
BCAM0442/3 R1 gccgcgtcgtgcggctagc - 
BCAM0442/3 F2 gctagccgcacgacgcggcggtgaggcaggctgtccgt
g 
- 
BCAM0442/3 R2 agctgaattcggtcgatgccgccgg EcoRI 
BCAM0714/5 F1 agcttctagaggccagttcgagcagttg XbaI 
BCAM0714/5 R1 tcacgcattacccttgaagaaacc - 
BCAM0714/5 F2 ggtttcttcaagggtaatgcgtgacagcgcgggcggcta
cg 
- 
BCAM0714/5 R2 agctgcatgcgcggcaggcttcatgttccgc SphI 
BCAM1417/8 F1 agcttctagagtatttcccgcgcatcacg XbaI 
BCAM1417/8 R1 tccgcgtaaccggttaagg - 
BCAM1417/8 F2 ccttaaccggttacgcggatgcactgacggcggtcgcg - 
BCAM1417/8 R2 agctgaattcagcatgcgatcgacgcgaag EcoRI 
BCAS0585/6 F1 agcttctagactcgaaagttcgttcttcgc XbaI 
BCAS0585/6 R1 tcgtgctcacgttcaacc - 
BCAS0585/6 F2 ggttgaacgtgagcacgacgtcgcattcgtggggacatg - 
BCAS0585/6 R2 agctgaattcatgcacatgctgatctcgatca EcoRI 
Primers for PCR and sequence validation of deletion mutants 
BCAM0442/3 ScrnF cttggcggagatctcgatgtc - 
BCAM0442/3 ScrnR gaattcctcgcccgtatccgctc - 
BCAM0714/5 ScrnF gttgaccgtcaacctcgacc - 
BCAM0714/5 ScrnR cggcatagtcgatttgctcg - 
BCAM1417/8 ScrnF gctgctgtcgttgagctggtag - 
BCAM1417/8 ScrnR aagctgctgcacacgatcc - 
BCAS0585/6 ScrnF tcgaggaatcgggtttcagcgtc - 
BCAS0585/6 ScrnR gtgtcgctgtcgaaattcatgtccc - 
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dhfr F gagtgccacctttggcttag - 
dhfr R aatgcttaggccacacgttc - 
pGPI-SceI F tgctcaatcaatcaccggatcc - 
pGPI-SceI R gaacacttaacggctgacatgg - 
pDA17 F ttgttgtggggtaggcagtc - 
pDA17 R accgcttctgcgttctgat - 
BCR1 497 tgaccgccgagaagagcaa - 
BCR2 497 ctcttcttcgtccatcgcctc - 
Primers for the generation of the pDA17::0442/3 complementation 
vector 
BCAM0442/3 C F acgtgctagctggatgcgaaatcgggcagacag NheI 
BCAM0442/3 C R acgtggtacccacgcgctaacgatcggc KpnI 
Primers for the generation of pGA-G1 promoter-gfp fusion vectors 
BCAM0442/3 Pr F agctggatccggatgcgaaatcgggcagacagcgatc BamHI 
BCAM0442/3 Pr R agctggatccggtgaggcaggctgtccgtgattccag BamHI 
BCAM0714/5 Pr F agctggatcctgattcaaagtctcgattcgtaggttttcaag
c 
BamHI 
BCAM0714/5 Pr R agctggatccgttcggttctgcggtaacgg BamHI 
BCAS0585/6 Pr F agctggatcctgcgcgagccggcggcgttag BamHI 
BCAS0585/6 Pr R agctggatcccgccggctccgtcgcattcgtgg BamHI 
pGA-G1 F ccttcaccctctccactgacag - 
pGA-G1 R gctttactaagctgatccggtgg - 
Note: Restriction site sequences are underlined. 
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Table A5.3 – List of primers pertinent to Chapter 5. 18 
Name Sequence (5’ – 3’) 
Enzyme 
site 
BCAM0433-50 F1 acgttctagacgcacgagcatcccttcgt XbaI 
BCAM0433-50 R1 gggacgatctagcggcgg - 
BCAM0433-50 F2 
ccgccgctagatcgtccccccaaatcggaacccaaagg
g 
- 
BCAM0433-50 R2 acgtgaattcgactggatgcgctcgg EcoRI 
BCAM0433-50 
ScrnF 
tcgaggatcaggcggttgcg - 
BCAM0433-50 
ScrnR 
gcgcagtatctcgcggacc - 
Note: Restriction site sequences are underlined. 
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Table A5.4 – List of primers pertinent to Chapter 6. 19 
Name Sequence (5’ – 3’) 
Enzyme 
site 
BCAM0716 F atcggaattcatgaaaacggcaaaactcgca EcoRI 
BCAM0716 R atcgtctagacatgtggccggtcatcattg XbaI 
BCAM0718 F atcggaattcatgaacatcccgcgtccg EcoRI 
BCAM0718 R atcgtctagaacgttcaaagcaccgcgaa XbaI 
BCAM0719 F atcggaattcatgcgcaatgtcgcgaag EcoRI 
BCAM0719 R atcgtctagaatcggtgaaagcctgacgc XbaI 
BCAM0720 F atcggaattcatgacaccgaccgcgaa EcoRI 
BCAM0720 R atcgtctagacgtcaggctttcaccga XbaI 
BCAM0721 F atcggaattcatgaccgatcaggccaagc EcoRI 
BCAM0721 R atcgtctagagttgcgctcaaagctgcg XbaI 
BCAM16-21 F atcggctagcccggtcgatcatggacaatc NheI 
BCAM16-21 R atcgtctagactggttccaccgatcctgatc XbaI 
pDA17 F ttgttgtggggtaggcagtc - 
pDA17 R accgcttctgcgttctgat - 
pMLS7 F gaatcgggttagttggtggc - 
pMLS7 R catgcctgcaggtcgac - 
pSCrhaB3 F gtcagtaacgagaaggtcgc - 
pSCrhaB3 R gtcgtcgtcgtccttgtagtc - 
BCAM16-17 R agctggtaccgttggggctccttgctgg KpnI 
BCAM18-19 F agctgctagccatggtgtgtccctgaagttc NheI 
BCAM18-19 R atcgtctagaatcggtgaaagcctgacgc XbaI 
BCAM20-21 F agctgctagcacgacctggtagccgtcg NheI 
BCAM0717 R agctggtacccgcgtgctctccttgatctggg KpnI 
Note: Restriction site sequences are underlined. 
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